TW202411300A - Curable composition - Google Patents

Curable composition Download PDF

Info

Publication number
TW202411300A
TW202411300A TW112112312A TW112112312A TW202411300A TW 202411300 A TW202411300 A TW 202411300A TW 112112312 A TW112112312 A TW 112112312A TW 112112312 A TW112112312 A TW 112112312A TW 202411300 A TW202411300 A TW 202411300A
Authority
TW
Taiwan
Prior art keywords
independently
group
integer
formula
hydrogen atom
Prior art date
Application number
TW112112312A
Other languages
Chinese (zh)
Inventor
本多義昭
佐藤友理
三橋尚志
Original Assignee
日商大金工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商大金工業股份有限公司 filed Critical 日商大金工業股份有限公司
Publication of TW202411300A publication Critical patent/TW202411300A/en

Links

Abstract

The present invention provides a curable composition comprising: component (A): a fluoropolyether group-containing acrylic compound containing a (meth)acrylic group, a hydrolyzable silane group, and a fluoropolyether group; component (B): a fluoropolyether group-containing silane compound containing a fluoropolyether group and a hydrolyzable silyl group; component (C): a cross-linking agent; component (D): a catalyst; component (E): a radical polymerization initiator; and component (F): a solvent.

Description

硬化性組成物 Hardening composition

本揭示係關於包含含氟化合物的硬化性組成物。 This disclosure relates to a hardening composition comprising a fluorine-containing compound.

已知包含某種含氟化合物之組成物能賦予具有優異的撥水性、撥油性、防污性等的硬化物(專利文獻1及2)。 It is known that a composition containing a certain fluorine-containing compound can impart excellent water repellency, oil repellency, antifouling properties, etc. to a cured product (Patent Documents 1 and 2).

[先前技術文獻] [Prior Art Literature]

[專利文獻] [Patent Literature]

[專利文獻1]日本特開2019-6843號公報 [Patent Document 1] Japanese Patent Publication No. 2019-6843

[專利文獻2]國際公開第2019/088126號 [Patent Document 2] International Publication No. 2019/088126

專利文獻1中記載之含氟聚醚基之丙烯酸化合物係藉由紫外線照射而硬化,惟在難以照射紫外線之部位,無法充分地硬化,會產生未硬化部分。此外,獲得的硬化物彈性模數低、延伸率差。引用文獻2中記 載之含氟聚醚基之矽烷化合物能夠藉由濕氣(水分)硬化,惟硬化速度慢,在塗佈時液體可能擴散滴落。 The fluorinated polyether-based acrylic compound described in Patent Document 1 is cured by ultraviolet irradiation, but it cannot be fully cured in areas where ultraviolet irradiation is difficult, resulting in uncured parts. In addition, the obtained cured product has a low elastic modulus and poor elongation. The fluorinated polyether-based silane compound described in Reference Document 2 can be cured by moisture (water), but the curing speed is slow and the liquid may diffuse and drip during coating.

本揭示之目的在於提供硬化性及成膜性優異的硬化性組成物。 The purpose of this disclosure is to provide a curable composition with excellent curability and film-forming properties.

本揭示包含下列態樣。 This disclosure includes the following aspects.

〔1〕一種硬化性組成物,係包含: [1] A hardening composition comprising:

成分(A):含有(甲基)丙烯酸基、水解性矽烷基、及氟聚醚基的含氟聚醚基之丙烯酸化合物, Component (A): a fluorinated polyether-containing acrylic compound containing a (meth) acrylic group, a hydrolyzable silyl group, and a fluorinated polyether group,

成分(B):含有氟聚醚基、及水解性矽基的含氟聚醚基之矽烷化合物, Component (B): A silane compound containing a fluorinated polyether group and a hydrolyzable silyl group,

成分(C):交聯劑, Ingredient (C): Crosslinking agent,

成分(D):觸媒, Ingredient (D): Catalyst,

成分(E):自由基聚合起始劑,以及 Component (E): free radical polymerization initiator, and

成分(F):溶劑。 Ingredient (F): Solvent.

〔2〕如上述〔1〕所述之硬化性組成物,其中,相對於成分(A)至成分(F)之合計量,成分(F)之含量,係20至90質量%。 [2] The curable composition as described in [1] above, wherein the content of component (F) is 20 to 90% by mass relative to the total amount of components (A) to (F).

〔3〕如上述〔1〕或〔2〕所述之硬化性組成物,其中,相對於成分(A)至成分(F)之合計量,成分(F)之含量,係40至90質量%。 [3] The curable composition as described in [1] or [2] above, wherein the content of component (F) is 40 to 90% by mass relative to the total amount of components (A) to (F).

〔4〕如上述〔1〕至〔3〕中任一項所述之硬化性組成物,其中,前述溶劑為脂肪族烴類、芳香族烴類、酯類、酮類、乙二醇醚類、醇類、乙二醇類、環狀醚類、醯胺類、醚醇類、碳數5至12之全氟脂肪族烴、多氟芳 香族烴、多氟脂肪族烴、氫氟烴、氫氯氟烴、或氫氟醚,或者此等之2種以上的混合溶劑。 [4] A curable composition as described in any one of [1] to [3] above, wherein the solvent is an aliphatic hydrocarbon, an aromatic hydrocarbon, an ester, a ketone, a glycol ether, an alcohol, an ethylene glycol, a cyclic ether, an amide, an ether alcohol, a perfluoroaliphatic hydrocarbon having 5 to 12 carbon atoms, a polyfluoroaromatic hydrocarbon, a polyfluoroaliphatic hydrocarbon, a hydrofluorocarbon, a hydrochlorofluorocarbon, or a hydrofluoroether, or a mixed solvent of two or more of these.

〔5〕如上述〔1〕至〔4〕中任一項所述之硬化性組成物,其中,前述溶劑為醇類、或氫氟醚,或者此等之2種以上的混合溶劑。 [5] A curable composition as described in any one of [1] to [4] above, wherein the solvent is an alcohol, or hydrofluoric ether, or a mixed solvent of two or more of these.

〔6〕如上述〔1〕至〔5〕中任一項所述之硬化性組成物,其中,前述溶劑為甲醇、乙醇、異丙醇、全氟丙基甲基醚、全氟丁基甲基醚、全氟丁基乙基醚、全氟己基甲基醚、或CF3CH2OCF2CHF2,或者此等之2種以上的混合溶劑。 [6] The curable composition as described in any one of [1] to [5] above, wherein the solvent is methanol, ethanol, isopropyl alcohol, perfluoropropyl methyl ether, perfluorobutyl methyl ether, perfluorobutyl ethyl ether, perfluorohexyl methyl ether, or CF 3 CH 2 OCF 2 CHF 2 , or a mixed solvent of two or more thereof.

〔7〕如上述〔1〕至〔6〕中任一項所述之硬化性組成物,其中,前述含氟聚醚基之丙烯酸化合物包含下述式(A1)、(A2)或(A3)所示之化合物: [7] A curable composition as described in any one of [1] to [6] above, wherein the aforementioned fluorinated polyether group-containing acrylic compound comprises a compound represented by the following formula (A1), (A2) or (A3):

RF1-XA-XBRAc m (A1) R F1 -X A -X B R Ac m (A1)

RAc mXB-XA-RF2-XA-XBRAc m (A2) R Ac m X B -X A -R F2 -X A -X B R Ac m (A2)

RAc mXB-XA-(RF2-Rg-Ra(RAc)m3-Rg)x-RF2-XA-XBRAc m (A3) R Ac m X B -X A -(R F2 -R g -R a (R Ac ) m3 -R g ) x -R F2 -X A -X B R Ac m (A3)

式中: In the formula:

RF1為Rf1-RF-Oq-, RF1 is Rf1 - RF - Oq- ,

RF2分別獨立地為-Rf2 p-RF-Oq-, RF2 is independently -Rf2p - RF - Oq- ,

Rf1為可被1個或超過1個之氟原子取代的C1-16烷基, Rf1 is a C1-16 alkyl group which may be substituted by 1 or more fluorine atoms,

Rf2為可被1個或超過1個之氟原子取代的C1-6伸烷基, Rf2 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms,

RF分別獨立地為二價之氟聚醚基, R and F are independently divalent fluoropolyether groups,

p為0或1, p is 0 or 1,

q分別獨立地為0或1, q is independently 0 or 1,

XA分別獨立地為單鍵、或二價之有機基, X and A are independently a single bond or a divalent organic group,

XB分別獨立地為(m+1)價之基, X and B are independently (m+1)-valent bases,

惟,各式中,至少1個XB為含有水解性矽基之(m+1)價的基, However, in each formula, at least one XB is a (m+1)-valent group containing a hydrolyzable silicon group.

RAc分別獨立地為-XD-XE(-XF-OCO-CR5=CH2)m’R Ac are independently -X D -X E (-X F -OCO-CR 5 =CH 2 ) m' ,

XD為單鍵、或二價之基, X D is a single bond or a divalent group,

XE為單鍵、或(m’+1)價之基, XE is a single bond or a (m'+1) valence base,

XF分別獨立地為單鍵、或二價之基, X and F are independently a single bond or a divalent group,

R5為氫原子、鹵素原子、或碳數1至8之一價之有機基, R5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms,

m’為1至10之整數, m’ is an integer from 1 to 10,

m分別獨立地為0至10之整數, m is an integer from 0 to 10 independently.

Ra分別獨立地為(m3+2)價之有機基, R a is independently an organic group with a valence of (m3+2),

m3為0至4之整數, m3 is an integer from 0 to 4,

惟,m及m3之至少一者為1以上, However, at least one of m and m3 is greater than 1,

Rg分別獨立地為-NRcCO-Re-、-NRcCOO-Re-、或-NRcCONRc-Re-,於此,此等基之左側係鍵結至RaR g is independently -NR c CO- Re -, -NR c COO- Re -, or -NR c CONR c -Re -, wherein the left side of these groups is bonded to Ra ,

Rc分別獨立地為氫原子、C1-6烷基、或C6-16芳基, R c are each independently a hydrogen atom, a C 1-6 alkyl group, or a C 6-16 aryl group,

Re分別獨立地為單鍵、或2價之有機基, R e each independently represents a single bond or a divalent organic group,

x為1以上之整數。 x is an integer greater than 1.

〔8〕如上述〔7〕所述之硬化性組成物,其中,RF分別獨立地為下述式所示之基: [8] The curable composition as described in [7] above, wherein R and F are independently a group represented by the following formula:

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3RFa 6)d-(OC2F4)e-(OCF2)f- -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f -

式中,RFa分別獨立地為氫原子、氟原子或氯原子, Wherein, R Fa is independently a hydrogen atom, a fluorine atom or a chlorine atom,

a、b、c、d、e及f分別獨立地為0至200之整數,a、b、c、d、e及f之和為1以上,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意,惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上。 a, b, c, d, e and f are each independently an integer from 0 to 200, the sum of a, b, c, d, e and f is 1 or more, and the order of presence of the repeating units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary, provided that, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more.

〔9〕如上述〔7〕或〔8〕所述之硬化性組成物,其中,RF分別獨立地為下述式(f1)、(f2)、(f3)、(f4)、(f5)、或(f6)所示之基: [9] The curable composition as described in [7] or [8] above, wherein R and F are independently a group represented by the following formula (f1), (f2), (f3), (f4), (f5), or (f6):

-(OC3F6)d-(OC2F4)e- (f1) -(OC 3 F 6 ) d -(OC 2 F 4 ) e - (f1)

式中,d為1至200之整數,e為0或1; In the formula, d is an integer from 1 to 200, and e is 0 or 1;

-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f2) -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f2)

式中,c及d分別獨立地為0至30之整數; In the formula, c and d are independently integers between 0 and 30;

e及f分別獨立地為1至200之整數; e and f are independently integers between 1 and 200;

c、d、e及f之和為10至200之整數; The sum of c, d, e and f is an integer between 10 and 200;

標註c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意; The order of the repeated units marked with c, d, e or f and enclosed in brackets in the formula is arbitrary;

-(R6-R7)g- (f3) -(R 6 -R 7 ) g - (f3)

式中,R6為OCF2或OC2F4Wherein, R 6 is OCF 2 or OC 2 F 4 ;

R7為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為選自此等基之2或3個基的組合; R7 is a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups selected from these groups ;

g為2至100之整數; g is an integer from 2 to 100;

-(R6-R7)g-Rt-(R7’-R6’)g’- (f4) -(R 6 -R 7 ) g -R t -(R 7' -R 6' ) g' - (f4)

式中,R6為OCF2或OC2F4Wherein, R 6 is OCF 2 or OC 2 F 4 ,

R7為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R7 is a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups independently selected from these groups,

R6’為OCF2或OC2F4R 6' is OCF 2 or OC 2 F 4 ,

R7’為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R 7' is a group selected from OC 2 F 4 , OC 3 F 6 , OC 4 F 8 , OC 5 F 10 and OC 6 F 12 , or a combination of 2 or 3 groups independently selected from these groups,

g為2至100之整數, g is an integer from 2 to 100,

g’為2至100之整數, g’ is an integer from 2 to 100,

RrR r is

Figure 112112312-A0202-12-0006-1
Figure 112112312-A0202-12-0006-1

式中,*顯示鍵結位置; In the formula, * shows the bond position;

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f5) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f5)

式中,e為1以上200以下之整數,a、b、c、d及f分別獨立地為0以上200以下之整數,a、b、c、d、e及f之和至少為1,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意; In the formula, e is an integer greater than 1 and less than 200, a, b, c, d and f are each independently an integer greater than 0 and less than 200, and the sum of a, b, c, d, e and f is at least 1. In addition, the order of the repeated units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary;

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f6) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f6)

式中,f為1以上200以下之整數,a、b、c、d及e分別獨立地為0以上200以下之整數,a、b、c、d、e及f之和至少為1,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意。 In the formula, f is an integer between 1 and 200, a, b, c, d, and e are each independently an integer between 0 and 200, and the sum of a, b, c, d, e, and f is at least 1. In addition, the order of the repeated units marked with a, b, c, d, e, or f and enclosed in parentheses in the formula is arbitrary.

〔10〕如上述〔7〕至〔9〕中任一項所述之硬化性組成物,其中,XE為單鍵。 [10] The curable composition as described in any one of [7] to [9] above, wherein XE is a single bond.

〔11〕如上述〔7〕至〔10〕中任一項所述之硬化性組成物,其中,XE為-XG-XH[11] The curable composition as described in any one of [7] to [10] above, wherein XE is -XG - XH ;

XG為單鍵, X G is a single key.

C1-6伸烷基, C 1-6 alkylene,

-(CH2)z9-O-(CH2)z10-(式中,z9為0至6之整數,z10為0至6之整數)、或-(CH2)z11-伸苯基-(CH2)z12-(式中,z11為0至6之整數,z12為0至6之整數); -(CH 2 ) z9 -O-(CH 2 ) z10 -(wherein z9 is an integer from 0 to 6, and z10 is an integer from 0 to 6), or -(CH 2 ) z11 -phenylene-(CH 2 ) z12 -(wherein z11 is an integer from 0 to 6, and z12 is an integer from 0 to 6);

XH為如下者 X H is the following

Figure 112112312-A0202-12-0007-2
Figure 112112312-A0202-12-0007-2

R8為氫原子、或C1-6烷基。 R8 is a hydrogen atom or a C1-6 alkyl group.

〔12〕如上述〔7〕至〔11〕中任一項所述之硬化性組成物,其中,XD為-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-、-OCONH-、-NHCOO-、-NH-CO-NH-、-CH2CH(OH)CH2-、-CH(CH2OH)CH2-、-(OSiR14 2)d5-、 [12] The curable composition according to any one of [7] to [11] above, wherein XD is -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-, -OCONH-, -NHCOO-, -NH-CO-NH- , -CH2CH (OH) CH2- , -CH( CH2OH ) CH2- , -( OSiR142 ) d5- ,

Figure 112112312-A0202-12-0008-3
Figure 112112312-A0202-12-0008-3

式中,*及**顯示鍵結位置,*鍵結至XB,**鍵結至XEWherein, * and ** indicate the bond positions, * is bonded to X B , ** is bonded to X E ;

R14為C1-6烷基、或C6-16芳基; R 14 is C 1-6 alkyl or C 6-16 aryl;

d5為1至10之整數。 d5 is an integer from 1 to 10.

〔13〕如上述〔7〕至〔12〕中任一項所述之硬化性組成物,其中,XF為單鍵、 [13] The curable composition as described in any one of [7] to [12] above, wherein X F is a single bond,

C1-6伸烷基、 C 1-6 alkylene,

-(CH2)z5-O-(CH2)z6-(式中,z5為0至6之整數,z6為0至6之整數)、或-(CH2)z7-伸苯基-(CH2)z8-(式中,z7為0至6之整數,z8為0至6之整數)。 -(CH 2 ) z5 -O-(CH 2 ) z6 -(wherein z5 is an integer from 0 to 6, and z6 is an integer from 0 to 6), or -(CH 2 ) z7 -phenylene-(CH 2 ) z8 -(wherein z7 is an integer from 0 to 6, and z8 is an integer from 0 to 6).

〔14〕如上述〔7〕至〔13〕中任一項所述之硬化性組成物,其中,R5為氫原子、或甲基。 [14] The curable composition as described in any one of [7] to [13] above, wherein R 5 is a hydrogen atom or a methyl group.

〔15〕如上述〔7〕至〔14〕中任一項所述之硬化性組成物,其中,XA分別獨立地為單鍵、或下述式所示之基; [15] The curable composition as described in any one of [7] to [14] above, wherein X and A are each independently a single bond or a group represented by the following formula:

-(CαR11 )s1-R12 t1- -(C α R 11 ) s1 -R 12 t1 -

式中: In the formula:

R11分別獨立地為氫原子或氟原子, R 11 is independently a hydrogen atom or a fluorine atom,

α分別獨立地為1至10之整數, α is an integer from 1 to 10 independently.

R12分別獨立地為-O-、-CO-、-NR10-、-CONR10-、-NR10CO-、-COO-、-OCO-、或-OCONH-, R 12 are independently -O-, -CO-, -NR 10 -, -CONR 10 -, -NR 10 CO-, -COO-, -OCO-, or -OCONH-,

R10為氫原子或C1-6烷基, R10 is a hydrogen atom or a C1-6 alkyl group,

s1為0至3之整數, s1 is an integer from 0 to 3,

t1為0至3之整數, t1 is an integer between 0 and 3,

s1與t1之合計為1以上, The sum of s1 and t1 is greater than 1,

標註s1或t1並以括弧括起之各重複單元在式中的存在順序為任意。 The order of the repeated units marked with s1 or t1 and enclosed in parentheses in the formula is arbitrary.

〔16〕如上述〔7〕至〔15〕中任一項所述之硬化性組成物,其中,XA為-CONR10-Cα1H2α1-、-(Cα2H2α2)-OCONR10-、-(Cα3H2α3)-、或-(Cα4H2α4)-O-(Cα5H2α5), [16] The hardenable composition according to any one of [7] to [15] above, wherein XA is -CONR10 - Cα1H2α1- , -(Cα2H2α2)-OCONR10-, -(Cα3H2α3 ) - , or - ( Cα4H2α4 )-O-( Cα5H2α5 ) ,

R10為氫原子或C1-6烷基, R10 is a hydrogen atom or a C1-6 alkyl group,

α1為1至10之整數, α1 is an integer from 1 to 10,

α2為1至10之整數, α2 is an integer from 1 to 10,

α3為1至10之整數, α3 is an integer from 1 to 10,

α4為0至6之整數, α4 is an integer from 0 to 6,

α5為0至6之整數。 α5 is an integer between 0 and 6.

〔17〕如上述〔7〕至〔16〕中任一項所述之硬化性組成物,其中,XB分別獨立地為包含下述式所示之基的基; [17] The curable composition as described in any one of [7] to [16] above, wherein X and B are each independently a group comprising a group represented by the following formula:

SiR1 nbRsb 4-nb SiR 1 nb R sb 4-nb

式中: In the formula:

R1為羥基或水解性基, R1 is a hydroxyl group or a hydrolyzable group,

Rsb為單鍵, R sb is a single bond.

nb為1或2。 nb is 1 or 2.

〔18〕如上述〔7〕至〔16〕中任一項所述之硬化性組成物,其中,XB分別獨立地為XBa(RSi)na所示之基; [18] The hardenable composition as described in any one of [7] to [16] above, wherein X B is independently a group represented by X Ba (R Si ) na ;

式中: In the formula:

XBa分別獨立地為(m+na+1)價之基, X Ba are independently (m+na+1)-valence bases,

RSi分別獨立地為-XC-SiR1 n’R2 3-n’R Si are independently -X C -SiR 1 n' R 2 3-n' ,

XC為碳數1至10之二價之有機基, X C is a divalent organic group having 1 to 10 carbon atoms,

R1分別獨立地為羥基或水解性基, R1 is independently a hydroxyl group or a hydrolyzable group,

R2分別獨立地為氫原子或1價之有機基, R2 is independently a hydrogen atom or a monovalent organic group,

n’為1至3之整數, n’ is an integer from 1 to 3,

na為1至10之整數。 na is an integer from 1 to 10.

〔19〕如上述〔18〕所述之硬化性組成物,其中,XC為C1-6伸烷基、 [19] The curable composition as described in [18] above, wherein X C is a C 1-6 alkylene group,

-(CH2)z1-O-(CH2)z2-(式中,z1為0至6之整數,z2為0至6之整數)、或-(CH2)z3-伸苯基-(CH2)z4-(式中,z3為0至6之整數,z4為0至6之整數)。 -(CH 2 ) z1 -O-(CH 2 ) z2 -(wherein z1 is an integer from 0 to 6, and z2 is an integer from 0 to 6), or -(CH 2 ) z3 -phenylene-(CH 2 ) z4 -(wherein z3 is an integer from 0 to 6, and z4 is an integer from 0 to 6).

〔20〕如上述〔18〕或〔19〕所述之硬化性組成物,其中,n’為3。 [20] A curable composition as described in [18] or [19] above, wherein n' is 3.

〔21〕如上述〔18〕至〔20〕中任一項所述之硬化性組成物,其中,XBa為3價之基,n為1,m為1。 [21] The curable composition as described in any one of [18] to [20] above, wherein X Ba is a trivalent group, n is 1, and m is 1.

〔22〕如上述〔20〕至〔21〕中任一項所述之硬化性組成物,其中,XBa為N、或-C(-O-)-,n為1,m為1。 [22] The curable composition as described in any one of [20] to [21] above, wherein X Ba is N or -C(-O-)-, n is 1, and m is 1.

〔23〕如上述〔7〕至〔20〕中任一項所述之硬化性組成物,其中,式(A3)為 [23] A curable composition as described in any one of [7] to [20] above, wherein formula (A3) is

Rb 2N-Rd-CO-(RF2-CO-NRc-Ra(RAc)m3-NRc-CO)x-RF2-CO-Rd-NRb 2 (A3-b) R b 2 NR d -CO-(R F 2 -CO-NR c -R a (R Ac ) m3 -NR c -CO) x -R F 2 -CO-R d -NR b 2 (A3-b)

式中, In the formula,

Rb分別獨立地為RSi、RAc、或RcR b is independently R Si , R Ac , or R c ,

惟,Rb之至少1個為RSiHowever, at least one of R b is R Si ,

RSi分別獨立地為-XC-SiR1 n’R2 3-n’R Si are independently -X C -SiR 1 n' R 2 3-n' ,

XC為碳數1至10之二價之有機基, X C is a divalent organic group having 1 to 10 carbon atoms,

R1分別獨立地為羥基或水解性基, R1 is independently a hydroxyl group or a hydrolyzable group,

R2分別獨立地為氫原子或1價之有機基, R2 is independently a hydrogen atom or a monovalent organic group,

n’為1至3之整數, n’ is an integer from 1 to 3,

Rd分別獨立地為單鍵、或二價之有機基, R d are each independently a single bond or a divalent organic group,

RF2、Ra、Rc、RAc、m3、及x與請求項4之記載同義。 RF2 , Ra , Rc , RAc , m3, and x have the same meanings as those described in claim 4.

〔24〕如上述〔23〕所述之硬化性組成物,其中,與式(A3)中之位於各末端的N原子鍵結的Rb之1個為RSi、其他為Rc或RAc[24] The curable composition as described in [23] above, wherein one of the R b bonded to each terminal N atom in formula (A3) is R Si , and the other is R c or R Ac .

〔25〕如上述〔23〕或〔24〕所述之硬化性組成物,其中,Rd分別獨立地為單鍵、或-(CH2)z17-NR10-(CH2)z18-(式中,R10為氫原子或C1-6烷基,z17為0至6之整數,z18為0至6之整數)。 [25] The curable composition as described in [23] or [24] above, wherein R d is independently a single bond or -(CH 2 ) z17 -NR 10 -(CH 2 ) z18 - (wherein R 10 is a hydrogen atom or a C 1-6 alkyl group, z17 is an integer from 0 to 6, and z18 is an integer from 0 to 6).

〔26〕如上述〔7〕至〔25〕中任一項所述之硬化性組成物,其中,Ra分別獨立地為下述式所示之基: [26] The curable composition as described in any one of [7] to [25] above, wherein Ra is independently a group represented by the following formula:

-R9-(Ra’-R9)k- -R 9 -(R a' -R 9 ) k -

式中: In the formula:

R9分別獨立地為C1-6伸烷基, R 9 are each independently C 1-6 alkylene,

Ra’分別獨立地為3價之基, R a' is independently a trivalent group,

k為1至4之整數。 k is an integer from 1 to 4.

〔27〕如上述〔26〕所述之硬化性組成物,其中,Ra’分別獨立地為在N、-C(-O-)-、碳-碳原子間可包含胺鍵結、醯胺鍵結、胺甲酸乙酯鍵結、脲鍵結、醚鍵結、或酯鍵結之3價之基。 [27] The curable composition as described in [26] above, wherein Ra ' is independently a trivalent group which may include an amine bond, an amide bond, a urethane bond, a urea bond, an ether bond, or an ester bond between N, -C(-O-)-, and a carbon-carbon atom.

〔28〕如上述〔26〕或〔27〕所述之硬化性組成物,其中,k為1或2。 [28] The curable composition as described in [26] or [27] above, wherein k is 1 or 2.

〔29〕如上述〔7〕至〔28〕中任一項所述之硬化性組成物,其中,Rc分別獨立地為氫原子或C1-6烷基。 [29] The curable composition as described in any one of [7] to [28] above, wherein R c is independently a hydrogen atom or a C 1-6 alkyl group.

〔30〕如上述〔7〕至〔29〕中任一項所述之硬化性組成物,其中,x為1以上5以下之整數。 [30] A curable composition as described in any one of [7] to [29] above, wherein x is an integer of 1 to 5.

〔31〕如上述〔7〕至〔30〕中任一項所述之硬化性組成物,其中,前述含氟聚醚基之丙烯酸化合物包含式(A1)或(A2)所示之化合物。 [31] A curable composition as described in any one of [7] to [30] above, wherein the fluorinated polyether group-containing acrylic compound comprises a compound represented by formula (A1) or (A2).

〔32〕如上述〔7〕至〔30〕中任一項所述之硬化性組成物,其中,前述含氟聚醚基之丙烯酸化合物包含式(A3)所示之化合物。 [32] A curable composition as described in any one of [7] to [30] above, wherein the fluorinated polyether group-containing acrylic compound comprises a compound represented by formula (A3).

〔33〕如上述〔1〕至〔32〕中任一項所述之硬化性組成物,其中,前述含氟聚醚基之矽烷化合物為下述式(B1)或(B2)所示之含氟聚醚基之矽烷化合物, [33] A curable composition as described in any one of [1] to [32] above, wherein the aforementioned fluorinated polyether group-containing silane compound is a fluorinated polyether group-containing silane compound represented by the following formula (B1) or (B2),

RF3 α-XZ-RSi β (B1) RF3α - XZ - RSiβ ( B1 )

RSi γ-XZ-RF4-XZ-RSi γ (B2) R Si γ -X Z -R F4 -X Z -R Si γ (B2)

式中: In the formula:

RF3分別獨立地為Rf3-RFB-Oq3-; R F3 is independently Rf 3 -R FB -O q3 -;

RF4為-Rf4 p3-RFB-Oq3-; RF4 is -Rf4p3 - RFB - Oq3- ;

Rf3分別獨立地為可被1個或超過1個之氟原子取代的C1-16烷基; Rf 3 are each independently a C 1-16 alkyl group which may be substituted with 1 or more 1 fluorine atoms;

Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基; Rf4 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms;

RFB分別獨立地為2價之氟聚醚基; R and FB are each independently a divalent fluoropolyether group;

p3為0或1; p3 is 0 or 1;

q3分別獨立地為0或1; q3 is independently 0 or 1;

RSi分別獨立地為包含與羥基、水解性基、氫原子或1價之有機基鍵結的Si原子之1價之基; R Si are each independently a monovalent group comprising a Si atom bonded to a hydroxyl group, a hydrolyzable group, a hydrogen atom or a monovalent organic group;

至少1個之RSi為包含與羥基或水解性基鍵結的Si原子之1價之基; At least one R Si is a monovalent group including a Si atom bonded to a hydroxyl group or a hydrolyzable group;

XZ分別獨立地為單鍵或2至10價之有機基; X and Z are each independently a single bond or a 2- to 10-valent organic group;

α為1至9之整數; α is an integer from 1 to 9;

β為1至9之整數; β is an integer from 1 to 9;

γ分別獨立地為1至9之整數。 γ is an integer from 1 to 9 independently.

〔34〕如上述〔33〕所述之硬化性組成物,其中,RSi為下述式(S1)、(S2)、(S3)、(S4)或(S5)所示之基: [34] The curable composition as described in [33] above, wherein R Si is a group represented by the following formula (S1), (S2), (S3), (S4) or (S5):

Figure 112112312-A0202-12-0014-4
Figure 112112312-A0202-12-0014-4

- SiR25 n1R26 3-n1 (S2) -SiR 25 n1 R 26 3-n1 (S2)

- SiRa1 k1Rb1 l1Rc1 m1 (S3) -SiR a1 k1 R b1 l1 R c1 m1 (S3)

- CRd1 k2Re1 l2Rf1 m2 (S4) - CR d1 k2 R e1 l2 R f1 m2 (S4)

- NRg1Rh1 (S5) -NR g1 R h1 (S5)

式中: In the formula:

R25分別獨立地為羥基或水解性基; R25 are each independently a hydroxyl group or a hydrolyzable group;

R26分別獨立地為氫原子或1價之有機基; R26 are each independently a hydrogen atom or a monovalent organic group;

n1在每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數; n1 is an integer from 0 to 3 independently in each (SiR 25 n1 R 26 3-n1 ) unit;

X11分別獨立地為單鍵或2價之有機基; X11 is independently a single bond or a divalent organic group;

R27分別獨立地為氫原子或1價之有機基; R27 are each independently a hydrogen atom or a monovalent organic group;

t分別獨立地為2以上之整數; t are each independently an integer greater than 2;

R28分別獨立地為氫原子、鹵素原子或-X11-SiR25 n1R26 3-n1R 28 are each independently a hydrogen atom, a halogen atom or -X 11 -SiR 25 n1 R 26 3-n1 ;

R29分別獨立地為單鍵、氧原子、碳數1至6之伸烷基或碳數1至6之伸烷氧基; R29 is independently a single bond, an oxygen atom, an alkylene group having 1 to 6 carbon atoms, or an alkoxyene group having 1 to 6 carbon atoms;

Ra1分別獨立地為-Z1-SiR21 p1R22 q1R23 r1R a1 is independently -Z 1 -SiR 21 p1 R 22 q1 R 23 r1 ;

Z1分別獨立地為氧原子或2價之有機基; Z 1 each independently represents an oxygen atom or a divalent organic group;

R21分別獨立地為-Z1’-SiR21’ p1’R22’ q1’R23’ r1’R 21 is independently -Z 1' -SiR 21' p1' R 22' q1' R 23' r1' ;

R22分別獨立地為羥基或水解性基; R22 are each independently a hydroxyl group or a hydrolyzable group;

R23分別獨立地為氫原子或1價之有機基; R23 are each independently a hydrogen atom or a monovalent organic group;

p1分別獨立地為0至3之整數; p1 is an integer from 0 to 3 independently;

q1分別獨立地為0至3之整數; q1 is an integer from 0 to 3 independently;

r1分別獨立地為0至3之整數; r1 is an integer from 0 to 3 independently;

Z1’分別獨立地為氧原子或2價之有機基; Z 1' is independently an oxygen atom or a divalent organic group;

R21’分別獨立地為-Z1”-SiR22” q1”R23” r1”R 21′ is independently -Z 1″ -SiR 22″ q1″ R 23″ r1″ ;

R22’分別獨立地為羥基或水解性基; R 22' is independently a hydroxyl group or a hydrolyzable group;

R23’分別獨立地為氫原子或1價之有機基; R 23' is independently a hydrogen atom or a monovalent organic group;

p1’分別獨立地為0至3之整數; p1’ is an integer from 0 to 3 independently;

q1’分別獨立地為0至3之整數; q1’ is an integer from 0 to 3 independently;

r1’分別獨立地為0至3之整數; r1’ is an integer from 0 to 3 independently;

Z1”分別獨立地為氧原子或2價之有機基; Z 1" are each independently an oxygen atom or a divalent organic group;

R22”分別獨立地為羥基或水解性基; R 22" are each independently a hydroxyl group or a hydrolyzable group;

R23”分別獨立地為氫原子或1價之有機基; R 23" are each independently a hydrogen atom or a monovalent organic group;

q1”分別獨立地為0至3之整數; q1" are independently integers from 0 to 3;

r1”分別獨立地為0至3之整數; r1" are independently integers from 0 to 3;

Rb1分別獨立地為羥基或水解性基; R b1 are each independently a hydroxyl group or a hydrolyzable group;

Rc1分別獨立地為氫原子或1價之有機基; R c1 each independently represents a hydrogen atom or a monovalent organic group;

k1分別獨立地為0至3之整數; k1 is an integer from 0 to 3 independently;

l1分別獨立地為0至3之整數; l1 are independently integers from 0 to 3;

m1分別獨立地為0至3之整數; m1 is an integer from 0 to 3 independently;

Rd1分別獨立地為-Z2-eR31 p2R32 q2R33 r2R d1 is independently -Z 2 -eR 31 p2 R 32 q2 R 33 r2 ;

Z2分別獨立地為單鍵、氧原子或2價之有機基; Z2 are each independently a single bond, an oxygen atom or a divalent organic group;

R31分別獨立地為-Z2’-CR32’ q2’R33’ r2’R 31 is independently -Z 2' -CR 32' q2' R 33' r2' ;

R32分別獨立地為-Z3-SiR34 n2R35 3-n2R 32 is independently -Z 3 -SiR 34 n2 R 35 3-n2 ;

R33分別獨立地為氫原子、羥基或1價之有機基; R 33 each independently represents a hydrogen atom, a hydroxyl group or a monovalent organic group;

p2分別獨立地為0至3之整數; p2 is an integer from 0 to 3 independently;

q2分別獨立地為0至3之整數; q2 is an integer from 0 to 3 independently;

r2分別獨立地為0至3之整數; r2 is an integer from 0 to 3 independently;

Z2’分別獨立地為單鍵、氧原子或2價之有機基; Z 2' is independently a single bond, an oxygen atom or a divalent organic group;

R32’分別獨立地為-Z3-SiR34 n2R35 3-n2R 32′ is independently -Z 3 -SiR 34 n2 R 35 3-n2 ;

R33’分別獨立地為氫原子、羥基或1價之有機基; R 33' is independently a hydrogen atom, a hydroxyl group or a monovalent organic group;

q2’分別獨立地為0至3之整數; q2’ is an integer from 0 to 3 independently;

r2’分別獨立地為0至3之整數; r2’ is an integer from 0 to 3 independently;

Z3分別獨立地為單鍵、氧原子或2價之有機基; Z 3 are each independently a single bond, an oxygen atom or a divalent organic group;

R34分別獨立地為羥基或水解性基; R 34 are each independently a hydroxyl group or a hydrolyzable group;

R35分別獨立地為氫原子或1價之有機基; R 35 is independently a hydrogen atom or a monovalent organic group;

n2分別獨立地為0至3之整數; n2 are independently integers from 0 to 3;

Re1分別獨立地為-Z3-SiR34 n2R35 3-n2R e1 is independently -Z 3 -SiR 34 n2 R 35 3-n2 ;

Rf1分別獨立地為氫原子、羥基或1價之有機基; R f1 are each independently a hydrogen atom, a hydroxyl group or a monovalent organic group;

k2分別獨立地為0至3之整數; k2 is an integer from 0 to 3 independently;

l2分別獨立地為0至3之整數; l2 are independently integers from 0 to 3;

m2分別獨立地為0至3之整數; m2 is an integer from 0 to 3 independently;

Rg1及Rh1分別獨立地為-Z4-SiR25 n1R26 3-n1、-Z4-SiRa1 k1Rb1 l1Rc1m1、-Z4-CRd1 k2Re1 l2Rf1 m2R g1 and R h1 are independently -Z 4 -SiR 25 n1 R 26 3-n1 , -Z 4 -SiR a1 k1 R b1 l1 R c 1 m1 , -Z 4 -CR d1 k2 R e1 l2 R f1 m2 ;

Z4分別獨立地為單鍵、氧原子或2價之有機基; Z 4 are each independently a single bond, an oxygen atom or a divalent organic group;

惟,式(S1)、(S2)、(S3)、(S4)及(S5)中,存在至少1個與羥基或水解性基鍵結的Si原子。 However, in formulas (S1), (S2), (S3), (S4) and (S5), there is at least one Si atom bonded to a hydroxyl group or a hydrolyzable group.

〔35〕如上述〔1〕至〔32〕中任一項所述之硬化性組成物,其中,前述含氟聚醚基之矽烷化合物為下述式(B3)所示之含氟聚醚基之矽烷化合物: [35] A curable composition as described in any one of [1] to [32] above, wherein the aforementioned fluorinated polyether group-containing silane compound is a fluorinated polyether group-containing silane compound represented by the following formula (B3):

R39 j-R38-NR37CO-(RF4-CONR37-R36-NR37CO)r-RF4-CONR37-R38-R39 j (B3) R39j -R38 - NR37CO- ( RF4 - CONR37 - R36 - NR37CO ) r - RF4 - CONR37 - R38 - R39j (B3 )

式中: In the formula:

RF4為-Rf4 p3-RFB-Oq3-; RF4 is -Rf4p3 - RFB - Oq3- ;

Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基; Rf4 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms;

RFB分別獨立地為2價之氟聚醚基; R and FB are each independently a divalent fluoropolyether group;

p3為0或1; p3 is 0 or 1;

q3為0或1; q3 is 0 or 1;

R36分別獨立地為2價之有機基, R 36 is independently a divalent organic group,

R37分別獨立地為氫原子或碳數1至8之一價之有機基, R 37 is independently a hydrogen atom or a monovalent organic group having 1 to 8 carbon atoms,

R38分別獨立地為(j+1)價之有機基, R 38 is independently a (j+1)-valent organic group,

R39分別獨立地為-SiR25 n1R26 3-n1R 39 is independently -SiR 25 n1 R 26 3-n1 ,

R25分別獨立地為羥基或水解性基; R25 are each independently a hydroxyl group or a hydrolyzable group;

R26分別獨立地為氫原子或1價之有機基; R26 are each independently a hydrogen atom or a monovalent organic group;

n1在每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數; n1 is an integer from 0 to 3 independently in each (SiR 25 n1 R 26 3-n1 ) unit;

j分別獨立地為1至9之整數, j is an integer from 1 to 9 independently,

r為1以上之整數。 r is an integer greater than 1.

〔36〕如上述〔33〕至〔35〕中任一項所述之硬化性組成物,其中,RFB分別獨立地為下述式所示之基, [36] The curable composition as described in any one of [33] to [35] above, wherein R FB is independently a group represented by the following formula:

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3RFa 6)d-(OC2F4)e-(OCF2)f- -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f -

式中,RFa分別獨立地為氫原子、氟原子或氯原子, Wherein, R Fa is independently a hydrogen atom, a fluorine atom or a chlorine atom,

a、b、c、d、e及f分別獨立地為0至200之整數,a、b、c、d、e及f之和為1以上,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意,惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上。 a, b, c, d, e and f are each independently an integer from 0 to 200, the sum of a, b, c, d, e and f is 1 or more, and the order of presence of the repeating units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary, provided that, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more.

〔37〕如上述〔1〕至〔36〕中任一項所述之硬化性組成物,其中,前述交聯劑為式(C1)所示之化合物: [37] A curable composition as described in any one of [1] to [36] above, wherein the crosslinking agent is a compound represented by formula (C1):

(Rg1-O)δ-Si-Rg2 4-δ (C1) (R g1 -O) δ -Si-R g2 4-δ (C1)

式中; In the formula;

Rg1於每次出現時分別獨立地為氫原子或1價之有機基; Rg1, at each occurrence, is independently a hydrogen atom or a monovalent organic group;

Rg2分別獨立地為1價之有機基; R g2 are each independently a monovalent organic group;

δ為2至4之整數。 δ is an integer between 2 and 4.

〔38〕如上述〔1〕至〔37〕中任一項所述之硬化性組成物,其中,前述交聯劑為四乙氧基矽烷、四甲氧基矽烷、甲基三乙氧基矽烷、甲基三甲氧基矽烷、二甲基二甲氧基矽烷、二甲基三甲氧基矽烷、胺基丙基三乙氧基矽烷、胺基丙基三甲氧基矽烷、十三氟正辛基三乙氧基矽烷、或十三氟正辛基三甲氧基矽烷。 [38] A curable composition as described in any one of [1] to [37] above, wherein the crosslinking agent is tetraethoxysilane, tetramethoxysilane, methyltriethoxysilane, methyltrimethoxysilane, dimethyldimethoxysilane, dimethyltrimethoxysilane, aminopropyltriethoxysilane, aminopropyltrimethoxysilane, tridecafluorooctyltriethoxysilane, or tridecafluorooctyltrimethoxysilane.

〔39〕如上述〔1〕至〔38〕中任一項所述之硬化性組成物,其中,前述觸媒為選自酸、鹼、過渡金屬,或者選自錫系觸媒、鈦系觸媒、氧化鋯系觸媒、鉍系觸媒、及有機胺系觸媒的金屬錯合物。 [39] A hardening composition as described in any one of [1] to [38] above, wherein the catalyst is a metal complex selected from an acid, a base, a transition metal, or a tin-based catalyst, a titanium-based catalyst, a zirconium oxide-based catalyst, a bismuth-based catalyst, and an organic amine-based catalyst.

〔40〕如上述〔1〕至〔39〕中任一項所述之硬化性組成物,其中,前述觸媒為乙酸、三氟乙酸、氨、三乙胺、二乙胺、Ti、Ni、Sn、二月桂酸二正丁基錫(IV)、二異丙氧基雙(乙醯乙酸乙酯)鈦、四正丁氧基鈦、四-2-乙基己氧基鈦、四乙醯丙酮鈦、四乙醯丙酮鋯、四正丁氧基鋯、二丁氧基雙(乙醯乙酸乙酯)鋯、或參(2-己酸乙酯)鉍。 [40] A curable composition as described in any one of [1] to [39] above, wherein the catalyst is acetic acid, trifluoroacetic acid, ammonia, triethylamine, diethylamine, Ti, Ni, Sn, di-n-butyltin(IV) dilaurate, titanium diisopropoxide (ethyl acetylacetate), titanium tetra-n-butoxide, titanium tetra-2-ethylhexyloxide, titanium tetraacetylacetonate, zirconium tetraacetylacetonate, zirconium tetra-n-butoxide, zirconium dibutoxide (ethyl acetylacetate), or bismuth tris(2-ethylhexanoate).

〔41〕如上述〔1〕至〔40〕中任一項所述之硬化性組成物,其中,前述自由基聚合起始劑為二酮類、醯偶姻類、醯偶姻醚類、噻噸酮類、二苯甲酮類、苯乙酮類、醌類、胺基苯甲酸類、鹵素化合物、醯基氧化膦類、或過氧化物。 [41] A curable composition as described in any one of [1] to [40] above, wherein the free radical polymerization initiator is a diketone, an acyloin, an acyloin ether, a thioxanthine, a benzophenone, an acetophenone, a quinone, an aminobenzoic acid, a halogen compound, an acylphosphine oxide, or a peroxide.

〔42〕如上述〔1〕至〔41〕中任一項所述之硬化性組成物,其中,前述自由基聚合起始劑為安息香、安息香甲基醚、安息香乙基醚、安息香異丙基醚、噻噸酮、2,4-二乙基噻噸酮、噻噸酮-4-磺酸、二苯甲酮、4,4’-雙(二甲基胺基)二苯甲酮、4,4’-雙(二乙基胺基)二苯甲酮、苯乙酮、2-(4-甲苯磺醯氧基)-2-苯基苯乙酮、對二甲基胺基苯乙酮、2,2’-二甲氧基-2-苯基苯乙酮、對甲氧基苯乙酮、2-甲基〔4-(甲基硫基)苯基〕-2-

Figure 112112312-A0202-12-0019-45
啉基-1-丙酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-12-0019-46
啉基苯基)-丁-1-酮、蒽醌、1,4-萘醌、2-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸(正丁氧基)乙酯、4-二甲基胺基苯甲酸異戊酯、4-二甲基胺基苯甲酸2-乙基己酯、苯甲醯氯、三鹵甲基苯基碸、醯基氧化膦、或二-三級丁基過氧化物、苯甲 醯甲酸甲酯、1-羥基-環己基-苯基-酮、1-〔4-(2-羥基乙氧基)-苯基〕-2-羥基-2-甲基-1-丙-1-酮、2-羥基-1-{4-〔4-(2-羥基-2-甲基-丙醯基)-苄基〕苯基}-2-甲基-丙-1-酮、2-甲基-1-(4-甲基硫基苯基)-2-
Figure 112112312-A0202-12-0020-47
啉基丙-1-酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-12-0020-48
啉基苯基)-1-丁酮、2-(二甲基胺基)-2-〔(4-甲基苯基)甲基〕-1-〔4-(4-
Figure 112112312-A0202-12-0020-49
啉基)苯基〕-1-丁酮、雙(2,4,6-三甲基苯甲醯基)-苯基氧化膦、雙(η5-2,4-環戊二烯-1-基)-雙(2,6-二氟-3-(1H-吡咯-1-基)-苯基)鈦、1,2-辛二酮,1-〔4-(苯基硫基)-,2-(O-苯甲醯基肟)〕、乙酮,1-〔9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基〕-,1-(0-乙醯肟)、2-羥基-2-甲基-1-苯基-丙-1-酮、2,4,6-三甲基苯甲醯基-二苯基-氧化膦、三級丁基氫過氧化物、氫過氧化異丙苯、二異丙苯氫過氧化物、對薄荷烷過氧化氫、或三級甲基丁基氫過氧化物。 [42] The curable composition as described in any one of [1] to [41] above, wherein the radical polymerization initiator is benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, thiothione, 2,4-diethylthiothione, thiothione-4-sulfonic acid, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, p-methoxyacetophenone, 2-methyl [4-(methylthio)phenyl]-2-
Figure 112112312-A0202-12-0019-45
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-12-0019-46
1-Butanone, anthraquinone, 1,4-naphthoquinone, ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate (n-butoxy) ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, benzoyl chloride, trihalomethylphenyl sulfone, acylphosphine oxide, or di-tert-butyl peroxide benzoic acid methyl ester, 1-hydroxy-cyclohexyl-phenyl-ketone, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, 2-methyl-1-(4-methylthiophenyl)-2-
Figure 112112312-A0202-12-0020-47
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-12-0020-48
1-Butanone, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-
Figure 112112312-A0202-12-0020-49
1-Butanone, bis(2,4,6-trimethylbenzyl)-phenylphosphine oxide, bis(η5-2,4-cyclopentadien-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium, 1,2-octanedione, 1-〔4-(phenylthio)-, 2-(O-benzyloxime)〕, ethyl ketone, 1-〔9-ethyl- 6-(2-methylbenzyl)-9H-carbazol-3-yl]-, 1-(0-acetyl oxime), 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2,4,6-trimethylbenzyl-diphenyl-phosphine oxide, tertiary butyl hydroperoxide, isopropylbenzene hydroperoxide, diisopropylbenzene hydroperoxide, p-menthane hydroperoxide, or tertiary methyl butyl hydroperoxide.

〔43〕如上述〔1〕至〔42〕中任一項所述之硬化性組成物,其更含有溶劑。 [43] A hardening composition as described in any one of [1] to [42] above, further comprising a solvent.

〔44〕一種硬化物,係由上述〔1〕至〔43〕中任一項所述之硬化性組成物獲得者。 [44] A hardened material obtained from the hardening composition described in any one of [1] to [43] above.

〔45〕一種物品,係包含基材、以及由上述〔1〕至〔43〕中任一項所述之硬化性組成物形成在該基材之表面的層。 [45] An article comprising a substrate and a layer formed on the surface of the substrate by a curable composition described in any one of [1] to [43] above.

依據本揭示可提供硬化性優異的硬化性組成物。 According to the present disclosure, a hardening composition with excellent hardening properties can be provided.

使用於本說明書中之情況下,「一價之有機基」意指含有碳之1價基。作為1價之有機基,並無特別限定,惟可為烴基或其衍生物。烴基之衍生物意指在烴基之末端或分子鏈中,具有1個或超過1個之N、O、S、Si、醯胺、磺醯基、矽氧烷、羰基、羰氧基等之基。尚且,單獨顯示「有機基」之情況下,意指1價之有機基。此外,「2價之有機基」意指含有碳之2價基。作為該2價有機基,係列舉從有機基進一步使1個氫原子脫離的2價基。3價以上之有機基亦相同,係意指從有機基使所定之數的氫原子脫離的基。 When used in this specification, "monovalent organic group" means a univalent group containing carbon. There is no particular limitation on the monovalent organic group, but it can be a alkyl group or its derivative. The derivative of the alkyl group means a group having one or more N, O, S, Si, amide, sulfonyl, siloxane, carbonyl, carbonyloxy, etc. at the end of the alkyl group or in the molecular chain. Moreover, when "organic group" is shown alone, it means a monovalent organic group. In addition, "divalent organic group" means a divalent group containing carbon. As the divalent organic group, a divalent group is listed in which one hydrogen atom is further detached from the organic group. The same is true for trivalent or higher organic groups, which means a group in which a predetermined number of hydrogen atoms are detached from the organic group.

使用於本說明書中之情況下,「烴基」意指包含碳及氫之基,係意指從烴使氫原子脫離的基。作為該烴基,並無特別限定,惟係列舉C1-20烴基,例如:脂肪族烴基、芳香族烴基等。上述「脂肪族烴基」可係直鏈狀、分枝鏈狀或環狀之任一者,亦可係飽和或不飽和之任一者。此外,烴基可包含1個或超過1個之環結構。烴基可被1個或超過1個之取代基取代。 When used in this specification, "alkyl" means a group containing carbon and hydrogen, and means a group in which a hydrogen atom is separated from a hydrocarbon. The alkyl group is not particularly limited, but includes C 1-20 alkyl groups, such as aliphatic alkyl groups, aromatic alkyl groups, etc. The above-mentioned "aliphatic alkyl group" may be any of a straight chain, a branched chain or a ring, and may be any of saturated or unsaturated. In addition, the alkyl group may contain one or more ring structures. The alkyl group may be substituted by one or more substituents.

使用於本說明書中之情況下,作為「烴基」之取代基,並無特別限定,惟係列舉例如:鹵素原子、可被1個或超過1個之鹵素原子取代之選自C1-6烷基、C2-6烯基、C2-6炔基、C3-10環烷基、C3-10不飽和環烷基、5至10員之雜環基、5至10員之不飽和雜環基、C6-10芳基及5至10員之雜芳基的1個或超過1個之基。 When used in the present specification, the substituent of the "alkyl group" is not particularly limited, but includes, for example, a halogen atom, and one or more groups selected from C1-6 alkyl groups, C2-6 alkenyl groups, C2-6 alkynyl groups, C3-10 cycloalkyl groups, C3-10 unsaturated cycloalkyl groups, 5-10 membered heterocyclic groups, 5-10 membered unsaturated heterocyclic groups, C6-10 aryl groups, and 5-10 membered heteroaryl groups which may be substituted with one or more halogen atoms.

使用於本說明書中之情況下,「水解性基」意指能夠進行水解反應之基,亦即,藉由水解反應,能從化合物之主骨架脫離之基。作為 水解性基之例,係列舉-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、-NCO、或鹵素(此等式中,Rj表示取代或未取代之C1-4烷基)等。 When used in this specification, "hydrolyzable group" means a group that can undergo hydrolysis reaction, that is, a group that can be separated from the main skeleton of the compound by hydrolysis reaction. Examples of hydrolyzable groups include -ORj , -OCORj , -ON= CRj2 , -NRj2 , -NHRj , -NCO , -NCO, or halogen (in this formula, Rj represents a substituted or unsubstituted C1-4 alkyl group) and the like.

本揭示之硬化性組成物包含: The curable composition disclosed herein includes:

成分(A):含有(甲基)丙烯酸基、水解性矽烷基、及氟聚醚基的含氟聚醚基之丙烯酸化合物, Component (A): a fluorinated polyether-containing acrylic compound containing a (meth) acrylic group, a hydrolyzable silyl group, and a fluorinated polyether group,

成分(B):含有氟聚醚基、及水解性矽基的含氟聚醚基之矽烷化合物, Component (B): A silane compound containing a fluorinated polyether group and a hydrolyzable silyl group,

成分(C):交聯劑, Ingredient (C): Crosslinking agent,

成分(D):觸媒, Ingredient (D): Catalyst,

成分(E):自由基聚合起始劑,以及 Component (E): free radical polymerization initiator, and

成分(F):溶劑。 Ingredient (F): Solvent.

成分(A):含有(甲基)丙烯酸基、水解性矽烷基、及氟聚醚基的含氟聚醚基之丙烯酸化合物。 Component (A): A fluorinated polyether-containing acrylic compound containing a (meth)acrylic group, a hydrolyzable silyl group, and a fluorinated polyether group.

本揭示之硬化性組成物包含含有(甲基)丙烯酸基、水解性矽烷基、及氟聚醚基的含氟聚醚基之丙烯酸化合物。本揭示之硬化性組成物藉由包含上述含氟聚醚基之丙烯酸化合物,而具有UV硬化性。於此,(甲基)丙烯酸基包含丙烯酸基及甲基丙烯酸基。 The curable composition disclosed herein includes a fluorinated polyether-containing acrylic compound containing a (meth) acrylic group, a hydrolyzable silyl group, and a fluorinated polyether group. The curable composition disclosed herein has UV curability by including the above-mentioned fluorinated polyether-containing acrylic compound. Here, the (meth) acrylic group includes an acrylic group and a methacrylic group.

上述含氟聚醚基之丙烯酸化合物在分子中含有(甲基)丙烯酸基、水解性矽烷基、及氟聚醚基。 The above-mentioned fluorinated polyether group-containing acrylic compound contains a (meth) acrylic group, a hydrolyzable silyl group, and a fluorinated polyether group in the molecule.

於較佳態樣中,上述含氟聚醚基之丙烯酸化合物包含下述式(A1)、(A2)或(A3)所示之化合物: In a preferred embodiment, the above-mentioned fluorinated polyether-containing acrylic compound comprises a compound represented by the following formula (A1), (A2) or (A3):

RF1-XA-XBRAc m (A1) R F1 -X A -X B R Ac m (A1)

RAc mXB-XA-RF2-XA-XBRAc m (A2) R Ac m X B -X A -R F2 -X A -X B R Ac m (A2)

RAc mXB-XA-(RF2-Rg-Ra(RAc)m3-Rg)x-RF2-XA-XBRAc m (A3) R Ac m X B -X A -(R F2 -R g -R a (R Ac ) m3 -R g ) x -R F2 -X A -X B R Ac m (A3)

式中: In the formula:

RF1為Rf1-RF-Oq-, RF1 is Rf1 - RF - Oq- ,

RF2分別獨立地為Rf2 p-RF-Oq-, R F2 is independently Rf 2 p -R F -O q -,

Rf1為可被1個或超過1個之氟原子取代的C1-16烷基, Rf1 is a C1-16 alkyl group which may be substituted by 1 or more fluorine atoms,

Rf2為可被1個或超過1個之氟原子取代的C1-6伸烷基, Rf2 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms,

RF分別獨立地為二價之氟聚醚基, R and F are independently divalent fluoropolyether groups,

p為0或1, p is 0 or 1,

q分別獨立地為0或1, q is independently 0 or 1,

XA分別獨立地為單鍵、或二價之有機基, X and A are independently a single bond or a divalent organic group,

XB分別獨立地為(m+1)價之基, X and B are independently (m+1)-valent bases,

惟,各式中,至少1個XB為含有水解性矽基之(m+1)價的基, However, in each formula, at least one XB is a (m+1)-valent group containing a hydrolyzable silicon group.

RAc分別獨立地為-XD-XE(-XF-OCO-CR5=CH2)m’R Ac are independently -X D -X E (-X F -OCO-CR 5 =CH 2 ) m' ,

XD為單鍵、或二價之基, X D is a single bond or a divalent group,

XE為單鍵、或(m’+1)價之基, XE is a single bond or a (m'+1) valence base,

XF分別獨立地為單鍵、或二價之基, X and F are independently a single bond or a divalent group,

R5為氫原子、鹵素原子、或碳數1至8之一價之有機基, R5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms,

m’為1至10之整數, m’ is an integer from 1 to 10,

m分別獨立地為0至10之整數, m is an integer from 0 to 10 independently.

Ra分別獨立地為(m3+2)價之有機基, R a is independently an organic group with a valence of (m3+2),

m3為0至4之整數, m3 is an integer from 0 to 4,

惟,m及m3之至少一者為1以上, However, at least one of m and m3 is greater than 1,

Rg分別獨立地為-NRcCO-Re-、-NRcCOO-Re-、或-NRcCONRc-Re-,於此,此等基之左側係鍵結至RaR g is independently -NR c CO- Re -, -NR c COO- Re -, or -NR c CONR c -Re -, wherein the left side of these groups is bonded to Ra ,

Rc分別獨立地為氫原子、C1-6烷基、或C6-16芳基, R c are each independently a hydrogen atom, a C 1-6 alkyl group, or a C 6-16 aryl group,

Re分別獨立地為單鍵、或2價之有機基, R e each independently represents a single bond or a divalent organic group,

x為1以上之整數。 x is an integer greater than 1.

於一態樣中,上述含氟聚醚基之丙烯酸化合物包含式(A1)或(A2)所示之化合物。例如,上述含氟聚醚基之丙烯酸化合物為式(A1)或(A2)所示之化合物。 In one embodiment, the above-mentioned fluorinated polyether group-containing acrylic compound includes a compound represented by formula (A1) or (A2). For example, the above-mentioned fluorinated polyether group-containing acrylic compound is a compound represented by formula (A1) or (A2).

於一態樣中,上述含氟聚醚基之丙烯酸化合物包含式(A1)所示之化合物。例如,上述含氟聚醚基之丙烯酸化合物為式(A1)所示之化合物。 In one embodiment, the above-mentioned fluorinated polyether group-containing acrylic compound includes a compound represented by formula (A1). For example, the above-mentioned fluorinated polyether group-containing acrylic compound is a compound represented by formula (A1).

於一態樣中,上述含氟聚醚基之丙烯酸化合物包含式(A2)所示之化合物。例如,上述含氟聚醚基之丙烯酸化合物為式(A2)所示之化合物。 In one embodiment, the above-mentioned fluorinated polyether group-containing acrylic compound includes a compound represented by formula (A2). For example, the above-mentioned fluorinated polyether group-containing acrylic compound is a compound represented by formula (A2).

於一態樣中,上述含氟聚醚基之丙烯酸化合物包含式(A3)所示之化合物。例如,上述含氟聚醚基之丙烯酸化合物為式(A3)所示之化合物。 In one embodiment, the above-mentioned fluorinated polyether group-containing acrylic compound includes a compound represented by formula (A3). For example, the above-mentioned fluorinated polyether group-containing acrylic compound is a compound represented by formula (A3).

於較佳態樣中,上述含氟聚醚基之丙烯酸化合物包含式(A2)所示之化合物及/或式(A3)所示之化合物。例如,上述含氟聚醚基之丙烯酸化合物為式(A2)所示之化合物及/或式(A3)所示之化合物。 In a preferred embodiment, the above-mentioned fluorinated polyether group-containing acrylic compound includes a compound represented by formula (A2) and/or a compound represented by formula (A3). For example, the above-mentioned fluorinated polyether group-containing acrylic compound is a compound represented by formula (A2) and/or a compound represented by formula (A3).

於其他較佳態樣中,上述含氟聚醚基之丙烯酸化合物包含式(A2)所示之化合物及式(A3)所示之化合物。例如,上述含氟聚醚基之丙烯酸化合物為式(A2)所示之化合物及式(A3)所示之化合物。 In other preferred embodiments, the above-mentioned fluorinated polyether group-containing acrylic compound includes a compound represented by formula (A2) and a compound represented by formula (A3). For example, the above-mentioned fluorinated polyether group-containing acrylic compound is a compound represented by formula (A2) and a compound represented by formula (A3).

在兩末端具有(甲基)丙烯酸基的化合物(例如,式(A2)所示之化合物及式(A3)所示之化合物)與在單末端具有(甲基)丙烯酸基的化合物(例如,式(A1)所示之化合物)之莫耳比(兩末端化合物/單末端化合物)較佳為50/50至100/0,更佳為60/40至100/0,又更佳為90/10至100/0。 The molar ratio (compounds at both ends/compounds at one end) of the compound having (meth)acrylic acid groups at both ends (e.g., the compound represented by formula (A2) and the compound represented by formula (A3)) and the compound having (meth)acrylic acid groups at one end (e.g., the compound represented by formula (A1)) is preferably 50/50 to 100/0, more preferably 60/40 to 100/0, and even more preferably 90/10 to 100/0.

上述式(A1)中,RF1為Rf1-RF-Oq-。 In the above formula (A1), RF1 is Rf1 - RF - Oq- .

上述式(A2)及(A3)中,RF2為-Rf2 p-RF-Oq-。 In the above formulae (A2) and (A3), RF2 is -Rf2p - RF - Oq- .

上述式中,Rf1為可被1個或超過1個之氟原子取代的C1-16烷基。 In the above formula, Rf1 is a C1-16 alkyl group which may be substituted with 1 or more fluorine atoms.

上述可被1個或超過1個之氟原子取代的C1-16烷基中之「C1-16烷基」可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-6烷基,尤其係C1-3烷基,更佳為直鏈之C1-6烷基,尤其係C1-3烷基。 The "C 1-16 alkyl" in the above C 1-16 alkyl group which may be substituted with 1 or more fluorine atoms may be a straight chain or a branched chain, preferably a straight chain or a branched chain C 1-6 alkyl group, especially a C 1-3 alkyl group, more preferably a straight chain C 1-6 alkyl group, especially a C 1-3 alkyl group.

上述Rf1較佳為可被1個或超過1個之氟原子取代的C1-16烷基,更佳為CF2H-C1-15全氟伸烷基,又更佳為C1-16全氟烷基。 The above Rf1 is preferably a C1-16 alkyl group which may be substituted with one or more fluorine atoms, more preferably a CF2HC1-15perfluoroalkylene group, and even more preferably a C1-16perfluoroalkyl group.

上述C1-16全氟烷基可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-6全氟烷基,尤其係C1-3全氟烷基,更佳為直鏈之C1-6全氟烷基,尤其係C1-3全氟烷基,具體而言-CF3、-CF2CF3、或-CF2CF2CF3The C 1-16 perfluoroalkyl group may be a linear or branched chain, preferably a linear or branched C 1-6 perfluoroalkyl group, especially a C 1-3 perfluoroalkyl group, more preferably a linear C 1-6 perfluoroalkyl group, especially a C 1-3 perfluoroalkyl group, specifically -CF 3 , -CF 2 CF 3 , or -CF 2 CF 2 CF 3 .

上述式中,Rf2分別獨立地為可被1個或超過1個之氟原子取代的C1-6伸烷基。 In the above formula, Rf2 is independently a C1-6 alkylene group which may be substituted with 1 or more fluorine atoms.

上述可被1個或超過1個之氟原子取代的C1-6伸烷基中之「C1-6伸烷基」可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-3伸烷基,更佳為直鏈之C1-3伸烷基。 The "C 1-6 alkylene group" in the above C 1-6 alkylene group which may be substituted with 1 or more fluorine atoms may be a straight chain or a branched chain, preferably a straight chain or a branched chain C 1-3 alkylene group, more preferably a straight chain C 1-3 alkylene group.

上述Rf2較佳為可被1個或超過1個之氟原子取代的C1-6伸烷基,更佳為C1-6全氟伸烷基,又更佳為C1-3全氟伸烷基。 The above Rf2 is preferably a C1-6 alkylene group which may be substituted with one or more fluorine atoms, more preferably a C1-6 perfluoroalkylene group, and even more preferably a C1-3 perfluoroalkylene group.

上述C1-6全氟伸烷基可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-3全氟伸烷基,更佳為直鏈之C1-3全氟烷基,具體而言-CF2-、-CF2CF2-、或-CF2CF2CF2-。 The C 1-6 perfluoroalkylene group may be a linear or branched chain, preferably a linear or branched chain C 1-3 perfluoroalkylene group, more preferably a linear chain C 1-3 perfluoroalkylene group, specifically -CF 2 -, -CF 2 CF 2 -, or -CF 2 CF 2 CF 2 -.

上述式中,p為0或1。於一態樣中,p為0。於其他態樣中,p為1。 In the above formula, p is 0 or 1. In one embodiment, p is 0. In another embodiment, p is 1.

上述式中,q分別獨立地為0或1。於一態樣中,q為0。於其他態樣中,q為1。 In the above formula, q is independently 0 or 1. In one embodiment, q is 0. In another embodiment, q is 1.

上述式(A1)至(A3)中,RF分別獨立地為2價之氟聚醚基。 In the above formulae (A1) to (A3), RF is independently a divalent fluoropolyether group.

RF較佳為直鏈之二價之氟聚醚基。藉由設為直鏈之二價之氟聚醚基,黏度變得相對較低,塗佈性及可操作性提升。 RF is preferably a linear divalent fluoropolyether group. By using a linear divalent fluoropolyether group, the viscosity becomes relatively low, and the coating property and workability are improved.

RF較佳為下述式所示之基: RF is preferably a group represented by the following formula:

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3RFa 6)d-(OC2F4)e-(OCF2)f- -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f -

式中: In the formula:

RFa分別獨立地為氫原子、氟原子或氯原子, R Fa are each independently a hydrogen atom, a fluorine atom or a chlorine atom,

a、b、c、d、e及f分別獨立地為0至200之整數,a、b、c、d、e及f之和為1以上。標註a、b、c、d、e或f並以括弧括起之各重複單元在式 中的存在順序為任意。惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上。 a, b, c, d, e and f are each independently an integer from 0 to 200, and the sum of a, b, c, d, e and f is 1 or more. The order of the repetitive units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary. However, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more.

RFa較佳為氫原子或氟原子,更佳為氟原子。惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上。 R Fa is preferably a hydrogen atom or a fluorine atom, more preferably a fluorine atom. However, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more.

a、b、c、d、e及f較佳分別獨立地可為0至100之整數。 a, b, c, d, e and f are preferably integers between 0 and 100 independently.

a、b、c、d、e及f之和較佳為5以上,更佳為10以上,可為例如15以上或20以上。a、b、c、d、e及f之和較佳為200以下,更佳為100以下,又更佳為60以下,可為例如50以下或30以下。 The sum of a, b, c, d, e and f is preferably 5 or more, more preferably 10 or more, for example 15 or more or 20 or more. The sum of a, b, c, d, e and f is preferably 200 or less, more preferably 100 or less, and even more preferably 60 or less, for example 50 or less or 30 or less.

此等之重複單元可為直鏈狀或分枝鏈狀,且可包含環結構。例如,-(OC6F12)-可為-(OCF2CF2CF2CF2CF2CF2)-、-(OCF(CF3)CF2CF2CF2CF2)-、-(OCF2CF(CF3)CF2CF2CF2)-、-(OCF2CF2CF(CF3)CF2CF2)-、-(OCF2CF2CF2CF(CF3)CF2)-、-(OCF2CF2CF2CF2CF(CF3))-等。-(OC5F10)-可為-(OCF2CF2CF2CF2CF2)-、-(OCF(CF3)CF2CF2CF2)-、-(OCF2CF(CF3)CF2CF2)-、-(OCF2CF2CF(CF3)CF2)-、-(OCF2CF2CF2CF(CF3))-等。-(OC4F8)-可為-(OCF2CF2CF2CF2)-、-(OCF(CF3)CF2CF2)-、-(OCF2CF(CF3)CF2)-、-(OCF2CF2CF(CF3))-、-(OC(CF3)2CF2)-、-(OCF2C(CF3)2)-、-(OCF(CF3)CF(CF3))-、-(OCF(C2F5)CF2)-及-(OCF2CF(C2F5))-之任一者。-(OC3F6)-(亦即,上述式中,RFa為氟原子)可為-(OCF2CF2CF2)-、-(OCF(CF3)CF2)-及-(OCF2CF(CF3))-之任一者。-(OC2F4)-可為-(OCF2CF2)-及-(OCF(CF3))-之任一者。 These repeating units may be in the form of a linear chain or a branched chain, and may include a ring structure. For example, -( OC6F12 )- may be -( OCF2CF2CF2CF2CF2CF2CF2CF2 )-, -(OCF( CF3 ) CF2CF2CF2CF2CF2 )-, -( OCF2CF ( CF3) CF2CF2CF2CF2 ) -, -( OCF2CF2CF ( CF3)CF2CF2CF2) - , - ( OCF2CF2CF (CF3)CF2CF2CF2)-, -(OCF2CF2CF2CF2CF(CF3)CF2CF2 ) - , - ( OCF2CF2CF2CF2CF ( CF3 ) CF2 )-, -( OCF2CF2CF2CF2CF ( CF3 ) CF2 )-, -( OCF2CF2CF2CF2CF2CF ( CF3 ) )- , and the like. -( OC5F10 )- may be -( OCF2CF2CF2CF2CF2CF2 ) - , -(OCF( CF3 ) CF2CF2CF2CF2 ) -, -( OCF2CF ( CF3 )CF2CF2CF2 ) - , -( OCF2CF2CF ( CF3 ) CF2CF2 )-, -(OCF2CF2CF( CF3 ) CF2 )-, - ( OCF2CF2CF2CF ( CF3 ))- , or the like. -( OC4F8 )- may be any one of -( OCF2CF2CF2CF2 ) - , -(OCF( CF3 ) CF2CF2 ) - , -( OCF2CF ( CF3 ) CF2 )-, -( OCF2CF2CF ( CF3 ) ) -, -(OC(CF3)2CF2)-, -(OCF2C(CF3)2 ) - , - ( OCF( CF3 )CF( CF3 ))-, -(OCF( C2F5 ) CF2 ) -, and -( OCF2CF ( C2F5 ) )-. -(OC 3 F 6 )- (that is, in the above formula, R Fa is a fluorine atom) may be any of -(OCF 2 CF 2 CF 2 )-, -(OCF(CF 3 )CF 2 )-, and -(OCF 2 CF(CF 3 ))-. -(OC 2 F 4 )- may be any of -(OCF 2 CF 2 )- and -(OCF(CF 3 ))-.

上述環結構可為下述三員環、四員環、五員環、或六員環。 The above ring structure may be a three-membered ring, a four-membered ring, a five-membered ring, or a six-membered ring.

Figure 112112312-A0202-12-0028-5
Figure 112112312-A0202-12-0028-5

[式中,*顯示鍵結位置] [Where * indicates the key position]

於一態樣中,上述重複單元為直鏈狀。藉由將上述重複單元設為直鏈狀,可提升硬化物層之耐久性等。 In one embodiment, the above-mentioned repeating units are in a straight chain shape. By setting the above-mentioned repeating units in a straight chain shape, the durability of the hardened layer can be improved.

於一態樣中,上述重複單元為分枝鏈狀。 In one embodiment, the above-mentioned repeating unit is in the form of a branched chain.

於一態樣中,RF分別獨立地為下述式(f1)至(f6)之任一者所示之基。 In one embodiment, R and F are each independently a group represented by any one of the following formulae (f1) to (f6).

-(OC3F6)d-(OC2F4)e- (f1) -(OC 3 F 6 ) d -(OC 2 F 4 ) e - (f1)

[式中,d為1至200之整數,e為0或1,較佳為1]; [Wherein, d is an integer from 1 to 200, e is 0 or 1, preferably 1];

-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f2) -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f2)

[式中,c及d分別獨立地為0以上30以下之整數,e及f分別獨立地為1以上200以下之整數, [In the formula, c and d are independently integers greater than 0 and less than 30, e and f are independently integers greater than 1 and less than 200,

c、d、e及f之和為2以上, The sum of c, d, e and f is greater than 2,

標註c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意]; The order of the repeated units marked with c, d, e or f and enclosed in brackets in the formula is arbitrary];

-(R6-R7)g- (f3) -(R 6 -R 7 ) g - (f3)

[式中,R6為OCF2或OC2F4[wherein, R 6 is OCF 2 or OC 2 F 4 ,

R7可為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R7 may be a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups independently selected from these groups .

g為2至100之整數]; g is an integer from 2 to 100];

-(R6-R7)g-Rr-(R7’-R6’)g’- (f4) -(R 6 -R 7 ) g -R r -(R 7' -R 6' ) g' - (f4)

[式中,R6為OCF2或OC2F4[wherein, R 6 is OCF 2 or OC 2 F 4 ,

R7可為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R7 may be a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups independently selected from these groups .

R6’為OCF2或OC2F4R 6' is OCF 2 or OC 2 F 4 ,

R7’可為選自由OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R 7' may be a group selected from OC 2 F 4 , OC 3 F 6 , OC 4 F 8 , OC 5 F 10 and OC 6 F 12 , or a combination of 2 or 3 groups independently selected from these groups.

g為2至100之整數, g is an integer from 2 to 100,

g’為2至100之整數, g’ is an integer from 2 to 100,

RrR r is

Figure 112112312-A0202-12-0030-7
Figure 112112312-A0202-12-0030-7

(式中,*顯示鍵結位置)]; (where * indicates the key position)];

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f5) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f5)

[式中,e為1以上200以下之整數,a、b、c、d及f分別獨立地為0以上200以下之整數,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意] [In the formula, e is an integer greater than 1 and less than 200, a, b, c, d, and f are each independently an integer greater than 0 and less than 200, and the order of the repeated units marked with a, b, c, d, e, or f and enclosed in parentheses in the formula is arbitrary]

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f6) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f6)

[式中,f為1以上200以下之整數,a、b、c、d及e分別獨立地為0以上200以下之整數,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意] [In the formula, f is an integer greater than 1 and less than 200, a, b, c, d, and e are each independently an integer greater than 0 and less than 200, and the order of the repeated units marked with a, b, c, d, e, or f and enclosed in parentheses in the formula is arbitrary]

上述式(f1)中,d較佳為5至200,更佳為10至100,又更佳為15至50,例如25至35之整數。於一態樣中,e為1。於其他態樣中,e為0。上述式(f1)中之(OC3F6)較佳為(OCF2CF2CF2)、(OCF2CF(CF3))或 (OCF(CF3)CF2)所示之基,更佳為-(OCF2CF2CF2)d-所示之基。上述式(f1)中之(OC2F4)較佳為(OCF2CF2)、或(OCF(CF3))所示之基,更佳為(OCF2CF2)所示之基。 In the above formula (f1), d is preferably an integer of 5 to 200, more preferably 10 to 100, and even more preferably 15 to 50, for example, 25 to 35. In one embodiment, e is 1. In another embodiment, e is 0. (OC 3 F 6 ) in the above formula (f1) is preferably a group represented by (OCF 2 CF 2 CF 2 ), (OCF 2 CF(CF 3 )) or (OCF(CF 3 )CF 2 ), and more preferably a group represented by -(OCF 2 CF 2 CF 2 ) d -. (OC 2 F 4 ) in the above formula (f1) is preferably a group represented by (OCF 2 CF 2 ), or (OCF(CF 3 )), and more preferably a group represented by (OCF 2 CF 2 ).

上述式(f2)中,e及f分別獨立地較佳為5至200,更佳為10至200之整數。此外,c、d、e及f之和較佳為5以上,更佳為10以上,可為例如15以上或20以上。於一態樣中,上述式(f2)較佳為-(OCF2CF2CF2CF2)c-(OCF2CF2CF2)d-(OCF2CF2)e-(OCF2)f-所示之基。於其他態樣中,式(f2)可為-(OC2F4)e-(OCF2)f-所示之基。 In the above formula (f2), e and f are each independently preferably an integer of 5 to 200, more preferably an integer of 10 to 200. In addition, the sum of c, d, e and f is preferably 5 or more, more preferably 10 or more, for example, 15 or more or 20 or more. In one embodiment, the above formula (f2) is preferably a group represented by -(OCF 2 CF 2 CF 2 CF 2 ) c -(OCF 2 CF 2 CF 2 ) d -(OCF 2 CF 2 ) e -(OCF 2 ) f -. In other embodiments, the formula (f2) may be a group represented by -(OC 2 F 4 ) e -(OCF 2 ) f -.

上述式(f3)中,R6較佳為OC2F4。上述(f3)中,R7較佳為選自OC2F4、OC3F6及OC4F8之基,或者,為從此等基中獨立選擇之2或3個基的組合,更佳為選自OC3F6及OC4F8之基。作為獨立選自OC2F4、OC3F6及OC4F8之2或3個基之組合,並無特別限定,惟係列舉例如:-OC2F4OC3F6-、-OC2F4OC4F8-、-OC3F6OC2F4-、-OC3F6OC3F6-、-OC3F6OC4F8-、-OC4F8OC4F8-、-OC4F8OC3F6-、-OC4F8OC2F4-、-OC2F4OC2F4OC3F6-、-OC2F4OC2F4OC4F8-、-OC2F4OC3F6OC2F4-、-OC2F4OC3F6OC3F6-、-OC2F4OC4F8OC2F4-、-OC3F6OC2F4OC2F4-、-OC3F6OC2F4OC3F6-、-OC3F6OC3F6OC2F4-、及-OC4F8OC2F4OC2F4-等。上述式(f3)中,g較佳為3以上,更佳為5以上之整數。上述g較佳為50以下之整數。上述式(f3)中,OC2F4、OC3F6、OC4F8、OC5F10及OC6F12可為直鏈或分枝鏈之任一者,較佳為直鏈。此態樣中,上述式(f3)較佳為-(OC2F4-OC3F6)g-或-(OC2F4-OC4F8)g-。 In the above formula (f3), R6 is preferably OC2F4. In the above formula (f3), R7 is preferably a group selected from OC2F4, OC3F6 and OC4F8 , or a combination of two or three groups independently selected from these groups, and more preferably a group selected from OC3F6 and OC4F8 . The combination of two or three groups independently selected from OC2F4 , OC3F6 and OC4F8 is not particularly limited , but examples thereof include : -OC2F4OC3F6- , -OC2F4OC4F8- , -OC3F6OC2F4- , -OC3F6OC3F6- , -OC3F6OC4F8- , -OC4F8OC4F8- , -OC4F8OC3F6- , -OC4F8OC2F4- , -OC2F4OC2F4OC3F6- , -OC2F4OC2F4OC4F8- , -OC2F4OC3F6OC2F4- , -OC 2 F 4 OC 3 F 6 OC 3 F 6 -, -OC 2 F 4 OC 4 F 8 OC 2 F 4 -, -OC 3 F 6 OC 2 F 4 OC 2 F 4 -, -OC 3 F 6 OC 2 F 4 OC 3 F 6 -, -OC 3 F 6 OC 3 F 6 OC 2 F 4 -, and -OC 4 F 8 OC 2 F 4 OC 2 F 4 -. In the above formula (f3), g is preferably an integer of 3 or more, more preferably an integer of 5 or more. The above g is preferably an integer of 50 or less. In the above formula (f3), OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 may be a straight chain or a branched chain , preferably a straight chain. In this aspect, the above formula (f3) is preferably -(OC2F4 - OC3F6 ) g- or - ( OC2F4 - OC4F8 ) g- .

上述式(f4)中,R6、R7及g與上述式(f3)之記載同義,具有相同的態樣。R6’、R7’及g’分別與上述式(f3)記載之R6、R7及g同義,具有相同的態樣。Rr較佳為 In the above formula (f4), R 6 , R 7 and g have the same meanings and aspects as those described in the above formula (f3). R 6 ' , R 7 ' and g' have the same meanings and aspects as those described in the above formula (f3). R r is preferably

Figure 112112312-A0202-12-0032-8
Figure 112112312-A0202-12-0032-8

[式中,*顯示鍵結位置], [Where * indicates the key position],

更佳為 Better to

Figure 112112312-A0202-12-0032-9
Figure 112112312-A0202-12-0032-9

[式中,*顯示鍵結位置]。 [Where * indicates the key position].

上述式(f5)中,e較佳為1以上100以下,更佳為5以上100以下之整數。a、b、c、d、e及f之和較佳為5以上,更佳為10以上,例如10以上100以下。 In the above formula (f5), e is preferably an integer greater than 1 and less than 100, and more preferably an integer greater than 5 and less than 100. The sum of a, b, c, d, e and f is preferably greater than 5, and more preferably greater than 10, for example, greater than 10 and less than 100.

上述式(f6)中,f較佳為1以上100以下,更佳為5以上100以下之整數。a、b、c、d、e及f之和較佳為5以上,更佳為10以上,例如10以上100以下。 In the above formula (f6), f is preferably an integer greater than 1 and less than 100, and more preferably an integer greater than 5 and less than 100. The sum of a, b, c, d, e and f is preferably greater than 5, and more preferably greater than 10, for example, greater than 10 and less than 100.

於一態樣中,上述RF為上述式(f1)或(f2)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f1) or (f2).

於一態樣中,上述RF為上述式(f1)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f1).

於一態樣中,上述RF為上述式(f2)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f2).

於一態樣中,上述RF為上述式(f3)或(f4)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f3) or (f4).

於一態樣中,上述RF為上述式(f3)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f3).

於一態樣中,上述RF為上述式(f4)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f4).

於一態樣中,上述RF為上述式(f5)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f5).

於一態樣中,上述RF為上述式(f6)所示之基。 In one embodiment, the above-mentioned RF is a group represented by the above-mentioned formula (f6).

上述RF中,e對於f之比(以下稱為「e/f比」)為0.1至10,較佳為0.2至5,更佳為0.2至2,又更佳為0.2至1.5,再更佳為0.2至0.85。藉由將e/f比設為10以下,則更提升從此化合物獲得的硬化物層之耐久性及耐化學性(例如,相對於人工汗之耐久性)。e/f比更小,則更提升硬化物層之耐久性及耐化學性。另一方面,藉由將e/f比設為0.1以上,則可更提高化合物之穩定性。e/f比更大,則更提升化合物之穩定性。 In the above RF , the ratio of e to f (hereinafter referred to as "e/f ratio") is 0.1 to 10, preferably 0.2 to 5, more preferably 0.2 to 2, still more preferably 0.2 to 1.5, and still more preferably 0.2 to 0.85. By setting the e/f ratio to 10 or less, the durability and chemical resistance (for example, durability to artificial sweat) of the cured layer obtained from the compound are further improved. The smaller the e/f ratio, the further the durability and chemical resistance of the cured layer are improved. On the other hand, by setting the e/f ratio to 0.1 or more, the stability of the compound can be further improved. The larger the e/f ratio, the further the stability of the compound is improved.

於一態樣中,上述e/f比較佳為0.2至0.95,更佳為0.2至0.9。 In one embodiment, the above e/f ratio is preferably 0.2 to 0.95, and more preferably 0.2 to 0.9.

於一態樣中,就耐熱性之觀點而言,上述e/f比較佳為1.0以上,更佳為1.0至2.0。 In one embodiment, from the perspective of heat resistance, the above e/f ratio is preferably greater than 1.0, and more preferably 1.0 to 2.0.

於上述含氟聚醚基之丙烯酸化合物中,RF1及RF2部分之數目平均分子量,並非特別限定者,惟例如500至30,000,較佳為1,500至30,000,更佳為2,000至10,000。本說明書中,RF1及RF2之數目平均分子量係藉由19F-NMR所測定之值。 The number average molecular weight of RF1 and RF2 in the above fluorinated polyether group-containing acrylic compound is not particularly limited, but is, for example, 500 to 30,000, preferably 1,500 to 30,000, and more preferably 2,000 to 10,000. In this specification, the number average molecular weight of RF1 and RF2 is the value measured by 19 F-NMR.

上述式(A1)至(A3)中,RAc分別獨立地為-XD-XE(-XF-OCO-CR5=CH2)m’In the above formulae (A1) to (A3), R Ac is independently -X D -X E (-X F -OCO-CR 5 =CH 2 ) m' .

上述XD為單鍵、或二價之基,例如二價之有機基 The above X D is a single bond, or a divalent group, such as a divalent organic group

XD較佳為-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-、-OCONH-、-NHCOO-、-NH-CO-NH-、-CH2CH(OH)CH2-、-CH(CH2OH)CH2-、-(OSiR14 2)d5-、 XD is preferably -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-, -OCONH-, -NHCOO-, -NH-CO-NH- , -CH2CH (OH) CH2- , -CH ( CH2OH )CH2-, -( OSiR142 ) d5- ,

Figure 112112312-A0202-12-0034-10
Figure 112112312-A0202-12-0034-10

[式中,*及**顯示鍵結位置,*與XB鍵結,**與XE鍵結], [Where * and ** show the bond positions, * is bonded to X B , ** is bonded to X E ],

R14為C1-6烷基、或C6-16芳基, R 14 is a C 1-6 alkyl group or a C 6-16 aryl group,

d5為1至10之整數。此等基之左側係鍵結至XBd5 is an integer from 1 to 10. The left side of these bases is bonded to X B .

XD更佳為-CONH-、-CH2CH(OH)CH2-、或-CH(CH2OH)CH2-,更佳為-CONH-。 XD is more preferably -CONH-, -CH 2 CH(OH)CH 2 - or -CH(CH 2 OH)CH 2 -, and even more preferably -CONH-.

上述XE為單鍵、或(m’+1)價之基。 The above-mentioned XE is a single bond or a (m'+1)-valent group.

於一態樣中,XE為單鍵。 In one aspect, XE is a single key.

於一態樣中,XE為下述所示之三或四價之基。 In one embodiment, XE is a trivalent or tetravalent group as shown below.

-XG-XH -XG-X H

[式中: [Where:

XG為單鍵, X G is a single key.

C1-6伸烷基, C 1-6 alkylene,

-(CH2)z9-O-(CH2)z10-(式中,z9為0至6之整數,例如1至6之整數,z10為0至6之整數,例如1至6之整數)、或-(CH2)z11-伸苯基-(CH2)z12-(式中,z11為0至6之整數,例如1至6之整數,z12為0至6之整數,例如1至6之整數), -(CH 2 ) z9 -O-(CH 2 ) z10 -(wherein z9 is an integer from 0 to 6, for example, an integer from 1 to 6, and z10 is an integer from 0 to 6, for example, an integer from 1 to 6), or -(CH 2 ) z11 -phenylene-(CH 2 ) z12 -(wherein z11 is an integer from 0 to 6, for example, an integer from 1 to 6, and z12 is an integer from 0 to 6, for example, an integer from 1 to 6),

XH為如下者 X H is the following

Figure 112112312-A0202-12-0035-11
Figure 112112312-A0202-12-0035-11

R8為氫原子、或C1-6烷基] R8 is a hydrogen atom or a C1-6 alkyl group]

上述C1-6伸烷基可為直鏈或分枝鏈,較佳為直鏈。 The C 1-6 alkylene group may be a straight chain or a branched chain, preferably a straight chain.

於較佳態樣中,上述C1-6伸烷基為C2-4伸烷基。 In a preferred embodiment, the C 1-6 alkylene group is a C 2-4 alkylene group.

上述C1-6烷基較佳為C1-3烷基,更佳為甲基。 The C 1-6 alkyl group is preferably a C 1-3 alkyl group, more preferably a methyl group.

上述XF分別獨立地為單鍵、或二價之基,例如2價之有機基(較佳為碳數1至10之二價之有機基)。 The above X and F are each independently a single bond or a divalent group, such as a divalent organic group (preferably a divalent organic group having 1 to 10 carbon atoms).

於一態樣中,XFIn one embodiment, X F is

單鍵、 Single key,

C1-6伸烷基、 C 1-6 alkylene,

-(CH2)z5-O-(CH2)z6-(式中,z5為0至6之整數,例如1至6之整數,z6為0至6之整數,例如1至6之整數)、或 -(CH 2 ) z5 -O-(CH 2 ) z6 -(wherein z5 is an integer from 0 to 6, such as an integer from 1 to 6, and z6 is an integer from 0 to 6, such as an integer from 1 to 6), or

-(CH2)z7-伸苯基-(CH2)z8-(式中,z7為0至6之整數,例如1至6之整數,z8為0至6之整數,例如1至6之整數)。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。此等基之左側係鍵結至XB-(CH 2 ) z7 -phenylene-(CH 2 ) z8 - (wherein z7 is an integer from 0 to 6, such as an integer from 1 to 6, and z8 is an integer from 0 to 6, such as an integer from 1 to 6). These groups may be substituted with one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted. The left side of these groups is bonded to X B .

上述C1-6伸烷基可為直鏈或分枝鏈,較佳為直鏈。 The C 1-6 alkylene group may be a straight chain or a branched chain, preferably a straight chain.

於較佳態樣中,XF為C1-6伸烷基,較佳為C2-4伸烷基。 In a preferred embodiment, XF is C 1-6 alkylene, more preferably C 2-4 alkylene.

於一態樣中,XD、XE、及XF為單鍵。 In one aspect, XD , XE , and XF are single bonds.

上述R5為氫原子、鹵素原子、或碳數1至8之一價之有機基。 The above R 5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms.

上述一價之有機基較佳為C1-8烷基、C3-8環烷基、或C5-8芳基,更佳為C1-6烷基或苯基,又更佳為C1-3烷基,特佳為甲基。 The monovalent organic group is preferably a C 1-8 alkyl group, a C 3-8 cycloalkyl group, or a C 5-8 aryl group, more preferably a C 1-6 alkyl group or a phenyl group, still more preferably a C 1-3 alkyl group, and particularly preferably a methyl group.

於一態樣中,R5為氫原子。 In one embodiment, R 5 is a hydrogen atom.

於一態樣中,R5為甲基。 In one embodiment, R 5 is methyl.

上述m’為1至10之整數,較佳為1至3之整數,更佳為1。 The above m' is an integer from 1 to 10, preferably an integer from 1 to 3, and more preferably 1.

上述式(A1)至(A3)中,XA分別獨立地為單鍵、或二價之有機基。 In the above formulae (A1) to (A3), X and A are independently a single bond or a divalent organic group.

於一態樣中,XA分別獨立地為單鍵、或不含胺甲酸乙酯鍵結之二價之有機基。 In one embodiment, X and A are each independently a single bond or a divalent organic group not containing a urethane bond.

於較佳態樣中,XA分別獨立地單鍵、或下述所示之基。 In a preferred embodiment, X and A are independently single bonds or groups as shown below.

-(CαR11 )s1-R12 t1- -(C α R 11 ) s1 -R 12 t1 -

[式中: [Where:

R11分別獨立地為氫原子或氟原子, R 11 is independently a hydrogen atom or a fluorine atom,

α分別獨立地為1至10之整數, α is an integer from 1 to 10 independently.

R12分別獨立地為-O-、-CO-、-CONH-、-NHCO-、-COO-、-OCO-、或-OCONH-, R 12 is independently -O-, -CO-, -CONH-, -NHCO-, -COO-, -OCO-, or -OCONH-,

s1為0至3之整數, s1 is an integer from 0 to 3,

t1為0至3之整數, t1 is an integer between 0 and 3,

s1與t1之合計為1以上, The sum of s1 and t1 is greater than 1,

標註s1或t1並以括弧括起之各重複單元在式中的存在順序為任意] The order of the repeated units marked with s1 or t1 and enclosed in parentheses in the formula is arbitrary]

又,式中,左側係鍵結至RF1或RF2Also, in the formula, the left side is bonded to R F1 or R F2 .

於一態樣中,XA為單鍵。 In one aspect, XA is a single key.

於一態樣中,XA分別獨立地為上述-(CαR11 )s1-R12 t1-。 In one embodiment, XA is independently -(C α R 11 ) s1 -R 12 t1 - as described above.

上述R11較佳為氫原子。 The above R 11 is preferably a hydrogen atom.

上述α分別獨立地較佳為1至6之整數,更佳為1至4之整數,又更佳為2至4之整數。 The above α is preferably an integer from 1 to 6 independently, more preferably an integer from 1 to 4, and even more preferably an integer from 2 to 4.

上述R12分別獨立地較佳為-O-、-CO-、-NR10-、-CONH-、或-COO-,更佳為-CONH-。 The above R 12 is preferably independently -O-, -CO-, -NR 10 -, -CONH- or -COO-, and more preferably -CONH-.

上述R10為氫原子或C1-6烷基,較佳為氫原子。 The above R 10 is a hydrogen atom or a C 1-6 alkyl group, preferably a hydrogen atom.

上述s1較佳為1至3之整數,更佳為1或2,再更佳為1。 The above s1 is preferably an integer from 1 to 3, more preferably 1 or 2, and even more preferably 1.

上述t1較佳為0至2之整數,更佳為1或2,再更佳為1。 The above t1 is preferably an integer between 0 and 2, more preferably 1 or 2, and even more preferably 1.

於較佳態樣中, In the better samples,

R11為氫原子, R 11 is a hydrogen atom,

α為2至4之整數, α is an integer between 2 and 4,

R12為-O-、-CO-、-NR10-、-CONH-、或-COO-, R 12 is -O-, -CO-, -NR 10 -, -CONH-, or -COO-,

R10為氫原子或C1-6烷基, R10 is a hydrogen atom or a C1-6 alkyl group,

s1為1或2, s1 is 1 or 2,

t1為0或1。 t1 is 0 or 1.

更佳態樣中,XA為-CONR10-Cα1H2α1-、-(Cα2H2α2)-OCONR10-、-(Cα3H2α3)-、或-(Cα4H2α4)-O-(Cα5H2α5), In a more preferred embodiment, X A is -CONR 10 -C α1 H 2α1 -, -(C α2 H 2α2 )-OCONR 10 -, -(C α3 H 2α3 )-, or -(C α4 H 2α4 )-O-(C α5 H 2α5 ),

R10為氫原子或C1-6烷基, R10 is a hydrogen atom or a C1-6 alkyl group,

α1為1至10之整數, α1 is an integer from 1 to 10,

α2為1至10之整數, α2 is an integer from 1 to 10,

α3為1至10之整數, α3 is an integer from 1 to 10,

α4為0至6之整數, α4 is an integer between 0 and 6,

α5為0至6之整數。這些基的左側鍵結至RF1或RF2α5 is an integer from 0 to 6. The left side of these bases is bonded to R F1 or R F2 .

XA較佳為-CONH-CαH-。這些基的左側鍵結至RF1或RF2 XA is preferably -CONH-C α H -. The left side of these groups is bonded to RF1 or RF2 .

上述Cα1H2α1較佳為(CH2)α1The above-mentioned C α1 H 2α1 is preferably (CH 2 ) α1 .

上述Cα2H2α2較佳為(CH2)α2The above-mentioned C α2 H 2α2 is preferably (CH 2 ) α2 .

上述Cα3H2α3較佳為(CH2)α3The above-mentioned C α3 H 2α3 is preferably (CH 2 ) α3 .

上述Cα4H2α4較佳為(CH2)α4The above-mentioned C α4 H 2α4 is preferably (CH 2 ) α4 .

上述Cα5H2α5較佳為(CH2)α5The above-mentioned C α5 H 2α5 is preferably (CH 2 ) α5 .

上述式(A1)至(A3)中,XB分別獨立地為(m+1)價之基。惟,各式中,至少1個XB為含水解性矽基之(m+1)價之基。 In the above formulae (A1) to (A3), XB is independently a (m+1)-valent group. However, in each formula, at least one XB is a (m+1)-valent group containing a hydrolyzable silicon group.

於一態樣中,XB分別獨立地為含水解性矽基之(m+1)價之基。 In one embodiment, X and B are each independently a (m+1)-valent group containing a hydrolyzable silicon group.

於一態樣中,XB分別獨立地包含下述所示之基的基, In one embodiment, X and B each independently comprise a radical as shown below,

SiR1 nbRsb 4-nb SiR 1 nb R sb 4-nb

[式中: [Where:

R1為羥基或水解性基, R1 is a hydroxyl group or a hydrolyzable group,

Rsb為單鍵, R sb is a single bond.

nb為1或2], nb is 1 or 2],

或者,為下述所示之基。 Or, the base shown below.

XBa(RSi)na X Ba (R Si ) na

[式中: [Where:

XBa分別獨立地為(m+na+1)價之基, X Ba are independently (m+na+1)-valence bases,

RSi分別獨立地為-XC-SiR1 n’R2 3-n’R Si are independently -X C -SiR 1 n' R 2 3-n' ,

XC為碳數1至10之二價之有機基, X C is a divalent organic group having 1 to 10 carbon atoms,

R1分別獨立地為羥基或水解性基, R1 is independently a hydroxyl group or a hydrolyzable group,

R2分別獨立地為氫原子或1價之有機基, R2 is independently a hydrogen atom or a monovalent organic group,

n’為1至3之整數, n’ is an integer from 1 to 3,

na為1至10之整數] na is an integer from 1 to 10]

於一態樣中,XB分別獨立地為XBa(RSi)na所示之基。 In one embodiment, X B is independently X Ba (R Si ) na .

[式中: [Where:

XBa分別獨立地為(m+na+1)價之基, X Ba are independently (m+na+1)-valence bases,

RSi分別獨立地為-XC-SiR1 n’R2 3-n’R Si are independently -X C -SiR 1 n' R 2 3-n' ,

XC為碳數1至10之二價之有機基, X C is a divalent organic group having 1 to 10 carbon atoms,

R1分別獨立地為羥基或水解性基, R1 is independently a hydroxyl group or a hydrolyzable group,

R2分別獨立地為氫原子或1價之有機基, R2 is independently a hydrogen atom or a monovalent organic group,

n’為1至3之整數, n’ is an integer from 1 to 3,

na為1至10之整數] na is an integer from 1 to 10]

於這些態樣中,式(A1)及(A2)分別為下述式(A1-a)及(A2-a)所示: In these aspects, formula (A1) and (A2) are respectively represented by the following formula (A1-a) and (A2-a):

RF1-XA-XBaRSi naRAc m (A1-a) R F1 -X A -X Ba R Si na R Ac m (A1-a)

RAc mRSi naXBa-XA-RF2-XA-XBaRSi naRAc m (A2-a) R Ac m R Si na X Ba -X A -R F2 -X A -X Ba R Si na R Ac m (A2-a)

[式中,各記號與上述相同] [In the formula, all symbols are the same as above]

上述式(A1)至(A3)中,RSi分別獨立地為-XC-SiR1 n’R2 3-n’In the above formulae (A1) to (A3), R Si is independently -X C -SiR 1 n' R 2 3-n' .

上述XC為碳數1至10之二價之有機基。 The above X C is a divalent organic group having 1 to 10 carbon atoms.

於一態樣中,XC為C1-6伸烷基、 In one embodiment, X C is C 1-6 alkylene,

-(CH2)z1-O-(CH2)z2-(式中,z1為0至6之整數,例如1至6之整數,z2為0至6之整數,例如1至6之整數)、 -(CH 2 ) z1 -O-(CH 2 ) z2 -(wherein z1 is an integer from 0 to 6, for example, an integer from 1 to 6, and z2 is an integer from 0 to 6, for example, an integer from 1 to 6),

-(CH2)z3-伸苯基-(CH2)z4-(式中,z3為0至6之整數,例如1至6之整數,z4為0至6之整數,例如1至6之整數)、或-(CH2)z13-OCONH-(CH2)z14-(式中,z13為0至6之整數,z14為0至6之整數)。此等基例如可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。此等基之左側係鍵結至XB-(CH 2 ) z3 -phenylene-(CH 2 ) z4 - (wherein z3 is an integer from 0 to 6, for example, an integer from 1 to 6, and z4 is an integer from 0 to 6, for example, an integer from 1 to 6), or -(CH 2 ) z13 -OCONH-(CH 2 ) z14 - (wherein z13 is an integer from 0 to 6, and z14 is an integer from 0 to 6). These groups may be substituted with one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted. The left side of these groups is bonded to X B .

上述C1-6伸烷基可為直鏈或分枝鏈,較佳為直鏈。 The C 1-6 alkylene group may be a straight chain or a branched chain, preferably a straight chain.

於較佳態樣中,XC為C1-6伸烷基,較佳為C2-4伸烷基。 In a preferred embodiment, X C is C 1-6 alkylene, more preferably C 2-4 alkylene.

上述R1分別獨立地為羥基或水解性基。 The above R 1's are each independently a hydroxyl group or a hydrolyzable group.

R1較佳分別獨立地為水解性基。 It is preferred that R1 's are each independently a hydrolyzable group.

R1較佳分別獨立地為-ORh、-OCORh、-O-N=CRh 2、-NRh 2、-NHRh、-NCO、或鹵素(此等之式中,Rh表示取代或未取代之C1-4烷基),更佳為-ORh(亦即,烷氧基)。作為Rh,係列舉甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中,較佳 為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rh為甲基,於其他態樣中,Rh為乙基。 R 1 is preferably independently -OR h , -OCOR h , -ON=CR h 2 , -NR h 2 , -NHR h , -NCO, or halogen (in the formulas, R h represents a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR h (i.e., alkoxy group). R h includes unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among them, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, R h is methyl, and in another embodiment, R h is ethyl.

上述R2分別獨立地為氫原子或1價之有機基。這些1價之有機基為除了上述水解性基之外的1價之有機基。 The above R2 is independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

於R2中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In R 2 , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述式中,n’在每個(SiR1 n’R2 3-n’)單元分別獨立地為1至3之整數,較佳為2或3,更佳為3。 In the above formula, n' in each (SiR 1 n' R 2 3-n' ) unit is independently an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

上述na較佳為1至6之整數,更佳為1至3之整數,特佳為1。 The above na is preferably an integer from 1 to 6, more preferably an integer from 1 to 3, and particularly preferably 1.

於一態樣中,上述XBa為3價之基,較佳可為 In one embodiment, the above X Ba is a trivalent group, preferably

Figure 112112312-A0202-12-0041-13
Figure 112112312-A0202-12-0041-12
。於一態樣中,上述-C(-O-)-為O鍵結至RSi。於其他態樣中,-C(-O-)-為O鍵結至RAc
Figure 112112312-A0202-12-0041-13
,
Figure 112112312-A0202-12-0041-12
In one embodiment, the above-mentioned -C(-O-)- is O-bonded to R Si . In other embodiments, the -C(-O-)- is O-bonded to R Ac .

於較佳態樣中,XBa為N。此時,式中,m為1、n為1。 In a preferred embodiment, X Ba is N. In this case, m is 1 and n is 1.

於其他態樣中,XB分別獨立地為包含SiR1 nbRsb 4-nb所示之基的基, In other aspects, X and B are each independently a group including a group represented by SiR 1 nb R sb 4-nb ,

[式中: [Where:

R1為羥基或水解性基, R1 is a hydroxyl group or a hydrolyzable group,

Rsb為單鍵, R sb is a single key.

nb為1或2] nb is 1 or 2]

較佳為-XBb-SiR1 nbRsb 4-nb所示之基。 Preferred is a group represented by -X Bb -SiR 1 nb R sb 4-nb .

[式中: [Where:

XBb為單鍵、或2價之基, X Bb is a single bond or a divalent base,

R1為羥基或水解性基, R1 is a hydroxyl group or a hydrolyzable group,

Rsb為單鍵, R sb is a single bond.

nb為1或2] nb is 1 or 2]

於這些態樣中,式(A1)及(A2)分別為下述式(A1-b)及(A2-b)所示: In these aspects, formula (A1) and (A2) are respectively represented by the following formula (A1-b) and (A2-b):

RF1-XA-XBb-SiRa nbRAc m (A1-b) R F1 -X A -X Bb -SiR a nb R Ac m (A1-b)

RAc mRa nbSi-XBb-XA-RF2-XA-XBb-SiRa nbRAc m (A2-b) R Ac m R a nb Si-X Bb -X A -R F2 -X A -X Bb -SiR a nb R Ac m (A2-b)

[式中,各記號與上述同義] [In the formula, each symbol has the same meaning as above]

於一態樣中,nb為1。 In one state, nb is 1.

於其他態樣中,nb為2。 In other cases, nb is 2.

於一態樣中,XBb為單鍵。 In one aspect, X Bb is a single key.

於其他態樣中,XBb為2價之基、C1-6伸烷基。 In other aspects, XBb is a divalent group, a C1-6 alkylene group.

上述式(A1)及(A2)中,m分別獨立地為0至10之整數,n分別獨立地為1至10之整數。 In the above formulas (A1) and (A2), m is an integer from 0 to 10 independently, and n is an integer from 1 to 10 independently.

m較佳為1至10之整數,更佳為1至6之整數,又更佳為1至3之整數,再更佳為1。 m is preferably an integer from 1 to 10, more preferably an integer from 1 to 6, even more preferably an integer from 1 to 3, and even more preferably 1.

n較佳為1至6之整數,更佳為1至3之整數,特佳為1。 n is preferably an integer from 1 to 6, more preferably an integer from 1 to 3, and particularly preferably 1.

於較佳態樣中,m為1,n為1。 In the optimal case, m is 1 and n is 1.

上述(A3)中,Ra分別獨立地為(m3+2)價之有機基。 In the above (A3), Ra is independently an organic group having a valence of (m3+2).

於一態樣中,Ra為下述式所示之基: In one embodiment, Ra is a radical represented by the following formula:

-R9-(Ra’-R9)k- -R 9 -(R a' -R 9 ) k -

[式中: [Where:

R9分別獨立地為C1-6伸烷基, R 9 are each independently C 1-6 alkylene,

Ra’分別獨立地為3價之基,例如3價之有機基, R a' is independently a trivalent group, such as a trivalent organic group,

k為1至4之整數] k is an integer from 1 to 4]

這些基中,上述-C(-O-)-為O鍵結至RAcIn these groups, the above-mentioned -C(-O-)- is O-bonded to R Ac .

R9較佳為C1-4伸烷基,更佳為C2-4伸烷基。 R 9 is preferably a C 1-4 alkylene group, more preferably a C 2-4 alkylene group.

於一態樣中,k為0。 In one embodiment, k is 0.

於其他態樣中,k為1至4之整數。 In other forms, k is an integer from 1 to 4.

於較佳態樣中,k為1至2之整數。 In the preferred embodiment, k is an integer between 1 and 2.

於一態樣中,k為1。 In one embodiment, k is 1.

於一態樣中,k為2。 In one embodiment, k is 2.

於一態樣中,Ra’分別獨立地為包含N原子或O原子之3價之基。 In one embodiment, Ra ' is independently a trivalent group containing a N atom or an O atom.

於較佳態樣中,Ra’分別獨立地為在N、-C(-O-)-、碳-碳原子間可包含胺鍵結、醯胺鍵結、胺甲酸乙酯鍵結、脲鍵結、醚鍵結、或酯鍵結之3價之基 In a preferred embodiment, Ra ' is independently a trivalent group which may include an amine bond, an amide bond, a urethane bond, a urea bond, an ether bond, or an ester bond between N, -C(-O-)-, and a carbon-carbon atom.

於一態樣中,Ra’分別獨立地為下述之基: In one aspect, Ra ' is independently the following:

Figure 112112312-A0202-12-0043-14
Figure 112112312-A0202-12-0043-14

於一態樣中,Ra’為N。 In one aspect, Ra ' is N.

於一態樣中,Ra’為-C(-O-)-。 In one embodiment, Ra ' is -C(-O-)-.

上述式(A3)中,m3為0至4之整數。 In the above formula (A3), m3 is an integer from 0 to 4.

m3較佳為1至4之整數,更佳為1或2。 m3 is preferably an integer between 1 and 4, more preferably 1 or 2.

於一態樣中,m3為1。 In one embodiment, m3 is 1.

於一態樣中,m3為2。 In one embodiment, m3 is 2.

上述式(A3)中,Rg分別獨立地為-NRcCO-Re-、-NRcCOO-Re-、或-NRcCONRc-Re-。於此,此等基之左側係鍵結至RaIn the above formula (A3), R g is independently -NR c CO- Re -, -NR c COO- Re -, or -NR c CONR c -Re -, wherein the left side of these groups is bonded to Ra .

上述Rg較佳為-NRcCO-ReThe above-mentioned R g is preferably -NR c CO-R e .

上述Rc分別獨立地為氫原子、C1-6烷基、或C6-16芳基。 The above R c are independently a hydrogen atom, a C 1-6 alkyl group, or a C 6-16 aryl group.

上述C1-6烷基較佳為C1-3烷基,特佳為甲基。C1-6烷基可為直鏈或分枝鏈。 The C 1-6 alkyl group is preferably a C 1-3 alkyl group, and is particularly preferably a methyl group. The C 1-6 alkyl group may be a straight chain or a branched chain.

上述C6-16芳基較佳為C6-10芳基,更佳為苯基。 The above C 6-16 aryl group is preferably a C 6-10 aryl group, more preferably a phenyl group.

於一態樣中,Rc為氫原子。 In one embodiment, R c is a hydrogen atom.

於一態樣中,Rc為甲基。 In one embodiment, R c is methyl.

上述式中,Re分別獨立地為單鍵、或2價之有機基。 In the above formula, Re is independently a single bond or a divalent organic group.

於一態樣中,Re為單鍵。 In one aspect, Re is a single bond.

於一態樣中,Re分別獨立地為2價之有機基。 In one embodiment, Re is each independently a divalent organic group.

上述2價之有機基較佳為-R43-Ox2-R44-(式中,R43及R44分別獨立地為單鍵或C1-20伸烷基、x2為0或1)。這些C1-20伸烷基可為直鏈或分枝鏈,惟較佳為直鏈。這些C1-20伸烷基較佳為C1-10伸烷基,更佳為C1-6伸烷基,又更佳為C1-3伸烷基。 The above-mentioned divalent organic group is preferably -R 43 -O x2 -R 44 - (wherein R 43 and R 44 are independently a single bond or a C 1-20 alkylene group, and x2 is 0 or 1). These C 1-20 alkylene groups may be straight chains or branched chains, but are preferably straight chains. These C 1-20 alkylene groups are preferably C 1-10 alkylene groups, more preferably C 1-6 alkylene groups, and even more preferably C 1-3 alkylene groups.

上述式(A3)中,x為1以上之整數。 In the above formula (A3), x is an integer greater than 1.

於一態樣中,x較佳為1以上100以下之整數,更佳為1以上10以下之整數,又更佳為1以上5以下之整數,例如2以上10以下之整數,又更佳為2以上5以下之整數。 In one embodiment, x is preferably an integer greater than 1 and less than 100, more preferably an integer greater than 1 and less than 10, and even more preferably an integer greater than 1 and less than 5, for example, an integer greater than 2 and less than 10, and even more preferably an integer greater than 2 and less than 5.

於較佳態樣中,式(A3)為下述式(A3-a): In a preferred embodiment, formula (A3) is the following formula (A3-a):

Rb 2N-Rj-(RF2-Rg-Ra(RAc)m3-Rg)x-RF2-Rj-NRb 2 (A3-a) R b 2 NR j -(R F2 -R g -R a (R Ac ) m3 -R g ) x -R F2 -R j -NR b 2 (A3-a)

[式中, [Where,

Rb分別獨立地為RSi、RAc、或RcR b is independently R Si , R Ac , or R c ,

惟,Rb之至少1個為RSiHowever, at least one of R b is R Si ,

Rj分別獨立地為-CO-Rd-、-O-Rd-、或-NRc-Rd-,於此,此等基之左側係鍵結至RF2 Rj is independently -CO- Rd- , -ORd- , or -NRc - Rd- , wherein the left side of these groups is bonded to Rf2 ,

Rd分別獨立地為單鍵、或二價之有機基, R d are each independently a single bond or a divalent organic group,

RF2、Ra、Rc、RAc、m3、及x與上述同義] R F2 , Ra , R c , R Ac , m3 and x are the same as above]

上述式(A3-a)中,Rb分別獨立地為RSi、RAc、或RcIn the above formula (A3-a), R b is independently R Si , R Ac , or R c .

上述式(A3-a)中,至少1個之Rb為RSiIn the above formula (A3-a), at least one R b is R Si .

於較佳態樣中,與式(A3-a)之位於各末端的N原子鍵結的Rb之至少1個為RSiIn a preferred embodiment, at least one of the R b bonded to each terminal N atom of formula (A3-a) is R Si .

於一態樣中,與式(A3-a)之位於各末端的N原子鍵結的Rb之1個為RSi、其他為RcIn one embodiment, one of the R b bonded to the N atom at each terminal of the formula (A3-a) is R Si , and the other is R c .

於其他態樣中,與式(A3-a)之位於各末端的N原子鍵結的Rb之1個為RSi、其他為RAcIn another embodiment, one of the R b bonded to the N atom at each terminal of the formula (A3-a) is R Si , and the other is R Ac .

於較佳態樣中,RAc為-CONH-XF-OCO-CR5=CH2In a preferred embodiment, R Ac is -CONH-X F -OCO-CR 5 =CH 2 .

上述Rj分別獨立地為-CO-Rd-、-O-Rd-、或-NRc-Rd-。於此,此等基之左側係鍵結至RF2The above R j is independently -CO-R d -, -OR d -, or -NR c -R d -, wherein the left side of these groups is bonded to R F2 .

於一態樣中,Rj分別獨立地為-CO-Rd-。 In one embodiment, Rj is independently -CO- Rd- .

上述Rd分別獨立地為單鍵、或二價之有機基。 The above R d are each independently a single bond or a divalent organic group.

於一態樣中,Rd為單鍵。 In one aspect, Rd is a single bond.

於其他態樣中,Rd為二價之有機基。 In other aspects, Rd is a divalent organic group.

Rd中之二價之有機基為C1-10伸烷基,較佳為C2-6伸烷基、 The divalent organic group in Rd is a C 1-10 alkylene group, preferably a C 2-6 alkylene group,

-(CH2)z13-O-(CH2)z14-(式中,z13為0至6之整數,例如1至6之整數,z14為0至6之整數,例如1至6之整數)、 -(CH 2 ) z13 -O-(CH 2 ) z14 -(wherein z13 is an integer from 0 to 6, for example, an integer from 1 to 6, and z14 is an integer from 0 to 6, for example, an integer from 1 to 6),

-(CH2)z15-伸苯基-(CH2)z16-(式中,z15為0至6之整數,例如1至6之整數,z16為0至6之整數,例如1至6之整數)、或 -(CH 2 ) z15 -phenylene-(CH 2 ) z16 - (wherein z15 is an integer from 0 to 6, such as an integer from 1 to 6, and z16 is an integer from 0 to 6, such as an integer from 1 to 6), or

-(CH2)z17-NR10-(CH2)z18-(式中,R10為氫原子或C1-6烷基,z17為0至6之整數,z18為0至6之整數)。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。此等基之左側係鍵結至CO。 -(CH 2 ) z17 -NR 10 -(CH 2 ) z18 -(wherein R 10 is a hydrogen atom or a C 1-6 alkyl group, z17 is an integer from 0 to 6, and z18 is an integer from 0 to 6). These groups may be substituted with one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted. The left side of these groups is bonded to CO.

Rd中之二價之有機基較佳為-(CH2)z17-NR10-(CH2)z18-(式中,R10為氫原子或C1-6烷基,z17為0至6之整數,z18為0至6之整數),更佳為-NR10-(CH2)z18-(式中,R10為氫原子或C1-6烷基,z18為1至6之整數)。 The divalent organic group in Rd is preferably -( CH2 ) z17 - NR10- ( CH2 ) z18- (wherein R10 is a hydrogen atom or a C1-6 alkyl group, z17 is an integer from 0 to 6, and z18 is an integer from 0 to 6), and more preferably -NR10- ( CH2 ) z18- (wherein R10 is a hydrogen atom or a C1-6 alkyl group, and z18 is an integer from 1 to 6).

上述C1-10伸烷基可為直鏈或分枝鏈,較佳為直鏈。 The C 1-10 alkylene group may be a straight chain or a branched chain, preferably a straight chain.

於較佳態樣中,式(A3)為式(A3-b): In a preferred embodiment, formula (A3) is formula (A3-b):

Rb 2N-Rd-CO-(RF2-CO-NRc-Ra(RAc)m3-NRc-CO)x-RF2-CO-Rd-NRb 2 (A3-b) R b 2 NR d -CO-(R F 2 -CO-NR c -R a (R Ac ) m3 -NR c -CO) x -R F 2 -CO-R d -NR b 2 (A3-b)

[式中,RF2、Ra、Rb、Rc、Rd、RAc、m3、及x與上述同義] [wherein, R F2 , Ra , R b , R c , R d , R Ac , m3, and x have the same meanings as above]

上述式(A1)至(A3)所示之含氟聚醚基之丙烯酸化合物,並非特別限定者,惟可具有5×102至2×105之數目平均分子量。在這些範圍之中,就磨耗耐久性之觀點而言,較佳為具有2×103至1×105,更佳為具有3×103至2×104之數目平均分子量。又,這些「數目平均分子量」係藉由19F-NMR所測定的值。 The fluorinated polyether group-containing acrylic compounds represented by the above formulae (A1) to (A3) are not particularly limited, but may have a number average molecular weight of 5×10 2 to 2×10 5. Within these ranges, from the viewpoint of wear durability, the number average molecular weight is preferably 2×10 3 to 1×10 5 , and more preferably 3×10 3 to 2×10 4. In addition, these "number average molecular weights" are values measured by 19 F-NMR.

上述式(A1)及(A2)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得:首先,調配具有-NH-、-C(OH)-等之反應性部位的含氟聚醚基之矽烷化合物,其次,使具有(甲基)丙烯酸基的化合物與上述反應性部位反應。 The fluorinated polyether group-containing acrylic compounds represented by the above formulas (A1) and (A2) can be obtained by first preparing a fluorinated polyether group-containing silane compound having a reactive site such as -NH-, -C(OH)-, etc., and then reacting a compound having a (meth) acrylic group with the reactive site.

於一態樣中,上述式(A1)及(A2)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A1) and (A2) can be obtained by the following method. Make the compound represented by the following formula:

RF1-COOR21 R F1 -COOR 21

R21OOC-RF2-COOR21 R 21 OOC-R F2 -COOR 21

(式中,R21為氫原子或甲基、RF1及RF2與關於式(A1)及(A2)之記載同義。) (In the formula, R21 is a hydrogen atom or a methyl group, and RF1 and RF2 have the same meanings as those described in formulas (A1) and (A2).)

與下述式所示之化合物反應, React with the compound shown in the following formula,

R24-R23-NH-R22-SiR1 n’R2 3-n’ R 24 -R 23 -NH-R 22 -SiR 1 n' R 2 3-n'

(式中,R22為二價之基, (In the formula, R 22 is a divalent group,

R23為二價之基, R23 is a divalent group,

R24為NH2等之反應性基, R 24 is a reactive group such as NH 2 ,

R1、R2、及n’與關於式(A1)及(A2)之記載同義。) R 1 , R 2 , and n' have the same meanings as those described in relation to formulas (A1) and (A2).

而獲得下述式所示之化合物。 The compound shown in the following formula is obtained.

RF1-R25-R23-NH-R22-SiR1 n’R2 3-n’ R F1 -R 25 -R 23 -NH-R 22 -SiR 1 n' R 2 3-n'

R2 3-n’R1 n’Si-R22-HN-R23-R25-RF2-R25-R23-NH-R22-SiR1 n’R2 3-n’ R 2 3-n' R 1 n' Si-R 22 -HN-R 23 -R 25 -RF2 -R 25 -R 23 -NH-R 22 -SiR 1 n' R 2 3-n'

其次,使上述化合物與下述式, Next, the above compound is mixed with the following formula,

R34-R35-OCOCH=CH2 R 34 -R 35 -OCOCH=CH 2

(式中,R34為-NCO、-COOH、-COOCl等之反應性基, (In the formula, R 34 is a reactive group such as -NCO, -COOH, -COOCl, etc.,

R35為二價之基)、或 R 35 is a divalent group), or

R56-OCOCR57=CH2所示之化合物反應。 The compound represented by R 56 -OCOCR 57 =CH 2 is reacted.

(式中,R56為鹵素、H、或一價之烴基, (wherein, R 56 is a halogen, H, or a monovalent hydrocarbon group,

R57為氫原子或C1-3烷基) R 57 is a hydrogen atom or a C 1-3 alkyl group)

於一態樣中,上述式(A1)及(A2)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A1) and (A2) can be obtained by the following method. Make the compound represented by the following formula:

RF1-COF R F1 -COF

FOC-RF2-COF FOC-R F2 -COF

(式中,RF1及RF2與關於式(A1)及(A2)之記載同義。) (In the formula, R F1 and R F2 have the same meanings as those described in formulas (A1) and (A2).)

與Br-Mg-CH2CH=CH2反應而獲得下述式所示之化合物。 It reacts with Br-Mg-CH 2 CH=CH 2 to obtain the compound shown in the following formula.

RF1-C(OH)(CH2CH=CH2)2 R F1 -C(OH)(CH 2 CH=CH 2 ) 2

(CH2=CHCH2)2(HO)C-RF2-C(OH)(CH2CH=CH2)2 (CH 2 =CHCH 2 ) 2 (HO)CR F2 -C(OH)(CH 2 CH=CH 2 ) 2

其次,使上述化合物與下述式反應: Secondly, react the above compound with the following formula:

HSiR1 n’R2 3-n’ HSiR 1 n' R 2 3-n'

而獲得下述式所示之化合物。 The compound shown in the following formula is obtained.

RF1-C(OH)(CH2CH=CH2)2 R F1 -C(OH)(CH 2 CH=CH 2 ) 2

(R2 3-n’R1 n’Si-CH2CH2CH2)2(HO)C-RF2-C(OH)(CH2CH2CH2-SiR1 n’R2 3-n’)2 (R 2 3-n' R 1 n' Si-CH 2 CH 2 CH 2 ) 2 (HO)CR F2 -C(OH)(CH 2 CH 2 CH 2 -SiR 1 n' R 2 3-n' ) 2

其次,使上述化合物與下述式所示之化合物反應。 Next, the above compound is reacted with the compound represented by the following formula.

R34-R35-OCOCH=CH2 R 34 -R 35 -OCOCH=CH 2

(式中,R34為-NCO、-COOH等之反應性基, (In the formula, R 34 is a reactive group such as -NCO, -COOH, etc.,

R35為二價之基) R 35 is a divalent group)

於一態樣中,上述式(A1)及(A2)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A1) and (A2) can be obtained by the following method. Make the compound represented by the following formula:

HOCH2-RF2-CH2OH HOCH2 - RF2 - CH2OH

(式中,RF1及RF2與關於式(A1)及(A2)之記載同義。) (In the formula, R F1 and R F2 have the same meanings as those described in formulas (A1) and (A2).)

Figure 112112312-A0202-12-0049-15
反應,而獲得 and
Figure 112112312-A0202-12-0049-15
Reaction, and obtain

Figure 112112312-A0202-12-0049-16
Figure 112112312-A0202-12-0049-16

其次,使上述化合物與OCN-(CH2)3-SiR1 n’R2 3-n’反應, Next, the above compound is reacted with OCN-(CH 2 ) 3 -SiR 1 n' R 2 3-n' .

(式中,各記號與上述同義。) (In the formula, each symbol has the same meaning as above.)

而獲得下述所示之化合物。 The following compounds were obtained.

Figure 112112312-A0202-12-0049-17
Figure 112112312-A0202-12-0049-17

(式中,各記號與上述同義。) (In the formula, each symbol has the same meaning as above.)

於一態樣中,上述式(A1)及(A2)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A1) and (A2) can be obtained by the following method. Make the compound represented by the following formula:

Figure 112112312-A0202-12-0049-18
Figure 112112312-A0202-12-0049-18

(式中,各記號與上述同義。) (In the formula, each symbol has the same meaning as above.)

與HOOC=CH2反應,而獲得 Reaction with HOOC=CH 2 to obtain

Figure 112112312-A0202-12-0050-19
Figure 112112312-A0202-12-0050-19

(式中,各記號與上述同義。) (In the formula, each symbol has the same meaning as above.)

其次,使上述化合物與OCN-(CH2)3-SiR1 n’R2 3-n’反應 Next, the above compound is reacted with OCN-(CH 2 ) 3 -SiR 1 n' R 2 3-n'

(式中,各記號與上述同義。) (In the formula, each symbol has the same meaning as above.)

而獲得下述所示之化合物 The following compound was obtained

Figure 112112312-A0202-12-0050-20
Figure 112112312-A0202-12-0050-20

(式中,各記號與上述同義。) (In the formula, each symbol has the same meaning as above.)

於一態樣中,上述式(A3)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A3) can be obtained by the following method. Make the compound represented by the following formula:

R21OOC-RF2-COOR21 R 21 OOC-R F2 -COOR 21

[式中,R21為氫原子或甲基,RF2與關於式(A3)之記載同義] [In the formula, R21 is a hydrogen atom or a methyl group, and RF2 has the same meaning as described in formula (A3)]

與下述式反應: Reacts with the following formula:

NH2-R9-(NH-R9)k-NH2 NH 2 -R 9 -(NH-R 9 ) k -NH 2

[式中,R9、及k與關於式(A3)之記載同義] [wherein, R 9 and k have the same meanings as those described in formula (A3)]

而獲得R21OOC-(RF2-CONH-R9-(NH-R9)k-NHCO)x-RF2-COOR21R 21 OOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -R F2 -COOR 21 is obtained.

[式中,R21為氫原子或甲基,RF2、R9、及k與關於式(A3)之記載同義] [In the formula, R21 is a hydrogen atom or a methyl group, and RF2 , R9 , and k have the same meanings as described in relation to formula (A3)]

其次,使獲得的化合物與下述所示之化合物反應, Next, the obtained compound is reacted with the compound shown below,

NR23 mH2-m-R22-SiR1 n’R2 3-n’ NR 23 m H 2-m -R 22 -SiR 1 n' R 2 3-n'

[式中,R23為C1-6之烷基或苯基,m為0或1、R22為二價之基,R1、R2、及n’與關於式(A3)之記載同義] [In the formula, R 23 is a C 1-6 alkyl group or a phenyl group, m is 0 or 1, R 22 is a divalent group, and R 1 , R 2 , and n' have the same meanings as described in relation to formula (A3)]

而獲得下述式所示之化合物。 The compound shown in the following formula is obtained.

R2 3-n’R1 n’Si-R22-HNOC-(RF2-CONH-R9-(NH-R9)k-NHCO)x-RF2-CONH-R22-SiR1 n’R2 3-n’ R 2 3-n' R 1 n' Si-R 22 -HNOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -R F2 -CONH-R 22 -SiR 1 n' R 2 3-n'

其次,使獲得的化合物與下述式所示之化合物反應從而可獲得式(A3)所示之化合物。 Next, the obtained compound is reacted with a compound represented by the following formula to obtain a compound represented by formula (A3).

R34-R35-OCOCH=CH2 R 34 -R 35 -OCOCH=CH 2

[式中,R34為-NCO、-COOH等之反應性基, [In the formula, R 34 is a reactive group such as -NCO, -COOH, etc.,

R35為二價之基] R 35 is a divalent group]

於一態樣中,上述式(A3)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A3) can be obtained by the following method. Make the compound represented by the following formula:

R21OOC-RF2-COOR21 R 21 OOC-R F2 -COOR 21

[式中,R21為氫原子或甲基,RF2與關於式(A3)之記載同義] [In the formula, R21 is a hydrogen atom or a methyl group, and RF2 has the same meaning as described in formula (A3)]

與下述式反應: Reacts with the following formula:

NH2-R9-(CH(OH)-R9)k-NH2 NH 2 -R 9 -(CH(OH)-R 9 ) k -NH 2

[式中,R9、及k與關於式(A3)之記載同義] [wherein, R 9 and k have the same meanings as those described in formula (A3)]

而獲得下述式。 And the following formula is obtained.

R21OOC-(RF2-CONH-R9-(CH(OH)-R9)k-NHCO)x-RF2-COOR21 R 21 OOC-(R F2 -CONH-R 9 -(CH(OH)-R 9 ) k -NHCO) x -R F2 -COOR 21

[式中,R21為氫原子或甲基,RF2、R9、及k與關於式(A3)之記載同義] [In the formula, R21 is a hydrogen atom or a methyl group, and RF2 , R9 , and k have the same meanings as described in relation to formula (A3)]

其次,使獲得的化合物與下述所示之化合物反應, Next, the obtained compound is reacted with the compound shown below,

NR23 mH2-m-R22-SiR1 n’R2 3-n’ NR 23 m H 2-m -R 22 -SiR 1 n' R 2 3-n'

[式中,R23為C1-6之烷基或苯基,m為0或1、R22為二價之基,R1、R2、及n’與關於式(A3)之記載同義] [In the formula, R 23 is a C 1-6 alkyl group or a phenyl group, m is 0 or 1, R 22 is a divalent group, and R 1 , R 2 , and n' have the same meanings as described in relation to formula (A3)]

而獲得下述式所示之化合物。 The compound shown in the following formula is obtained.

R2 3-n’R1 n’Si-R22-HNOC-(RF2-CONH-R9-(CH(OH)-R9)k-NHCO)x-RF2-CONH-R22-SiR1 n’R2 3-n’ R 2 3-n' R 1 n' Si-R 22 -HNOC-(R F2 -CONH-R 9 -(CH(OH)-R 9 ) k -NHCO) x -R F2 -CONH-R 22 -SiR 1 n' R 2 3-n'

其次,使獲得的化合物與下述式所示之化合物反應,藉此可獲得式(A3)所示之化合物。 Next, the obtained compound is reacted with a compound represented by the following formula to obtain a compound represented by formula (A3).

R34-R35-OCOCH=CH2 R 34 -R 35 -OCOCH=CH 2

[式中,R34為-NCO、-COOH等之反應性基, [In the formula, R 34 is a reactive group such as -NCO, -COOH, etc.,

R35為二價之基] R 35 is a divalent group]

於一態樣中,上述式(A3)所示之含氟聚醚基之丙烯酸化合物可藉由下述而獲得。使下述式所示之化合物: In one embodiment, the fluorinated polyether group-containing acrylic compound represented by the above formula (A3) can be obtained by the following method. Make the compound represented by the following formula:

R21OOC-RF2-COOR21 R 21 OOC-R F2 -COOR 21

[式中,R21為氫原子或甲基,RF2與關於式(A3)之記載同義] [In the formula, R21 is a hydrogen atom or a methyl group, and RF2 has the same meaning as described in formula (A3)]

與下述式反應: Reacts with the following formula:

NH2-R9-(NH-R9)k-NH2 NH 2 -R 9 -(NH-R 9 ) k -NH 2

[式中,R9、及k與關於式(A3)之記載同義] [wherein, R 9 and k have the same meanings as those described in formula (A3)]

而獲得R21OOC-(RF2-CONH-R9-(NH-R9)k-NHCO)x-RF2-COOR21R 21 OOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -R F2 -COOR 21 is obtained.

[式中,R21為氫原子或甲基,RF2、R9、及k與關於式(A3)之記載同義] [In the formula, R21 is a hydrogen atom or a methyl group, and RF2 , R9 , and k have the same meanings as described in relation to formula (A3)]

其次,使獲得的化合物與下述所示之化合物反應, Next, the obtained compound is reacted with the compound shown below,

NH2-R9‘-NH2 NH 2 -R 9' -NH 2

[式中,R9‘與關於R9之記載同義] [wherein, R 9' has the same meaning as described for R 9 ]

而獲得下述式。 And the following formula is obtained.

R21OOC-(RF2-CONH-R9-(NH-R9)k-NHCO)x-(RF2-CONH-R9‘-NHCO)x’-RF2-COOR21 R 21 OOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -(R F2 -CONH-R 9 '-NHCO) x' -R F2 -COOR 21

[式中,R21為氫原子或甲基,RF2、R9、及k與關於式(A3)之記載同義,R9‘與關於R9之記載同義] [wherein, R 21 is a hydrogen atom or a methyl group, R F2 , R 9 , and k have the same meanings as described for formula (A3), and R 9′ has the same meaning as described for R 9 ]

其次,使獲得的化合物與下述所示之化合物反應, Next, the obtained compound is reacted with the compound shown below,

NR23 mH2-m-R22-SiR1 n’R2 3-n’ NR 23 m H 2-m -R 22 -SiR 1 n' R 2 3-n'

[式中,R23為C1-6之烷基或苯基,m為0或1,R22為二價之基,R1、R2、及n’與關於式(A3)之記載同義] [In the formula, R 23 is a C 1-6 alkyl group or a phenyl group, m is 0 or 1, R 22 is a divalent group, and R 1 , R 2 , and n' have the same meanings as described in relation to formula (A3)]

而獲得下述式所示之化合物。 The compound shown in the following formula is obtained.

R2 3-n’R1 n’Si-R22-HNOC-(RF2-CONH-R9-(NH-R9)k-NHCO)x-(RF2-CONH-R9‘-NHCO)x’-RF2-CONH-R22-SiR1 n’R2 3-n’ R 2 3-n' R 1 n' Si-R 22 -HNOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -(R F2 -CONH-R 9 '-NHCO) x' -R F2 -CONH-R 22 -SiR 1 n' R 2 3-n'

其次,使獲得的化合物與下述式所示之化合物反應,藉此可獲得式(A3)所示之化合物。 Next, the obtained compound is reacted with a compound represented by the following formula to obtain a compound represented by formula (A3).

R34-R35-OCOCH=CH2 R 34 -R 35 -OCOCH=CH 2

[式中,R34為-NCO、-COOH等之反應性基, [In the formula, R 34 is a reactive group such as -NCO, -COOH, etc.,

R35為二價之基] R 35 is a divalent group]

上述反應之各步驟之反應條件可依發明所屬技術領域中具有通常知識者適宜設定。 The reaction conditions of each step of the above reaction can be appropriately set according to those with common knowledge in the technical field to which the invention belongs.

成分(B):含有氟聚醚基、及水解性矽基的含氟聚醚基之矽烷化合物 Component (B): A fluorinated polyether-containing silane compound containing a fluorinated polyether group and a hydrolyzable silyl group

本揭示之硬化性組成物包含含有氟聚醚基、及水解性矽基的含氟聚醚基之矽烷化合物。本揭示之硬化性組成物藉由包含上述含氟聚醚基之矽烷化合物,而具有因濕氣(水分)引起的硬化性。 The curable composition disclosed herein includes a fluorinated polyether group-containing silane compound containing a fluorinated polyether group and a hydrolyzable silane group. The curable composition disclosed herein has a curing property caused by moisture (water) by including the above-mentioned fluorinated polyether group-containing silane compound.

上述含氟聚醚基之矽烷化合物在分子中含有氟聚醚基、及水解性矽基。 The above-mentioned fluorinated polyether group-containing silane compound contains a fluorinated polyether group and a hydrolyzable silane group in the molecule.

於較佳態樣中,含氟聚醚基之矽烷化合物為下述式(B1)或(B2)所示之化合物: In a preferred embodiment, the silane compound containing a fluorinated polyether group is a compound represented by the following formula (B1) or (B2):

RF3 α-XZ-RSi β (B1) RF3α - XZ - RSiβ ( B1 )

RSi γ-XZ-RF4-XZ-RSi γ (B2) R Si γ -X Z -R F4 -X Z -R Si γ (B2)

[式中: [Where:

RF3分別獨立地為Rf3-RFB-Oq3-; R F3 is independently Rf 3 -R FB -O q3 -;

RF4為-Rf4 p3-RFB-Oq3-; RF4 is -Rf4p3 - RFB - Oq3- ;

Rf3分別獨立地為可被1個或超過1個之氟原子取代的C1-16烷基; Rf 3 are each independently a C 1-16 alkyl group which may be substituted with 1 or more 1 fluorine atoms;

Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基; Rf4 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms;

RFB分別獨立地為2價之氟聚醚基; R and FB are each independently a divalent fluoropolyether group;

p3為0或1; p3 is 0 or 1;

q3分別獨立地為0或1; q3 is independently 0 or 1;

RSi分別獨立地為包含與羥基、水解性基、氫原子或1價之有機基鍵結的Si原子之1價之基; R Si are each independently a monovalent group comprising a Si atom bonded to a hydroxyl group, a hydrolyzable group, a hydrogen atom or a monovalent organic group;

至少1個之RSi為包含與羥基或水解性基鍵結的Si原子之1價之基; At least one R Si is a monovalent group including a Si atom bonded to a hydroxyl group or a hydrolyzable group;

XZ分別獨立地為單鍵或2至10價之有機基; X and Z are each independently a single bond or a 2- to 10-valent organic group;

α為1至9之整數; α is an integer from 1 to 9;

β為1至9之整數; β is an integer from 1 to 9;

γ分別獨立地為1至9之整數]。 γ is independently an integer from 1 to 9].

上述式(B1)中,RF3分別獨立地為Rf3-RFB-Oq3-。 In the above formula (B1), R F3 is independently Rf 3 -R FB -O q3 -.

上述式(B2)中,RF4為-Rf4 p3-RFB-Oq3-。 In the above formula (B2), R F4 is -Rf 4 p3 -R FB -O q3 -.

上述式中,Rf3分別獨立地為可被1個或超過1個之氟原子取代的C1-16烷基。 In the above formula, Rf 3 is independently a C 1-16 alkyl group which may be substituted with 1 or more fluorine atoms.

上述可被1個或超過1個之氟原子取代的C1-16烷基中之「C1-16烷基」可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-6烷基,尤其係C1-3烷基,更佳為直鏈之C1-6烷基,尤其係C1-3烷基。 The "C 1-16 alkyl" in the above C 1-16 alkyl group which may be substituted with 1 or more fluorine atoms may be a straight chain or a branched chain, preferably a straight chain or a branched chain C 1-6 alkyl group, especially a C 1-3 alkyl group, more preferably a straight chain C 1-6 alkyl group, especially a C 1-3 alkyl group.

上述Rf3較佳為可被1個或超過1個之氟原子取代的C1-16烷基,更佳為CF2H-C1-15全氟伸烷基,又更佳為C1-16全氟烷基。 The above Rf3 is preferably a C1-16 alkyl group which may be substituted with one or more fluorine atoms, more preferably a CF2HC1-15perfluoroalkylene group, and even more preferably a C1-16perfluoroalkyl group.

上述C1-16全氟烷基可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-6全氟烷基,尤其係C1-3全氟烷基,更佳為直鏈之C1-6全氟烷基,尤其係C1-3全氟烷基,具體而言-CF3、-CF2CF3、或-CF2CF2CF3The C 1-16 perfluoroalkyl group may be a linear or branched chain, preferably a linear or branched C 1-6 perfluoroalkyl group, especially a C 1-3 perfluoroalkyl group, more preferably a linear C 1-6 perfluoroalkyl group, especially a C 1-3 perfluoroalkyl group, specifically -CF 3 , -CF 2 CF 3 , or -CF 2 CF 2 CF 3 .

上述式中,Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基。 In the above formula, Rf4 is a C1-6 alkylene group which may be substituted with one or more fluorine atoms.

上述可被1個或超過1個之氟原子取代的C1-6伸烷基中之「C1-6伸烷基」可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-3伸烷基,更佳為直鏈之C1-3伸烷基。 The "C 1-6 alkylene group" in the above C 1-6 alkylene group which may be substituted with 1 or more fluorine atoms may be a straight chain or a branched chain, preferably a straight chain or a branched chain C 1-3 alkylene group, more preferably a straight chain C 1-3 alkylene group.

上述Rf4較佳為可被1個或超過1個之氟原子取代的C1-6伸烷基,更佳為C1-6全氟伸烷基,又更佳為C1-3全氟伸烷基。 The above Rf4 is preferably a C1-6 alkylene group which may be substituted with one or more fluorine atoms, more preferably a C1-6 perfluoroalkylene group, and even more preferably a C1-3 perfluoroalkylene group.

上述C1-6全氟伸烷基可為直鏈或分枝鏈,較佳為直鏈或分枝鏈之C1-3全氟伸烷基,更佳為直鏈之C1-3全氟伸烷基,具體而言-CF2-、-CF2CF2-、或-CF2CF2CF2-。 The C 1-6 perfluoroalkylene group may be a linear or branched chain, preferably a linear or branched chain C 1-3 perfluoroalkylene group, more preferably a linear chain C 1-3 perfluoroalkylene group, specifically -CF 2 -, -CF 2 CF 2 -, or -CF 2 CF 2 CF 2 -.

上述式中,p3為0或1。於一態樣中,p3為0。於其他態樣中,p3為1。 In the above formula, p3 is 0 or 1. In one embodiment, p3 is 0. In another embodiment, p3 is 1.

上述式中,q3分別獨立地為0或1。於一態樣中,q3為0。於其他態樣中,q3為1。 In the above formula, q3 is independently 0 or 1. In one embodiment, q3 is 0. In another embodiment, q3 is 1.

上述式(B1)及(B2)中,RFB分別獨立地為2價之氟聚醚基。 In the above formulae (B1) and (B2), R FB is independently a divalent fluoropolyether group.

RFB較佳為直鏈之二價之氟聚醚基。藉由設為直鏈之二價之氟聚醚基,黏度變得相對較低,塗佈性及可操作性提升。 R FB is preferably a linear divalent fluoropolyether group. By using a linear divalent fluoropolyether group, the viscosity becomes relatively low, and the coating property and workability are improved.

上述RFB為與上述RF相同的氟聚醚基,具有相同的態樣。 The above-mentioned R FB is the same fluoropolyether group as the above-mentioned RF and has the same aspect.

亦即,RFB較佳為下式所示之基: That is, R FB is preferably a base represented by the following formula:

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3RFa 6)d-(OC2F4)e-(OCF2)f- -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f -

[式中: [Where:

RFa分別獨立地為氫原子、氟原子或氯原子, R Fa are each independently a hydrogen atom, a fluorine atom or a chlorine atom,

a、b、c、d、e及f分別獨立地為0至200之整數,a、b、c、d、e及f之和為1以上。標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意。惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上]。 a, b, c, d, e and f are each independently an integer from 0 to 200, and the sum of a, b, c, d, e and f is 1 or more. The order of the repetitive units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary. However, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more].

於一態樣中,RFB分別獨立地為式(f1)至(f6)之任一者所示之基。 In one embodiment, R FB is independently a group represented by any one of formulas (f1) to (f6).

-(OC3F6)d-(OC2F4)e- (f1) -(OC 3 F 6 ) d -(OC 2 F 4 ) e - (f1)

[式中,d為1至200之整數,e為0或1]; [Wherein, d is an integer from 1 to 200, and e is 0 or 1];

-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f2) -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f2)

[式中,c及d分別獨立地為0以上30以下之整數,e及f分別獨立地為1以上200以下之整數, [In the formula, c and d are independently integers greater than 0 and less than 30, e and f are independently integers greater than 1 and less than 200,

c、d、e及f之和為2以上, The sum of c, d, e and f is greater than 2,

標註c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意]; The order of the repeated units marked with c, d, e or f and enclosed in brackets in the formula is arbitrary];

-(R6-R7)g- (f3) -(R 6 -R 7 ) g - (f3)

[式中,R6為OCF2或OC2F4[wherein, R 6 is OCF 2 or OC 2 F 4 ,

R7為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合、 R7 is a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups independently selected from these groups,

g為2至100之整數]; g is an integer from 2 to 100];

-(R6-R7)g-Rr-(R7’-R6’)g’- (f4) -(R 6 -R 7 ) g -R r -(R 7' -R 6' ) g' - (f4)

[式中,R6為OCF2或OC2F4[wherein, R 6 is OCF 2 or OC 2 F 4 ,

R7為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合、 R7 is a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups independently selected from these groups,

R6’為OCF2或OC2F4R 6' is OCF 2 or OC 2 F 4 ,

R7’為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R 7' is a group selected from OC 2 F 4 , OC 3 F 6 , OC 4 F 8 , OC 5 F 10 and OC 6 F 12 , or a combination of 2 or 3 groups independently selected from these groups,

g為2至100之整數, g is an integer from 2 to 100,

g’為2至100之整數, g’ is an integer from 2 to 100,

RrR r is

Figure 112112312-A0202-12-0058-21
Figure 112112312-A0202-12-0058-21

(式中,*顯示鍵結位置)]; (where * indicates the key position)];

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f5) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f5)

[式中,e為1以上200以下之整數,a、b、c、d及f分別獨立地為0以上200以下之整數,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意] [In the formula, e is an integer greater than 1 and less than 200, a, b, c, d, and f are each independently an integer greater than 0 and less than 200, and the order of the repeated units marked with a, b, c, d, e, or f and enclosed in parentheses in the formula is arbitrary]

-(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f6) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f6)

[式中,f為1以上200以下之整數,a、b、c、d及e分別獨立地為0以上200以下之整數,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意] [In the formula, f is an integer greater than 1 and less than 200, a, b, c, d, and e are each independently an integer greater than 0 and less than 200, and the order of the repeated units marked with a, b, c, d, e, or f and enclosed in parentheses in the formula is arbitrary]

於一態樣中,上述RFB為上述式(f1)或(f2)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f1) or (f2).

於一態樣中,上述RFB為上述式(f1)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f1).

於一態樣中,上述RFB為上述式(f2)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f2).

於一態樣中,上述RFB為上述式(f3)或(f4)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f3) or (f4).

於一態樣中,上述RFB為上述式(f3)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f3).

於一態樣中,上述RFB為上述式(f4)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f4).

於一態樣中,上述RFB為上述式(f5)所示之基。 In one embodiment, the R FB is a group represented by the above formula (f5).

於一態樣中,上述RFB為上述式(f6)所示之基。 In one embodiment, the above R FB is a group represented by the above formula (f6).

上述式(B1)及(B2)中,RSi分別獨立地為包含與羥基、水解性基、氫原子或1價之有機基鍵結的Si原子(以下亦稱為「水解性矽基」)之1價之基,至少1個之RSi包含與羥基或水解性基鍵結的Si原子之1價之基。 In the above formulae (B1) and (B2), R Si is independently a monovalent group comprising a Si atom bonded to a hydroxyl group, a hydrolyzable group, a hydrogen atom or a monovalent organic group (hereinafter also referred to as a "hydrolyzable silicon group"), and at least one R Si comprises a monovalent group comprising a Si atom bonded to a hydroxyl group or a hydrolyzable group.

於較佳態樣中,RSi包含與羥基或水解性基鍵結的Si原子之1價之基。 In a preferred embodiment, R Si includes a monovalent group of a Si atom bonded to a hydroxyl group or a hydrolyzable group.

於較佳態樣中,RSi為下述式(S1)、(S2)、(S3)、(S4)或(S5)所示之基。 In a preferred embodiment, R Si is a group represented by the following formula (S1), (S2), (S3), (S4) or (S5).

Figure 112112312-A0202-12-0059-22
Figure 112112312-A0202-12-0059-22

- SiR25 n1R26 3-n1 (S2) -SiR 25 n1 R 26 3-n1 (S2)

- SiRa1 k1Rb1 l1Rc1 m1 (S3) -SiR a1 k1 R b1 l1 R c1 m1 (S3)

- CRd1 k2Re1 l2Rf1 m2 (S4) - CR d1 k2 R e1 l2 R f1 m2 (S4)

- NRg1Rh1 (S5) -NR g1 R h1 (S5)

[式中: [Where:

R25分別獨立地為羥基或水解性基; R25 are each independently a hydroxyl group or a hydrolyzable group;

R26分別獨立地為氫原子或1價之有機基; R26 are each independently a hydrogen atom or a monovalent organic group;

n1在每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數; n1 is an integer from 0 to 3 independently in each (SiR 25 n1 R 26 3-n1 ) unit;

X11分別獨立地為單鍵或2價之有機基; X11 is independently a single bond or a divalent organic group;

R27分別獨立地為氫原子或1價之有機基; R27 are each independently a hydrogen atom or a monovalent organic group;

t分別獨立地為2以上之整數; t are each independently an integer greater than 2;

R28分別獨立地為氫原子、鹵素原子或-X11-SiR25 n1R26 3-n1R 28 are each independently a hydrogen atom, a halogen atom or -X 11 -SiR 25 n1 R 26 3-n1 ;

R29分別獨立地為單鍵、氧原子、碳數1至6之伸烷基或碳數1至6之伸烷氧基; R29 is independently a single bond, an oxygen atom, an alkylene group having 1 to 6 carbon atoms, or an alkoxyene group having 1 to 6 carbon atoms;

Ra1分別獨立地為-Z1-SiR21 p1R22 q1R23 r1R a1 is independently -Z 1 -SiR 21 p1 R 22 q1 R 23 r1 ;

Z1分別獨立地為氧原子或2價之有機基; Z 1 each independently represents an oxygen atom or a divalent organic group;

R21分別獨立地為-Z1’-SiR21’ p1’R22’ q1’R23’ r1’R 21 is independently -Z 1' -SiR 21' p1' R 22' q1' R 23' r1' ;

R22分別獨立地為羥基或水解性基; R22 are each independently a hydroxyl group or a hydrolyzable group;

R23分別獨立地為氫原子或1價之有機基; R23 are each independently a hydrogen atom or a monovalent organic group;

p1分別獨立地為0至3之整數; p1 is an integer from 0 to 3 independently;

q1分別獨立地為0至3之整數; q1 is an integer from 0 to 3 independently;

r1分別獨立地為0至3之整數; r1 is an integer from 0 to 3 independently;

Z1’分別獨立地為氧原子或2價之有機基; Z 1' is independently an oxygen atom or a divalent organic group;

R21’分別獨立地為-Z1”-SiR22” q1”R23” r1”R 21′ is independently -Z 1″ -SiR 22″ q1″ R 23″ r1″ ;

R22’分別獨立地為羥基或水解性基; R 22' is independently a hydroxyl group or a hydrolyzable group;

R23’分別獨立地為氫原子或1價之有機基; R 23' is independently a hydrogen atom or a monovalent organic group;

p1’分別獨立地為0至3之整數; p1’ is an integer from 0 to 3 independently;

q1’分別獨立地為0至3之整數; q1’ is an integer from 0 to 3 independently;

r1’分別獨立地為0至3之整數; r1’ is an integer from 0 to 3 independently;

Z1”分別獨立地為氧原子或2價之有機基; Z 1" are each independently an oxygen atom or a divalent organic group;

R22”分別獨立地為羥基或水解性基; R 22" are each independently a hydroxyl group or a hydrolyzable group;

R23”分別獨立地為氫原子或1價之有機基; R 23" are each independently a hydrogen atom or a monovalent organic group;

q1”分別獨立地為0至3之整數; q1" are independently integers from 0 to 3;

r1”分別獨立地為0至3之整數; r1" are independently integers from 0 to 3;

Rb1分別獨立地為羥基或水解性基; R b1 are each independently a hydroxyl group or a hydrolyzable group;

Rc1分別獨立地為氫原子或1價之有機基; R c1 each independently represents a hydrogen atom or a monovalent organic group;

k1分別獨立地為0至3之整數; k1 is an integer from 0 to 3 independently;

l1分別獨立地為0至3之整數; l1 are independently integers from 0 to 3;

m1分別獨立地為0至3之整數; m1 is an integer from 0 to 3 independently;

Rd1分別獨立地為-Z2-CR31 p2R32 q2R33 r2R d1 is independently -Z 2 -CR 31 p2 R 32 q2 R 33 r2 ;

Z2分別獨立地為單鍵、氧原子或2價之有機基; Z2 are each independently a single bond, an oxygen atom or a divalent organic group;

R31分別獨立地為-Z2’-CR32’ q2’R33’ r2’R 31 is independently -Z 2' -CR 32' q2' R 33' r2' ;

R32分別獨立地為-Z3-SiR34 n2R35 3-n2R 32 is independently -Z 3 -SiR 34 n2 R 35 3-n2 ;

R33分別獨立地為氫原子、羥基或1價之有機基; R 33 each independently represents a hydrogen atom, a hydroxyl group or a monovalent organic group;

p2分別獨立地為0至3之整數; p2 is an integer from 0 to 3 independently;

q2分別獨立地為0至3之整數; q2 is an integer from 0 to 3 independently;

r2分別獨立地為0至3之整數; r2 is an integer from 0 to 3 independently;

Z2’分別獨立地為單鍵、氧原子或2價之有機基; Z 2' is independently a single bond, an oxygen atom or a divalent organic group;

R32’分別獨立地為-Z3-SiR34 n2R35 3-n2R 32′ is independently -Z 3 -SiR 34 n2 R 35 3-n2 ;

R33’分別獨立地為氫原子、羥基或1價之有機基; R 33' is independently a hydrogen atom, a hydroxyl group or a monovalent organic group;

q2’分別獨立地為0至3之整數; q2’ is an integer from 0 to 3 independently;

r2’分別獨立地為0至3之整數; r2’ is an integer from 0 to 3 independently;

Z3分別獨立地為單鍵、氧原子或2價之有機基; Z 3 are each independently a single bond, an oxygen atom or a divalent organic group;

R34分別獨立地為羥基或水解性基; R 34 are each independently a hydroxyl group or a hydrolyzable group;

R35分別獨立地為氫原子或1價之有機基; R 35 is independently a hydrogen atom or a monovalent organic group;

n2分別獨立地為0至3之整數; n2 is an integer from 0 to 3 independently;

Re1分別獨立地為-Z3-SiR34 n2R35 3-n2R e1 is independently -Z 3 -SiR 34 n2 R 35 3-n2 ;

Rf1分別獨立地為氫原子、羥基或1價之有機基; R f1 are each independently a hydrogen atom, a hydroxyl group or a monovalent organic group;

k2分別獨立地為0至3之整數; k2 is an integer from 0 to 3 independently;

l2分別獨立地為0至3之整數; l2 are independently integers from 0 to 3;

m2分別獨立地為0至3之整數; m2 is an integer from 0 to 3 independently;

Rg1及Rh1分別獨立地為-Z4-SiR25 n1R26 3-n1、-Z4-SiRa1 k1Rb1 l1Rc1 m1、-Z4-CRd1 k2Re1 l2Rf1 m2R g1 and R h1 are independently -Z 4 -SiR 25 n1 R 26 3-n1 , -Z 4 -SiR a1 k1 R b1 l1 R c1 m1 , -Z 4 -CR d1 k2 R e1 l2 R f1 m2 ;

Z4分別獨立地為單鍵、氧原子或2價之有機基; Z 4 are each independently a single bond, an oxygen atom or a divalent organic group;

惟,式(S1)、(S2)、(S3)、(S4)及(S5)中,存在至少1個與羥基或水解性基鍵結的Si原子] However, in formulas (S1), (S2), (S3), (S4) and (S5), there is at least one Si atom bonded to a hydroxyl group or a hydrolyzable group]

上述式中,R25分別獨立地為羥基或水解性基。 In the above formula, R25 is independently a hydroxyl group or a hydrolyzable group.

R25較佳分別獨立地為水解性基。 It is preferred that R25 is independently a hydrolyzable group.

R25較佳分別獨立地為-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、或鹵素(此等之式中,Rj表示取代或未取代之C1-4烷基),更佳為-ORj(亦即,烷氧基)。作為Rj,係列舉:甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中, 較佳為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rj為甲基,於其他態樣中,Rj為乙基。 R 25 is preferably independently -OR j , -OCOR j , -ON=CR j 2 , -NR j 2 , -NHR j , -NCO, or halogen (in the formulas, R j represents a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR j (i.e., alkoxy group). R j includes: unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among them, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, R j is methyl, and in another embodiment, R j is ethyl.

上述式中,R26分別獨立地為氫原子或1價之有機基。這些1價之有機基,為除了上述水解性基以外的1價之有機基。 In the above formula, R26 is independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

R26中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In R 26 , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述式中,n1在每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數。惟,RSi屬於式(S1)或(S2)所示之基之情況下,式(B1)及式(B2)之末端的RSi部分(以下亦簡稱為式(B1)及式(B2)之「末端部分」)中,至少存在1個n1屬於1至3之(SiR25 n1R26 3-n1)單元。亦即,這些末端部分中,所有之n1不會同時為0。換言之,式(B1)及式(B2)之末端部分中,存在至少1個與羥基或水解性基鍵結的Si原子。 In the above formula, n1 is an integer from 0 to 3 in each (SiR 25 n1 R 26 3-n1 ) unit independently. However, when R Si belongs to the group represented by formula (S1) or (S2), there is at least one (SiR 25 n1 R 26 3-n1 ) unit in which n1 is 1 to 3 in the terminal R Si portion of formula (B1) and formula (B2) (hereinafter also referred to as the "terminal portion" of formula ( B1 ) and formula ( B2 )). That is, in these terminal portions, all n1s are not 0 at the same time . In other words, there is at least one Si atom bonded to a hydroxyl group or a hydrolyzable group in the terminal portion of formula (B1) and formula (B2).

n1在每個(SiR25 n1R26 3-n1)單元分別獨立地較佳為1至3之整數,更佳為2至3,再更佳為3。 In each (SiR 25 n1 R 26 3-n1 ) unit, n1 is independently preferably an integer of 1 to 3, more preferably 2 to 3, and even more preferably 3.

上述式中,X11分別獨立地為單鍵或2價之有機基。這些2價之有機基較佳為-R41-Ox-R42-(式中,R41及R42分別獨立地為單鍵或C1-20伸烷基,x為0或1)。這些C1-20伸烷基可為直鏈或分枝鏈,較佳為直鏈。這些C1-20伸烷基較佳為C1-10伸烷基,更佳為C1-6伸烷基,又更佳為C1-3伸烷基。 In the above formula, X 11 is independently a single bond or a divalent organic group. These divalent organic groups are preferably -R 41 -O x -R 42 - (wherein R 41 and R 42 are independently a single bond or a C 1-20 alkylene group, and x is 0 or 1). These C 1-20 alkylene groups may be straight chains or branched chains, preferably straight chains. These C 1-20 alkylene groups are preferably C 1-10 alkylene groups, more preferably C 1-6 alkylene groups, and even more preferably C 1-3 alkylene groups.

於一態樣中,X11分別獨立地為-C1-6伸烷基-O-C1-6伸烷基-或-O-C1-6伸烷基-。 In one embodiment, X 11 is independently -C 1-6 alkylene-OC 1-6 alkylene- or -OC 1-6 alkylene-.

於較佳態樣中,X11分別獨立地為單鍵或直鏈之C1-6伸烷基,較佳為單鍵或直鏈之C1-3伸烷基,更佳為單鍵或直鏈之C1-2伸烷基,又更佳為直鏈之C1-2伸烷基。 In a preferred embodiment, X 11 is independently a single bond or a straight chain C 1-6 alkylene group, preferably a single bond or a straight chain C 1-3 alkylene group, more preferably a single bond or a straight chain C 1-2 alkylene group, and even more preferably a straight chain C 1-2 alkylene group.

上述式中,R27分別獨立地為氫原子或1價之有機基。這些1價之有機基較佳為C1-20烷基。這些C1-20烷基可為直鏈或分枝鏈,較佳為直鏈。 In the above formula, R 27 is independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are preferably C 1-20 alkyl groups. These C 1-20 alkyl groups may be straight chain or branched chain, preferably straight chain.

於較佳態樣中,R27分別獨立地為氫原子或直鏈之C1-6烷基,較佳為氫原子或直鏈之C1-3烷基,較佳為氫原子或甲基。 In a preferred embodiment, R 27 is independently a hydrogen atom or a linear C 1-6 alkyl group, preferably a hydrogen atom or a linear C 1-3 alkyl group, preferably a hydrogen atom or a methyl group.

上述式中,t分別獨立地為2以上之整數。 In the above formula, t is independently an integer greater than 2.

於較佳態樣中,t分別獨立地為2至10之整數,較佳為2至6之整數。 In a preferred embodiment, t is independently an integer between 2 and 10, preferably an integer between 2 and 6.

上述式中,R28分別獨立地為氫原子、鹵素原子或-X11-SiR25 n1R26 3-n1。這些鹵素原子較佳為碘原子、氯原子或氟原子,更佳為氟原子。於較佳態樣中,R28為氫原子。 In the above formula, R 28 is independently a hydrogen atom, a halogen atom or -X 11 -SiR 25 n1 R 26 3-n1 . These halogen atoms are preferably iodine atoms, chlorine atoms or fluorine atoms, more preferably fluorine atoms. In a preferred embodiment, R 28 is a hydrogen atom.

上述式中,R29分別獨立地為單鍵、氧原子、碳數1至6之伸烷基或碳數1至6之伸烷氧基。 In the above formula, R29 is independently a single bond, an oxygen atom, an alkylene group having 1 to 6 carbon atoms, or an alkoxyene group having 1 to 6 carbon atoms.

於一態樣中,R29分別獨立地為氧原子、碳數1至6之伸烷基或碳數1至6之伸烷氧基。 In one embodiment, R 29 is independently an oxygen atom, an alkylene group having 1 to 6 carbon atoms, or an alkoxyene group having 1 to 6 carbon atoms.

於較佳態樣中,R29為單鍵。 In a preferred embodiment, R 29 is a single key.

於一態樣中,式(S1)為下述式(S1-a)。 In one embodiment, formula (S1) is the following formula (S1-a).

Figure 112112312-A0202-12-0065-23
Figure 112112312-A0202-12-0065-23

[式中, [Where,

R25、R26、R27、X11、及n1與上述式(S1)之記載同義; R 25 , R 26 , R 27 , X 11 , and n1 have the same meanings as those described in the above formula (S1);

t1及t2分別獨立地為1以上之整數,較佳為1至10之整數,更佳為2至10之整數,例如1至5之整數或2至5之整數; t1 and t2 are each independently an integer greater than 1, preferably an integer from 1 to 10, more preferably an integer from 2 to 10, for example, an integer from 1 to 5 or an integer from 2 to 5;

標註t1及t2並以括弧括起之各重複單元在式中的存在順序為任意] The order of the repeated units marked with t1 and t2 and enclosed in parentheses in the formula is arbitrary]

於較佳態樣中,式(S1)為下述式(S1-b)。 In a preferred embodiment, formula (S1) is the following formula (S1-b).

Figure 112112312-A0202-12-0065-24
Figure 112112312-A0202-12-0065-24

[式中,R25、R26、R27、X11、n1及t與上述式(S1)之記載同義] [wherein, R 25 , R 26 , R 27 , X 11 , n1 and t have the same meanings as those in the above formula (S1)]

上述式中,Ra1分別獨立地為-Z1-SiR21 p1R22 q1R23 r1In the above formula, Ra1 is independently -Z1 -SiR21p1R22q1R23r1 .

上述Z1分別獨立地為氧原子或2價之有機基。尚且,作為以下Z1記載的結構,右側係鍵結至(SiR21 p1R22 q1R23 r1)。 The above Z1 's are independently an oxygen atom or a divalent organic group. In the structure described below as Z1 , the right side is bonded to ( SiR21p1R22q1R23r1 ).

於較佳態樣中,Z1為2價之有機基。 In a preferred embodiment, Z1 is a divalent organic group.

於較佳態樣中,Z1不含與Z1鍵結的Si原子形成矽氧烷鍵結者。較佳為式(S3)中,(Si-Z1-Si)不含矽氧烷鍵結。 In a preferred embodiment, Z 1 does not contain a siloxane bond with the Si atom bonded to Z 1. Preferably, in formula (S3), (Si-Z 1 -Si) does not contain a siloxane bond.

上述Z1較佳為C1-6伸烷基、-(CH2)z1-O-(CH2)z2-(式中,z1為0至6之整數,例如1至6之整數,z2為0至6之整數,例如1至6之整數)或-(CH2)z3-伸苯基-(CH2)z4-(式中,z3為0至6之整數,例如1至6之整數,z4為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈 或分枝鏈,較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above Z1 is preferably C1-6 alkylene, -( CH2 ) z1 -O-( CH2 ) z2- (wherein z1 is an integer from 0 to 6, for example, an integer from 1 to 6, and z2 is an integer from 0 to 6, for example, an integer from 1 to 6) or -( CH2 ) z3 -phenylene-( CH2 ) z4- (wherein z3 is an integer from 0 to 6, for example, an integer from 1 to 6, and z4 is an integer from 0 to 6, for example, an integer from 1 to 6). These C1-6 alkylene groups may be straight chains or branched chains, preferably straight chains. These groups may be substituted, for example, by one or more substituents selected from fluorine atoms, C1-6 alkyl groups, C2-6 alkenyl groups, and C2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z1為C1-6伸烷基或-(CH2)z3-伸苯基-(CH2)z4-,較佳為-伸苯基-(CH2)z4-。Z1屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z1 is a C1-6 alkylene group or -( CH2 ) z3 -phenylene-( CH2 ) z4- , preferably -phenylene-( CH2 ) z4- . When Z1 is one of these groups, higher light resistance, especially ultraviolet resistance, can be obtained.

於其他較佳態樣中,上述Z1為C1-3伸烷基。於一態樣中,Z1可為-CH2CH2CH2-。於其他態樣中,Z1為-CH2CH2-。 In other preferred embodiments, Z 1 is C 1-3 alkylene. In one embodiment, Z 1 may be -CH 2 CH 2 CH 2 -. In other embodiments, Z 1 is -CH 2 CH 2 -.

上述R21分別獨立地為-Z1’-SiR21’ p1’R22’ q1’R23’ r1’The above R 21 's are independently -Z 1' -SiR 21' p1' R 22' q1' R 23' r1' .

上述Z1’分別獨立地為氧原子或2價之有機基。尚且,作為以下Z1’記載的結構,右側係鍵結至(SiR21’ p1’R22’ q1’R23’ r1’)。 The above Z 1' is independently an oxygen atom or a divalent organic group. In the structure described below as Z 1' , the right side is bonded to (SiR 21' p1' R 22' q1' R 23' r1' ).

於較佳態樣中,Z1’為2價之有機基。 In a preferred embodiment, Z 1' is a divalent organic group.

於較佳態樣中,Z1’不含與Z1’鍵結的Si原子形成矽氧烷鍵結者。較佳為式(S3)中,(Si-Z1’-Si)不含矽氧烷鍵結。 In a preferred embodiment, Z 1′ does not contain a siloxane bond with the Si atom to which Z 1′ is bonded. Preferably, in formula (S3), (Si—Z 1′ —Si) does not contain a siloxane bond.

上述Z1’較佳為C1-6伸烷基、-(CH2)z1’-O-(CH2)z2’-(式中,z1’為0至6之整數,例如1至6之整數,z2’為0至6之整數,例如1至6之整數)或-(CH2)z3’-伸苯基-(CH2)z4’-(式中,z3’為0至6之整數,例如1至6之整數,z4’為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈或分枝鏈,惟較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above Z 1' is preferably a C 1-6 alkylene group, -(CH 2 ) z1' -O-(CH 2 ) z2' -(wherein z1' is an integer from 0 to 6, for example, an integer from 1 to 6, and z2' is an integer from 0 to 6, for example, an integer from 1 to 6) or -(CH 2 ) z3' -phenylene-(CH 2 ) z4' -(wherein z3' is an integer from 0 to 6, for example, an integer from 1 to 6, and z4' is an integer from 0 to 6, for example, an integer from 1 to 6). These C 1-6 alkylene groups may be straight chains or branched chains, but are preferably straight chains. These groups may be substituted, for example, by one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z1’為C1-6伸烷基或-(CH2)z3’-伸苯基-(CH2)z4’-,較佳為-伸苯基-(CH2)z4’-。Z1’屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z 1' is a C 1-6 alkylene group or -(CH 2 ) z3' -phenylene-(CH 2 ) z4' -, preferably -phenylene-(CH 2 ) z4' - . When Z 1' is one of these groups, higher light resistance, especially UV resistance, can be obtained.

於其他較佳態樣中,上述Z1’為C1-3伸烷基。於一態樣中,Z1’可為-CH2CH2CH2-。於其他態樣中,Z1’可為-CH2CH2-。 In other preferred aspects, the above Z 1' is a C 1-3 alkylene group. In one aspect, Z 1' can be -CH 2 CH 2 CH 2 -. In other aspects, Z 1' can be -CH 2 CH 2 -.

上述R21’分別獨立地為-Z1”-SiR22” q1”R23” r1”The above R 21′ is independently -Z 1″ -SiR 22″ q1″ R 23″ r1″ .

上述Z1”分別獨立地為氧原子或2價之有機基。尚且,作為以下Z1”記載的結構,右側係鍵結至(SiR22” q1”R23” r1”)。 The above-mentioned Z 1" is independently an oxygen atom or a divalent organic group. In addition, in the structure described as Z 1" below, the right side is bonded to (SiR 22" q1" R 23" r1" ).

於較佳態樣中,Z1”為2價之有機基。 In a preferred embodiment, Z 1" is a divalent organic group.

於較佳態樣中,Z1”不含與Z1”鍵結的Si原子形成矽氧烷鍵結者。較佳為式(S3)中,(Si-Z1”-Si)不含矽氧烷鍵結。 In a preferred embodiment, Z 1″ does not contain a siloxane bond with the Si atom bonded to Z 1″ . Preferably, in formula (S3), (Si-Z 1″ -Si) does not contain a siloxane bond.

上述Z1”較佳為C1-6伸烷基、-(CH2)z1”-O-(CH2)z2”-(式中,z1”為0至6之整數,例如1至6之整數,z2”為0至6之整數,例如1至6之整數)或-(CH2)z3”-伸苯基-(CH2)z4”-(式中,z3”為0至6之整數,例如1至6之整數,z4”為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈或分枝鏈,惟較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above-mentioned Z 1 " is preferably a C 1-6 alkylene group, -(CH 2 ) z1" -O-(CH 2 ) z2" - (wherein z1" is an integer from 0 to 6, for example, an integer from 1 to 6, and z2" is an integer from 0 to 6, for example, an integer from 1 to 6) or -(CH 2 ) z3" -phenylene-(CH 2 ) z4" - (wherein z3" is an integer from 0 to 6, for example, an integer from 1 to 6, and z4" is an integer from 0 to 6, for example, an integer from 1 to 6). These C 1-6 alkylene groups may be straight chains or branched chains, but are preferably straight chains. These groups may be substituted, for example, by one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z1”為C1-6伸烷基或-(CH2)z3”-伸苯基-(CH2)z4”-,較佳為-伸苯基-(CH2)z4”-。Z1”屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z 1" is a C 1-6 alkylene group or -(CH 2 ) z3" -phenylene-(CH 2 ) z4" -, preferably -phenylene-(CH 2 ) z4" -. When Z 1" is one of these groups, higher light resistance, especially UV resistance, can be obtained.

於其他較佳態樣中,上述Z1”為C1-3伸烷基。於一態樣中,Z1”可為-CH2CH2CH2-。於其他態樣中,Z1”可為-CH2CH2-。 In other preferred aspects, the above Z 1″ is a C 1-3 alkylene group. In one aspect, Z 1″ may be -CH 2 CH 2 CH 2 -. In other aspects, Z 1″ may be -CH 2 CH 2 -.

上述R22”分別獨立地為羥基或水解性基。 The above R 22" are each independently a hydroxyl group or a hydrolyzable group.

上述R22”較佳分別獨立地為水解性基。 The above R 22" are preferably each independently a hydrolyzable group.

上述R22”較佳分別獨立地為-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、或鹵素(此等之式中,Rj表示取代或未取代之C1-4烷基),更佳為-ORj(亦即,烷氧基)。作為Rj,係列舉:甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中,較佳為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rj為甲基,於其他態樣中,Rj為乙基。 The above R 22" is preferably independently -OR j , -OCOR j , -ON=CR j 2 , -NR j 2 , -NHR j , -NCO, or halogen (in the formulas, R j represents a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR j (i.e., alkoxy group). R j includes: unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among them, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, R j is methyl, and in other embodiments, R j is ethyl.

上述R23”分別獨立地為氫原子或1價之有機基。這些1價之有機基為除了上述水解性基以外的1價之有機基。 The above R 23" are each independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

上述R23”中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In the above R 23" , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述q1”分別獨立地為0至3之整數,上述r1”分別獨立地為0至3之整數。尚且,q1”與r1”之合計在(SiR22” q1”R23” r1”)單元中為3。 The above q1" is independently an integer from 0 to 3, and the above r1" is independently an integer from 0 to 3. Moreover, the total of q1" and r1" is 3 in the (SiR 22" q1" R 23" r1" ) unit.

上述q1”在每個(SiR22” q1”R23” r1”)單元分別獨立地較佳為1至3之整數,更佳為2至3,再更佳為3。 The above q1” in each (SiR 22” q1” R 23” r1” ) unit is preferably an integer from 1 to 3, more preferably 2 to 3, and even more preferably 3.

上述R22’分別獨立地為羥基或水解性基。 The above R 22' are each independently a hydroxyl group or a hydrolyzable group.

R22’較佳分別獨立地為水解性基。 It is preferred that R 22' is independently a hydrolyzable group.

R22’較佳分別獨立地為-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、或鹵素(此等之式中,Rj表示取代或未取代之C1-4烷基), 更佳為-ORj(亦即,烷氧基)。作為Rj,係列舉:甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中,較佳為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rj為甲基,於其他態樣中,Rj為乙基。 R 22' is preferably independently -OR j , -OCOR j , -ON=CR j 2 , -NR j 2 , -NHR j , -NCO, or halogen (in the formulas, R j represents a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR j (i.e., alkoxy). R j includes: unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among them, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, R j is methyl, and in another embodiment, R j is ethyl.

上述R23’分別獨立地為氫原子或1價之有機基。這些1價之有機基為除了上述水解性基以外的1價之有機基。 The above R 23' is independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

R23’中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In R 23' , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述p1’分別獨立地為0至3之整數,q1’分別獨立地為0至3之整數,r1’分別獨立地為0至3之整數。尚且,p’、q1’及r1’之合計在(SiR21’ p1’R22’ q1’R23’ r1’)單元中為3。 The above p1' is independently an integer from 0 to 3, q1' is independently an integer from 0 to 3, and r1' is independently an integer from 0 to 3. Moreover, the total of p', q1' and r1' in the (SiR 21' p1' R 22' q1' R 23' r1' ) unit is 3.

於一態樣中,p1’為0。 In one embodiment, p1’ is 0.

於一態樣中,p1’在每個(SiR21’ p1’R22’ q1’R23’ r1’)單元分別獨立地可為1至3之整數、2至3之整數、或3。於較佳態樣中,p1’為3。 In one embodiment, p1' in each (SiR 21' p1' R 22' q1' R 23' r1' ) unit can be independently an integer from 1 to 3, an integer from 2 to 3, or 3. In a preferred embodiment, p1' is 3.

於一態樣中,q1’在每個(SiR21’ p1’R22q1’R23’ r1’)單元分別獨立地為1至3之整數,較佳為2至3之整數,更佳為3。 In one embodiment, q1' in each (SiR 21' p1' R 22 'q1' R 23' r1' ) unit is independently an integer from 1 to 3, preferably an integer from 2 to 3, and more preferably 3.

於一態樣中,p1’為0,q1’在每(SiR21’ p1’R22’ q1’R23’ r1’)單元分別獨立地為1至3之整數,較佳為2至3之整數,再更佳為3。 In one embodiment, p1' is 0, and q1' in each (SiR 21' p1' R 22' q1' R 23' r1' ) unit is independently an integer from 1 to 3, preferably an integer from 2 to 3, and more preferably 3.

上述R22分別獨立地為羥基或水解性基。 The above R 22 are each independently a hydroxyl group or a hydrolyzable group.

R22較佳分別獨立地為水解性基。 It is preferred that R22 is independently a hydrolyzable group.

R22較佳分別獨立地為-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、或鹵素(此等之式中,Rj表示取代或未取代之C1-4烷基), 更佳為-ORj(亦即,烷氧基)。作為Rj,係列舉甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中,較佳為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rj為甲基,於其他態樣中,Rj為乙基。 R 22 is preferably independently -OR j , -OCOR j , -ON=CR j 2 , -NR j 2 , -NHR j , -NCO, or halogen (in the formulas, R j represents a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR j (i.e., alkoxy). R j includes unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among these, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, R j is methyl, and in another embodiment, R j is ethyl.

上述R23分別獨立地為氫原子或1價之有機基。這些1價之有機基為除了上述水解性基以外的1價之有機基。 The above R23 are each independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

R23中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In R 23 , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述p1分別獨立地為0至3之整數,q1分別獨立地為0至3之整數,r1分別獨立地為0至3之整數。尚且,p1、q1及r1之合計在(SiR21 p1R22 q1R23 r1)單元中為3。 The above p1 is independently an integer from 0 to 3, q1 is independently an integer from 0 to 3, and r1 is independently an integer from 0 to 3. In addition, the total of p1, q1 and r1 is 3 in the (SiR 21 p1 R 22 q1 R 23 r1 ) unit.

於一態樣中,p1為0。 In one embodiment, p1 is 0.

於一態樣中,p1在每個(SiR21 p1R22 q1R23 r1)單元分別獨立地為1至3之整數、2至3之整數、或3。於較佳態樣中,p1為3。 In one aspect, p1 in each (SiR 21 p1 R 22 q1 R 23 r1 ) unit is independently an integer from 1 to 3, an integer from 2 to 3, or 3. In a preferred aspect, p1 is 3.

於一態樣中,q1在每個(SiR21 p1R22 q1R23 r1)單元分別獨立地為1至3之整數較佳為2至3之整數,更佳為3。 In one aspect, q1 in each (SiR 21 p1 R 22 q1 R 23 r1 ) unit is independently an integer from 1 to 3, preferably an integer from 2 to 3, and more preferably 3.

於一態樣中,p1為0,q1在每個(SiR21 p1R22 q1R23 r1)單元分別獨立地為1至3之整數,較佳為2至3之整數,再更佳為3。 In one aspect, p1 is 0, and q1 is independently an integer from 1 to 3, preferably an integer from 2 to 3, and more preferably 3, in each (SiR 21 p1 R 22 q1 R 23 r1 ) unit.

上述式中,Rb1分別獨立地為羥基或水解性基。 In the above formula, R b1 is independently a hydroxyl group or a hydrolyzable group.

上述Rb1較佳分別獨立地為水解性基。 It is preferred that the above R b1 are each independently a hydrolyzable group.

上述Rb1較佳分別獨立地為-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、或鹵素(此等之式中,Rj表示取代或未取代之C1-4烷 基),更佳為-ORj(亦即,烷氧基)。作為Rj,係列舉:甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中,較佳為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rj為甲基,於其他態樣中,Rj為乙基。 The above Rb1 is preferably independently -ORj , -OCORj , -ON= CRj2 , -NRj2 , -NHRj , -NCO, or halogen (in the formulas, Rj represents a substituted or unsubstituted C1-4 alkyl group), more preferably -ORj (i.e., alkoxy). Rj includes: unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among them, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, Rj is methyl, and in another embodiment, Rj is ethyl.

上述式中,Rc1分別獨立地為氫原子或1價之有機基。這些1價之有機基為除了上述水解性基的1價之有機基。 In the above formula, R c1 is independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

上述Rc1中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In the above R c1 , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述k1分別獨立地為0至3之整數,l1分別獨立地為0至3之整數,m1分別獨立地為0至3之整數。尚且,k1、l1及m1之合計在(SiRa1 k1Rb1 l1Rc1 m1)單元中為3。 The above k1 is independently an integer between 0 and 3, l1 is independently an integer between 0 and 3, and m1 is independently an integer between 0 and 3. Furthermore, the total of k1, l1 and m1 is 3 in the unit (SiR a1 k1 R b1 l1 R c1 m1 ).

於一態樣中,k1在每個(SiRa1 k1Rb1 l1Rc1 m1)單元分別獨立地為1至3之整數,較佳為2或3,更佳為3。於較佳態樣中,k1為3。 In one aspect, k1 in each (SiR a1 k1 R b1 l1 R c1 m1 ) unit is independently an integer from 1 to 3, preferably 2 or 3, and more preferably 3. In a preferred aspect, k1 is 3.

上述式(B1)及(B2)中,RSi屬於式(S3)所示之基之情況下,較佳為式(B1)及式(B2)之末端部分中,至少存在2個經羥基或水解性基鍵結的Si原子。 In the above formulae (B1) and (B2), when R Si belongs to the group represented by formula (S3), it is preferred that at least two Si atoms bonded via a hydroxyl group or a hydrolyzable group exist in the terminal portions of formulae (B1) and (B2).

於較佳態樣中,式(S3)所示之基具有-Z1-SiR22 q1R23 r1(式中,q1為1至3之整數,較佳為2或3,更佳為3,r1為0至2之整數)、-Z1’-SiR22’ q1’R23’ r1’(式中,q1’為1至3之整數,較佳為2或3,更佳為3,r1’為0至2之整數)、或-Z1”-SiR22” q1”R23” r1”(式中,q1”為1至3之整數,較佳為2或3,更佳為3,r1”為0至2之整數)之任一個。Z1、Z1’、Z1”、R22、R23、R22’、R23’、R22”、及R23”與上述同義。 In a preferred embodiment, the group represented by formula (S3) has any one of -Z 1 -SiR 22 q1 R 23 r1 (wherein q1 is an integer from 1 to 3, preferably 2 or 3, more preferably 3, and r1 is an integer from 0 to 2), -Z 1' -SiR 22' q1' R 23' r1' (wherein q1' is an integer from 1 to 3, preferably 2 or 3, more preferably 3, and r1' is an integer from 0 to 2), or -Z 1" -SiR 22" q1" R 23" r1" (wherein q1" is an integer from 1 to 3, preferably 2 or 3, more preferably 3, and r1" is an integer from 0 to 2). Z 1 , Z 1' , Z 1" , R 22 , R 23 , R 22' , R 23' , R 22” , and R 23” are the same as above.

於較佳態樣中,於式(S3)中,R21’存在之情況下,至少1個,較佳為所有的R21’中,q1”為1至3之整數,較佳為2或3,更佳為3。 In a preferred embodiment, in formula (S3), when R 21' exists, in at least one, preferably all, R 21' , q1" is an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

於較佳態樣中,於式(S3)中,R21存在之情況下,至少1個,較佳為所有的R21中,p1’為0,q1’為1至3之整數,較佳為2或3,更佳為3。 In a preferred embodiment, in formula (S3), when R 21 exists, in at least one, preferably all, R 21 , p1' is 0, and q1' is an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

於較佳態樣中,於式(S3)中,Ra1存在之情況下,至少1個,較佳為所有的Ra1中,p1為0,q1為1至3之整數,較佳為2或3,更佳為3。 In a preferred embodiment, in formula (S3), when Ra1 exists, in at least one, preferably all, Ra1 , p1 is 0, and q1 is an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

於較佳態樣中,於式(S3)中,k1為2或3,較佳為3,p1為0,q1為2或3,較佳為3。 In a preferred embodiment, in formula (S3), k1 is 2 or 3, preferably 3, p1 is 0, and q1 is 2 or 3, preferably 3.

Rd1分別獨立地為-Z2-CR31 p2R32 q2R33 r2R d1 is independently -Z 2 -CR 31 p2 R 32 q2 R 33 r2 .

3Z2分別獨立地為單鍵、氧原子或2價之有機基。尚且,作為以下Z2記載的結構,右側係鍵結至(CR31 p2R32 q2R33 r2)。 3Z 2 is independently a single bond, an oxygen atom or a divalent organic group. In the following structure represented by Z 2 , the right side is bonded to (CR 31 p2 R 32 q2 R 33 r2 ).

於較佳態樣中,Z2為2價之有機基。 In a preferred embodiment, Z 2 is a divalent organic group.

上述Z2較佳為C1-6伸烷基、-(CH2)z5-O-(CH2)z6-(式中,z5為0至6之整數,例如1至6之整數,z6為0至6之整數,例如1至6之整數)或-(CH2)z7-伸苯基-(CH2)z8-(式中,z7為0至6之整數,例如1至6之整數,z8為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈或分枝鏈,較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above Z2 is preferably C1-6 alkylene, -( CH2 ) z5 -O-( CH2 ) z6- (wherein z5 is an integer from 0 to 6, for example, an integer from 1 to 6, and z6 is an integer from 0 to 6, for example, an integer from 1 to 6) or -( CH2 ) z7 -phenylene-( CH2 ) z8- (wherein z7 is an integer from 0 to 6, for example, an integer from 1 to 6, and z8 is an integer from 0 to 6, for example, an integer from 1 to 6). These C1-6 alkylene groups may be straight chains or branched chains, preferably straight chains. These groups may be substituted, for example, by one or more substituents selected from fluorine atoms, C1-6 alkyl groups, C2-6 alkenyl groups, and C2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z2為C1-6伸烷基或-(CH2)z7-伸苯基-(CH2)z8-,較佳為-伸苯基-(CH2)z8-。Z2屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z 2 is a C 1-6 alkylene group or -(CH 2 ) z7 -phenylene-(CH 2 ) z8 -, preferably -phenylene-(CH 2 ) z8 -. When Z 2 is one of these groups, higher light resistance, especially ultraviolet resistance, can be obtained.

於其他較佳態樣中,上述Z2為C1-3伸烷基。於一態樣中,Z2可為-CH2CH2CH2-。於其他態樣中,Z2可為-CH2CH2-。 In other preferred aspects, the above Z 2 is a C 1-3 alkylene group. In one aspect, Z 2 can be -CH 2 CH 2 CH 2 -. In other aspects, Z 2 can be -CH 2 CH 2 -.

R31分別獨立地為-Z2’-CR22’ q2’R33’ r2’R 31 is independently -Z 2' -CR 22' q2' R 33' r2' .

Z2’分別獨立地為單鍵、氧原子或2價之有機基。尚且,作為以下Z2’記載的結構,右側係鍵結至(CR32’ q2’R33’ r2’)。 Z 2' is independently a single bond, an oxygen atom or a divalent organic group. In the structure described below as Z 2' , the right side is bonded to (CR 32' q2' R 33' r2' ).

上述Z2’較佳為C1-6伸烷基、-(CH2)z5’-O-(CH2)z6’-(式中,z5’為0至6之整數,例如1至6之整數,z6’為0至6之整數,例如1至6之整數)或-(CH2)z7’-伸苯基-(CH2)z8’-(式中,z7’為0至6之整數,例如1至6之整數,z8’為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈或分枝鏈,惟較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above Z 2' is preferably a C 1-6 alkylene group, -(CH 2 ) z5' -O-(CH 2 ) z6' -(wherein z5' is an integer from 0 to 6, for example, an integer from 1 to 6, and z6' is an integer from 0 to 6, for example, an integer from 1 to 6) or -(CH 2 ) z7' -phenylene-(CH 2 ) z8' -(wherein z7' is an integer from 0 to 6, for example, an integer from 1 to 6, and z8' is an integer from 0 to 6, for example, an integer from 1 to 6). These C 1-6 alkylene groups may be straight chains or branched chains, but are preferably straight chains. These groups may be substituted, for example, by one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z2’為C1-6伸烷基或-(CH2)z7’-伸苯基-(CH2)z8’-,較佳為-伸苯基-(CH2)z8’-。Z2’屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z 2' is a C 1-6 alkylene group or -(CH 2 ) z7' -phenylene-(CH 2 ) z8' -, preferably -phenylene-(CH 2 ) z8' - . When Z 2 ' is one of these groups, higher light resistance, especially ultraviolet resistance, can be obtained.

於其他較佳態樣中,上述Z2’為C1-3伸烷基。於一態樣中,Z2’可為-CH2CH2CH2-。於其他態樣中,Z2’可為-CH2CH2-。 In other preferred aspects, the above Z 2' is a C 1-3 alkylene group. In one aspect, Z 2' can be -CH 2 CH 2 CH 2 -. In other aspects, Z 2' can be -CH 2 CH 2 -.

上述R32’分別獨立地為-Z3-SiR34 n2R35 3-n2The above R 32' is independently -Z 3 -SiR 34 n2 R 35 3-n2 .

上述Z3分別獨立地為單鍵、氧原子或2價之有機基。尚且,作為以下Z3記載的結構,右側係鍵結至(SiR34 n2R35 3-n2)。 The above Z 3 is independently a single bond, an oxygen atom or a divalent organic group. In the structure described below as Z 3 , the right side is bonded to (SiR 34 n2 R 35 3-n2 ).

於一態樣中,Z3為氧原子。 In one embodiment, Z 3 is an oxygen atom.

於一態樣中,Z3為2價之有機基。 In one embodiment, Z 3 is a divalent organic group.

上述Z3較佳為C1-6伸烷基、-(CH2)z5”-O-(CH2)z6”-(式中,z5”為0至6之整數,例如1至6之整數,z6”為0至6之整數,例如1至6之整數)或-(CH2)z7”-伸苯基-(CH2)z8”-(式中,z7”為0至6之整數,例如1至6之整數,z8”為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈或分枝鏈,惟較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above Z 3 is preferably a C 1-6 alkylene group, -(CH 2 ) z5” -O-(CH 2 ) z6” -(wherein z5” is an integer from 0 to 6, for example, an integer from 1 to 6, and z6” is an integer from 0 to 6, for example, an integer from 1 to 6) or -(CH 2 ) z7” -phenylene-(CH 2 ) z8” -(wherein z7” is an integer from 0 to 6, for example, an integer from 1 to 6, and z8” is an integer from 0 to 6, for example, an integer from 1 to 6). These C 1-6 alkylene groups may be straight chains or branched chains, but are preferably straight chains. These groups, for example, may be substituted with one or more substituents selected from fluorine atoms, C 1-6 alkyl groups, C 2-6 alkenyl groups, and C 2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z3為C1-6伸烷基或-(CH2)z7”-伸苯基-(CH2)z8”-,較佳為-伸苯基-(CH2)z8”-。Z3屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z 3 is a C 1-6 alkylene group or -(CH 2 ) z7″ -phenylene-(CH 2 ) z8″ -, preferably -phenylene-(CH 2 ) z8″ -. When Z 3 is one of these groups, higher light resistance, especially UV resistance, can be obtained.

於其他較佳態樣中,上述Z3為C1-3伸烷基。於一態樣中,Z3可為-CH2CH2CH2-。於其他態樣中,Z3可為-CH2CH2-。 In other preferred aspects, the above Z 3 is a C 1-3 alkylene group. In one aspect, Z 3 may be -CH 2 CH 2 CH 2 -. In other aspects, Z 3 may be -CH 2 CH 2 -.

上述R34分別獨立地為羥基或水解性基。 The above R 34 are each independently a hydroxyl group or a hydrolyzable group.

R34較佳分別獨立地為水解性基。 It is preferred that R 34 each independently be a hydrolyzable group.

R34較佳分別獨立地為-ORj、-OCORj、-O-N=CRj 2、-NRj 2、-NHRj、-NCO、或鹵素(此等之式中,Rj表示取代或未取代之C1-4烷基),更佳為-ORj(亦即,烷氧基)。作為Rj,係列舉甲基、乙基、丙基、異丙基、正丁基、異丁基等之未取代烷基;氯甲基等之取代烷基。此等之中,較佳 為烷基,尤其係未取代烷基,更佳為甲基或乙基。於一態樣中,Rj為甲基,於其他態樣中,Rj為乙基。 R 34 is preferably independently -OR j , -OCOR j , -ON=CR j 2 , -NR j 2 , -NHR j , -NCO, or halogen (in the formulas, R j represents a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR j (i.e., alkoxy group). R j includes unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, etc.; substituted alkyl groups such as chloromethyl, etc. Among these, alkyl groups are preferred, especially unsubstituted alkyl groups, and methyl or ethyl groups are more preferred. In one embodiment, R j is methyl, and in another embodiment, R j is ethyl.

上述R35分別獨立地為氫原子或1價之有機基。這些1價之有機基為除了上述水解性基的1價之有機基。 The above R 35 is independently a hydrogen atom or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

上述R35中,1價之有機基較佳為C1-20烷基,更佳為C1-6烷基,又更佳為甲基。 In the above R 35 , the monovalent organic group is preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group, and even more preferably a methyl group.

上述式中,n2在每個(SiR34 n2R35 3-n2)單元分別獨立地為0至3之整數。惟,RSi屬於式(S4)所示之基之情況下,式(B1)及式(B2)之末端部分中,至少存在1個n2屬於1至3的(SiR34 n2R35 3-n2)單元。亦即,這些末端部分中,所有之n2不會同時為0。換言之,式(B1)及式(B2)之末端部分中,存在至少1個羥基或水解性基鍵結的Si原子。 In the above formula, n2 is an integer from 0 to 3 in each (SiR 34 n2 R 35 3-n2 ) unit independently. However, when R Si belongs to the group represented by formula (S4), there is at least one (SiR 34 n2 R 35 3-n2 ) unit in which n2 belongs to 1 to 3 in the terminal part of formula (B1) and formula (B2). That is, in these terminal parts, all n2 will not be 0 at the same time. In other words, there is at least one Si atom bonded to a hydroxyl group or a hydrolyzable group in the terminal part of formula (B1) and formula (B2).

n2在每個(SiR34 n2R35 3-n2)單元分別獨立地較佳為1至3之整數,更佳為2至3,再更佳為3。 In each (SiR 34 n2 R 35 3-n2 ) unit, n2 is independently preferably an integer of 1 to 3, more preferably 2 to 3, and even more preferably 3.

上述R33’分別獨立地為氫原子、羥基或1價之有機基。這些1價之有機基為除了上述水解性基的1價之有機基。 The above R 33' is independently a hydrogen atom, a hydroxyl group or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

上述R33’中,1價之有機基較佳為C1-20烷基或-(CsH2s)t1-(O-CsH2s)t2(式中,s為1至6之整數,較佳為2至4之整數,t1為1或0,較佳為0,t2為1至20之整數,較佳為2至10之整數,更佳為2至6之整數),更佳為C1-20烷基,又更佳為C1-6烷基,特佳為甲基。 In the above R 33' , the monovalent organic group is preferably a C 1-20 alkyl group or -(C s H 2s ) t1 -(OC s H 2s ) t2 (wherein s is an integer from 1 to 6, preferably an integer from 2 to 4, t1 is 1 or 0, preferably 0, and t2 is an integer from 1 to 20, preferably an integer from 2 to 10, and more preferably an integer from 2 to 6), more preferably a C 1-20 alkyl group, still more preferably a C 1-6 alkyl group, and particularly preferably a methyl group.

於一態樣中,R33’為羥基。 In one embodiment, R 33' is hydroxy.

於其他態樣中,R33’為1價之有機基,較佳為C1-20烷基,更佳為C1-6烷基。 In other aspects, R 33′ is a monovalent organic group, preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group.

q2’分別獨立地為0至3之整數,上述r2’分別獨立地為0至3之整數。尚且,q2’與r2’之合計在(CR32’ q2’R33’ r2’)單元中為3。 q2' is independently an integer between 0 and 3, and r2' is independently an integer between 0 and 3. Furthermore, the sum of q2' and r2' is 3 in the unit (CR 32' q2' R 33' r2' ).

q2’在每個(CR32’ q2’R33’ r2’)單元分別獨立地較佳為1至3之整數,更佳為2至3,再更佳為3。 q2' in each (CR 32' q2' R 33' r2' ) unit is preferably an integer from 1 to 3, more preferably 2 to 3, and even more preferably 3.

R32分別獨立地為-Z3-SiR34 n2R35 3-n2。這些-Z3-SiR34 n2R35 3-n2與上述R32’中之記載同義。 R 32' is independently -Z 3 -SiR 34 n2 R 35 3-n2 . These -Z 3 -SiR 34 n2 R 35 3-n2 have the same meanings as those described in the above R 32' .

上述R33分別獨立地為氫原子、羥基或1價之有機基。這些1價之有機基為除了上述水解性基的1價之有機基。 The above R 33 is independently a hydrogen atom, a hydroxyl group or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

上述R33中,1價之有機基較佳為C1-20烷基或-(CsH2s)t1-(O-CsH2s)t2(式中,s為1至6之整數,較佳為2至4之整數,t1為1或0,較佳為0,t2為1至20之整數,較佳為2至10之整數,更佳為2至6之整數),更佳為C1-20烷基,又更佳為C1-6烷基,特佳為甲基。 In the above R 33 , the monovalent organic group is preferably a C 1-20 alkyl group or -(C s H 2s ) t1 -(OC s H 2s ) t2 (wherein s is an integer from 1 to 6, preferably an integer from 2 to 4, t1 is 1 or 0, preferably 0, and t2 is an integer from 1 to 20, preferably an integer from 2 to 10, and more preferably an integer from 2 to 6), more preferably a C 1-20 alkyl group, still more preferably a C 1-6 alkyl group, and particularly preferably a methyl group.

於一態樣中,R33為羥基。 In one embodiment, R 33 is hydroxy.

於其他態樣中,R33為1價之有機基,較佳為C1-20烷基,更佳為C1-6烷基。 In other aspects, R 33 is a monovalent organic group, preferably a C 1-20 alkyl group, more preferably a C 1-6 alkyl group.

上述p2分別獨立地為0至3之整數,q2分別獨立地為0至3之整數,r2分別獨立地為0至3之整數。尚且,p2、q2及r2之合計在(CR31 p2R32 q2R33 r2)單元中為3。 The above p2 is independently an integer between 0 and 3, q2 is independently an integer between 0 and 3, and r2 is independently an integer between 0 and 3. Furthermore, the total of p2, q2 and r2 is 3 in the unit (CR 31 p2 R 32 q2 R 33 r2 ).

於一態樣中,p2為0。 In one embodiment, p2 is 0.

於一態樣中,p2在每個(CR31 p2R32 q2R33 r2)單元分別獨立地可為1至3之整數、2至3之整數、或3。於較佳態樣中,p2為3。 In one aspect, p2 in each (CR 31 p2 R 32 q2 R 33 r2 ) unit can be independently an integer from 1 to 3, an integer from 2 to 3, or 3. In a preferred aspect, p2 is 3.

於一態樣中,q2在每個(CR31 p2R32 q2R33 r2)單元分別獨立地為1至3之整數,較佳為2至3之整數,更佳為3。 In one aspect, q2 in each (CR 31 p2 R 32 q2 R 33 r2 ) unit is independently an integer from 1 to 3, preferably an integer from 2 to 3, and more preferably 3.

於一態樣中,p2為0,q2在每個(CR31 p2R32 q2R33 r2)單元分別獨立地為1至3之整數,較佳為2至3之整數,再更佳為3。 In one aspect, p2 is 0, and q2 is independently an integer from 1 to 3 in each (CR 31 p2 R 32 q2 R 33 r2 ) unit, preferably an integer from 2 to 3, and more preferably 3.

上述Re1分別獨立地為-Z3-SiR34 n2R35 3-n2。這些-Z3-SiR34 n2R35 3-n2與上述R32’中之記載同義。 The above-mentioned R e1 is independently -Z 3 -SiR 34 n2 R 35 3-n2 . These -Z 3 -SiR 34 n2 R 35 3-n2 have the same meanings as those described in the above-mentioned R 32' .

上述Rf1分別獨立地為氫原子、羥基或1價之有機基。這些1價之有機基為除了上述水解性基的1價之有機基。 The above R f1 is independently a hydrogen atom, a hydroxyl group or a monovalent organic group. These monovalent organic groups are monovalent organic groups other than the above-mentioned hydrolyzable groups.

上述Rf1中,1價之有機基較佳為C1-20烷基或-(CsH2s)t1-(O-CsH2s)t2(式中,s為1至6之整數,較佳為2至4之整數,t1為1或0,較佳為0,t2為1至20之整數,較佳為2至10之整數,更佳為2至6之整數),更佳為C1-20烷基,又更佳為C1-6烷基,特佳為甲基。 In the above R f1 , the monovalent organic group is preferably a C 1-20 alkyl group or -(C s H 2s ) t1 -(OC s H 2s ) t2 (wherein s is an integer from 1 to 6, preferably an integer from 2 to 4, t1 is 1 or 0, preferably 0, and t2 is an integer from 1 to 20, preferably an integer from 2 to 10, and more preferably an integer from 2 to 6), more preferably a C 1-20 alkyl group, still more preferably a C 1-6 alkyl group, and particularly preferably a methyl group.

於一態樣中,Rf1為羥基。 In one embodiment, R f1 is hydroxy.

於其他態樣中,Rf1為1價之有機基,較佳為C1-20烷基,更佳為C1-6烷基。 In other aspects, Rf1 is a monovalent organic group, preferably a C1-20 alkyl group, more preferably a C1-6 alkyl group.

上述k2分別獨立地為0至3之整數,l2分別獨立地為0至3之整數,m2分別獨立地為0至3之整數。尚且,k2、l2及m2之合計在(CRd1 k2Re1 l2Rf1 m2)單元中為3。 The above k2 is independently an integer between 0 and 3, l2 is independently an integer between 0 and 3, and m2 is independently an integer between 0 and 3. Moreover, the total of k2, l2 and m2 is 3 in the unit (CR d1 k2 R e1 l2 R f1 m2 ).

上述式(B1)及(B2)中,RSi屬於式(S4)所示之基之情況下,較佳為式(B1)及式(B2)之末端部分中,至少存在2個經羥基或水解性基鍵結的Si原子。 In the above formulae (B1) and (B2), when R Si belongs to the group represented by formula (S4), it is preferred that at least two Si atoms bonded via a hydroxyl group or a hydrolyzable group exist in the terminal portions of formulae (B1) and (B2).

於一態樣中,RSi屬於式(S4)所示之基之情況下,n2為1至3,較佳為2或3,更佳為3(SiR34 n2R35 3-n2)單元在式(B1)及式(B2)之各末端部分中,存在2個以上,例如2至27個,較佳為2至9個,更佳為2至6個,又更佳為2至3個,特佳為3個。 In one embodiment, when R Si belongs to the group represented by formula (S4), n2 is 1 to 3, preferably 2 or 3, and more preferably 3. There are 2 or more (SiR 34 n2 R 35 3-n2 ) units in each terminal part of formula (B1) and formula (B2), for example, 2 to 27, preferably 2 to 9, more preferably 2 to 6, even more preferably 2 to 3, and particularly preferably 3.

於較佳態樣中,式(S4)中,R32’存在之情況下,至少1個,較佳為所有的R32’中,n2為1至3之整數,較佳為2或3,更佳為3。 In a preferred embodiment, in formula (S4), when R 32′ exists, in at least one, preferably all, R 32′ , n2 is an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

於較佳態樣中,式(S4)中,R32存在之情況下,至少1個,較佳為所有的R32中,n2為1至3之整數,較佳為2或3,更佳為3。 In a preferred embodiment, in formula (S4), when R 32 exists, in at least one, preferably all, R 32 , n2 is an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

於較佳態樣中,式(S4)中,Re1存在之情況下,至少1個,較佳為所有的Ra1中,n2為1至3之整數,較佳為2或3,更佳為3。 In a preferred embodiment, in formula (S4), when Re1 exists, at least one, preferably all, of Re1 , n2 is an integer from 1 to 3, preferably 2 or 3, and more preferably 3.

於較佳態樣中,式(S4)中,k2為0,l2為2或3,較佳為3,n2為2或3,較佳為3。 In a preferred embodiment, in formula (S4), k2 is 0, l2 is 2 or 3, preferably 3, and n2 is 2 or 3, preferably 3.

上述Rg1及Rh1分別獨立地為-Z4-SiR25 n1R26 3-n1、-Z4-SiRa1 k1Rb1 l1Rc1 m1、-Z4-CRd1 k2Re1 l2Rf1 m2。於此,R25、R26、Ra1、Rb2、Rc1、Rd1、Re1、Rf1、n1、k1、l1、m1、k2、l2、及m2與上述同義。 The above R g1 and R h1 are independently -Z 4 -SiR 25 n1 R 26 3-n1 , -Z 4 -SiR a1 k1 R b1 l1 R c1 m1 , -Z 4 -CR d1 k2 Re1 l2 R f1 m2 , respectively. Here, R 25 , R 26 , Ra1 , R b2 , R c1 , R d1 , Re1 , R f1 , n1, k1, l1, m1, k2, l2, and m2 have the same meanings as above.

於較佳態樣中,Rg1及Rh1分別獨立地為-Z4-SiR25 n1R26 3-n1In a preferred embodiment, R g1 and R h1 are independently -Z 4 -SiR 25 n1 R 26 3-n1 .

上述Z4分別獨立地為單鍵、氧原子或2價之有機基。尚且,作為以下Z4記載的結構,右側係鍵結至(SiR25 n1R26 3-n1)。 The above Z 4 is independently a single bond, an oxygen atom or a divalent organic group. In the structure described below as Z 4 , the right side is bonded to (SiR 25 n1 R 26 3-n1 ).

於一態樣中,Z4為氧原子。 In one embodiment, Z 4 is an oxygen atom.

於一態樣中,Z4為2價之有機基。 In one embodiment, Z 4 is a divalent organic group.

上述Z4較佳為C1-6伸烷基、-(CH2)z5”-O-(CH2)z6”-(式中,z5”為0至6之整數,例如1至6之整數,z6”為0至6之整數,例如1至6之 整數)或-(CH2)z7”-伸苯基-(CH2)z8”-(式中,z7”為0至6之整數,例如1至6之整數,z8”為0至6之整數,例如1至6之整數)。這些C1-6伸烷基可為直鏈或分枝鏈,惟較佳為直鏈。此等基,例如,可被選自氟原子、C1-6烷基、C2-6烯基、及C2-6炔基之1個或超過1個之取代基取代,惟較佳為未取代。 The above Z4 is preferably C1-6 alkylene, -( CH2 ) z5" -O-( CH2 ) z6" -(wherein z5" is an integer from 0 to 6, for example, an integer from 1 to 6, and z6" is an integer from 0 to 6, for example, an integer from 1 to 6) or -( CH2 ) z7" -phenylene-( CH2 ) z8" -(wherein z7" is an integer from 0 to 6, for example, an integer from 1 to 6, and z8" is an integer from 0 to 6, for example, an integer from 1 to 6). These C1-6 alkylene groups may be straight chains or branched chains, but are preferably straight chains. These groups may be substituted, for example, by one or more substituents selected from fluorine atoms, C1-6 alkyl groups, C2-6 alkenyl groups, and C2-6 alkynyl groups, but are preferably unsubstituted.

於較佳態樣中,Z4為C1-6伸烷基或-(CH2)z7”-伸苯基-(CH2)z8”-,較佳為-伸苯基-(CH2)z8”-。Z3屬於這些基之情況下,可獲得更高的光耐性,尤其係紫外線耐性。 In a preferred embodiment, Z 4 is a C 1-6 alkylene group or -(CH 2 ) z7″ -phenylene-(CH 2 ) z8″ -, preferably -phenylene-(CH 2 ) z8″ -. When Z 3 is one of these groups, higher light resistance, especially UV resistance, can be obtained.

於其他較佳態樣中,上述Z4為C1-3伸烷基。於一態樣中,Z4可為-CH2CH2CH2-。於其他態樣中,Z4可為-CH2CH2-。 In other preferred aspects, the above Z 4 is a C 1-3 alkylene group. In one aspect, Z 4 may be -CH 2 CH 2 CH 2 -. In another aspect, Z 4 may be -CH 2 CH 2 -.

於一態樣中,RSi為式(S2)、(S3)、(S4)或(S5)所示之基。此等之化合物可形成具有高表面滑性的硬化物層。 In one embodiment, R Si is a group represented by formula (S2), (S3), (S4) or (S5). These compounds can form a hardened layer with high surface slip.

於一態樣中,RSi為式(S3)、(S4)或(S5)所示之基。此等之化合物,由於在單末端具有複數的水解性基,因此可形成與基材的密著強、具有高磨耗耐久性的硬化物層。 In one embodiment, R Si is a group represented by formula (S3), (S4) or (S5). Since these compounds have a plurality of hydrolyzable groups at one end, they can form a hardened layer that has strong adhesion to the substrate and high wear resistance.

於一態樣中,RSi為式(S3)或(S4)所示之基。此等之化合物,由於可在單末端具有從一個Si原子或C原子支化的複數個水解性基,因此可形成具有更高磨耗耐久性的硬化物層。 In one embodiment, R Si is a group represented by formula (S3) or (S4). Since these compounds have a plurality of hydrolyzable groups branched from one Si atom or C atom at one end, they can form a hardened layer having higher wear durability.

於一態樣中,RSi為式(S1)所示之基。 In one embodiment, R Si is a group represented by formula (S1).

於一態樣中,RSi為式(S2)所示之基。 In one embodiment, R Si is a group represented by formula (S2).

於一態樣中,RSi為式(S3)所示之基。 In one embodiment, R Si is a group represented by formula (S3).

於一態樣中,RSi為式(S4)所示之基。 In one embodiment, R Si is a group represented by formula (S4).

於一態樣中,RSi為式(S5)所示之基。 In one embodiment, R Si is a group represented by formula (S5).

上述式(B1)及(B2)中,XZ被理解為連接主要提供撥水性及表面滑性等之氟聚醚部份(RF3及RF4)及提供與基材之鍵結能力的部分(RSi)的連接體。因此,只要係式(B1)及(B2)所示之化合物可穩定地存在者,則該XZ可為單鍵,亦可為任何基。 In the above formulae (B1) and (B2), XZ is understood to be a linker that connects the fluoropolyether portion ( RF3 and RF4 ) that mainly provides hydrophobicity and surface slipperiness and the portion ( RSi ) that provides bonding ability with the substrate. Therefore, as long as the compounds represented by formulae (B1) and (B2) can exist stably, XZ may be a single bond or any group.

上述式(B1)中,α為1至9之整數,β為1至9之整數。此等之α及β可因應XZ之價數變化。α及β之和與XZ之價數相同。例如,XZ屬於10價之有機基之情況下,α及β之和為10,可為例如α為9且β為1、α為5且β為5、或α為1且β為9。此外,XZ屬於2價之有機基之情況下,α及β為1。 In the above formula (B1), α is an integer from 1 to 9, and β is an integer from 1 to 9. These α and β may vary according to the valence of XZ . The sum of α and β is the same as the valence of XZ . For example, when XZ is a devalent organic group, the sum of α and β is 10, and α is 9 and β is 1, α is 5 and β is 5, or α is 1 and β is 9. In addition, when XZ is a divalent organic group, α and β are 1.

上述式(B2)中,γ為1至9之整數。γ可因應XZ之價數變化。亦即,γ係從XZ之價數減去1後的值。 In the above formula (B2), γ is an integer from 1 to 9. γ can change according to the valence of XZ . That is, γ is the value obtained by subtracting 1 from the valence of XZ .

XZ分別獨立地為單鍵或2至10價之有機基; X and Z are each independently a single bond or a 2- to 10-valent organic group;

上述XZ中之2至10價之有機基較佳為2至8價之有機基。於一態樣中,這些2至10價之有機基較佳為2至4價之有機基,更佳為2價之有機基。於其他態樣中,這些2至10價之有機基較佳為3至8價之有機基,更佳為3至6價之有機基。 The 2- to 10-valent organic group in XZ is preferably a 2- to 8-valent organic group. In one embodiment, these 2- to 10-valent organic groups are preferably 2- to 4-valent organic groups, and more preferably 2-valent organic groups. In other embodiments, these 2- to 10-valent organic groups are preferably 3- to 8-valent organic groups, and more preferably 3- to 6-valent organic groups.

於一態樣中,XZ為單鍵或2價之有機基,α為1、β為1。 In one embodiment, XZ is a single bond or a divalent organic group, α is 1, and β is 1.

於一態樣中,XZ為單鍵或2價之有機基,γ為1。 In one embodiment, XZ is a single bond or a divalent organic group, and γ is 1.

於一態樣中,XZ為3至6價之有機基,α為1、β為2至5。 In one embodiment, XZ is a tri- to hexavalent organic group, α is 1, and β is 2-5.

於一態樣中,XZ為3至6價之有機基、γ為2至5。 In one embodiment, XZ is a 3-6 valent organic group, and γ is 2-5.

於一態樣中,XZ為3價之有機基,α為1、β為2。 In one embodiment, XZ is a trivalent organic group, α is 1, and β is 2.

於一態樣中,XZ為3價之有機基,γ為2。 In one embodiment, XZ is a trivalent organic group, and γ is 2.

XZ屬於單鍵或2價之有機基之情況下,式(B1)及(B2)為下述式(B1’)及(B2’)所示。 When X Z is a single bond or a divalent organic group, formula (B1) and (B2) are represented by the following formula (B1') and (B2').

RF3-XZ-RSi (B1’) R F3 -X Z -R Si (B1')

RSi-XZ-RF4-XZ-RSi (B2’) R Si -X Z -R F4 -X Z -R Si (B2')

於一態樣中,XZ為單鍵。 In one aspect, XZ is a single key.

於其他態樣中,XZ為2價之有機基。 In other aspects, XZ is a divalent organic group.

於一態樣中,作為XZ,係列舉例如,單鍵或下述式所示之2價之有機基。 In one embodiment, X Z is, for example, a single bond or a divalent organic group represented by the following formula.

-(R51)p5-(X51)q5- -(R 51 ) p5 -(X 51 ) q5 -

[式中: [Where:

R51表示單鍵、-(CH2)s5-或鄰、間或對伸苯基,較佳為-(CH2)s5-, R 51 represents a single bond, -(CH 2 ) s5 - or o-, m- or p-phenyl, preferably -(CH 2 ) s5 -,

s5為1至20之整數,較佳為1至6之整數,更佳為1至3之整數,再更佳為1或2, s5 is an integer from 1 to 20, preferably an integer from 1 to 6, more preferably an integer from 1 to 3, and even more preferably 1 or 2.

X51表示-(X52)l5-, X51 represents -( X52 ) 15- ,

X52分別獨立地表示選自-O-、-S-、鄰、間或對伸苯基、-C(O)O-、-Si(R53)2-、-(Si(R53)2O)m5-Si(R53)2-、-CONR54-、-O-CONR54-、-NR54-及-(CH2)n5-所組成之群組的基, X52 each independently represents a group selected from the group consisting of -O-, -S-, o-, m- or p-phenylene, -C(O)O-, -Si( R53 ) 2- , -(Si( R53 ) 2O ) m5 -Si( R53 ) 2- , -CONR54- , -O- CONR54- , -NR54- and -( CH2 ) n5- ,

R53分別獨立地表示苯基、C1-6烷基或C1-6烷氧基,較佳為苯基或C1-6烷基,更佳為甲基, R 53 each independently represents a phenyl group, a C 1-6 alkyl group or a C 1-6 alkoxy group, preferably a phenyl group or a C 1-6 alkyl group, more preferably a methyl group,

R54分別獨立地表示氫原子、苯基或C1-6烷基(較佳為甲基), R 54 each independently represents a hydrogen atom, a phenyl group or a C 1-6 alkyl group (preferably a methyl group),

m5於每次出現時分別獨立地為1至100之整數,較佳為1至20之整數, m5 is an integer from 1 to 100 independently each time it appears, preferably an integer from 1 to 20.

n5於每次出現時分別獨立地為1至20之整數,較佳為1至6之整數,更佳為1至3之整數, n5 is independently an integer from 1 to 20 each time it appears, preferably an integer from 1 to 6, and more preferably an integer from 1 to 3,

l5為1至10之整數,較佳為1至5之整數,更佳為1至3之整數, l5 is an integer from 1 to 10, preferably an integer from 1 to 5, and more preferably an integer from 1 to 3.

p5為0或1, p5 is 0 or 1,

q5為0或1, q5 is 0 or 1,

於此,p5及q5之至少一方為1,標註p5或q5並以括弧括起之各重複單元在式中的存在順序為任意] Here, at least one of p5 and q5 is 1, and the order of existence of the repeated units marked with p5 or q5 and enclosed in parentheses in the formula is arbitrary]

於此,XZ(典型而言XZ之氫原子)可被選自氟原子、C1-3烷基及C1-3氟烷基之1個或超過1個之取代基取代。於較佳態樣中,XZ不被此等基取代。 Here, XZ (typically a hydrogen atom of XZ ) may be substituted by one or more substituents selected from a fluorine atom, a C1-3 alkyl group and a C1-3 fluoroalkyl group. In a preferred embodiment, XZ is not substituted by these groups.

於較佳態樣中,上述XZ分別獨立地為-(R51)p5-(X51)q5-R52-。R52表示單鍵、-(CH2)t5-或鄰、間或對伸苯基,較佳為-(CH2)t5-。t5為1至20之整數,較佳為2至6之整數,更佳為2至3之整數。於此,R52(典型而言R52之氫原子)可被選自氟原子、C1-3烷基及C1-3氟烷基之1個或超過1個之取代基取代。於較佳態樣中,R56不被此等基取代。 In a preferred embodiment, the above X Z are independently -(R 51 ) p5 -(X 51 ) q5 -R 52 -. R 52 represents a single bond, -(CH 2 ) t5 - or o-, m- or p-phenyl, preferably -(CH 2 ) t5 -. T5 is an integer from 1 to 20, preferably an integer from 2 to 6, and more preferably an integer from 2 to 3. Here, R 52 (typically a hydrogen atom of R 52 ) may be substituted by one or more substituents selected from a fluorine atom, a C 1-3 alkyl group and a C 1-3 fluoroalkyl group. In a preferred embodiment, R 56 is not substituted by these groups.

較佳為上述XZ分別獨立地可為單鍵、 Preferably, the above X and Z can be a single key,

C1-20伸烷基、 C 1-20 alkylene,

-R51-X53-R52-、或 -R 51 -X 53 -R 52 -, or

-X54-R5- -X 54 -R 5 -

[式中,R51及R52與上述同義, [wherein, R 51 and R 52 have the same meanings as above,

X53表示 X 53 means

-O-、 -O-,

-S-、 -S-,

-C(O)O-、 -C(O)O-,

-CONR54-、 -CONR 54 -

-O-CONR54-、 -O-CONR 54 -

-Si(R53)2-、 -Si(R 53 ) 2 -,

-(Si(R53)2O)m5-Si(R53)2-、 -(Si(R 53 ) 2 O) m5 -Si(R 53 ) 2 -,

-O-(CH2)u5-(Si(R53)2O)m5-Si(R53)2-、 -O-(CH 2 ) u5 -(Si(R 53 ) 2 O) m5 -Si(R 53 ) 2 -,

-O-(CH2)u5-Si(R53)2-O-Si(R53)2-CH2CH2-Si(R53)2-O-Si(R53)2-、 -O-(CH 2 ) u5 -Si(R 53 ) 2 -O-Si(R 53 ) 2 -CH 2 CH 2 -Si(R 53 ) 2 -O-Si(R 53 ) 2 -,

-O-(CH2)u5-Si(OCH3)2OSi(OCH3)2-、 -O-(CH 2 ) u5 -Si(OCH 3 ) 2 OSi(OCH 3 ) 2 -,

-CONR54-(CH2)u5-(Si(R53)2O)m5-Si(R53)2-、 -CONR 54 -(CH 2 ) u5 -(Si(R 53 ) 2 O) m5 -Si(R 53 ) 2 -,

-CONR54-(CH2)u5-N(R54)-、或 -CONR 54 -(CH 2 ) u5 -N(R 54 )-, or

-CONR54-(鄰、間或對伸苯基)-Si(R53)2- -CONR 54 -(o-, m- or p-phenyl)-Si(R 53 ) 2 -

(式中,R53、R54及m5與上述同義, (wherein, R 53 , R 54 and m5 have the same meanings as above,

u5為1至20之整數,較佳為2至6之整數,更佳為2至3之整數), u5 is an integer from 1 to 20, preferably an integer from 2 to 6, and more preferably an integer from 2 to 3),

X54表示 X 54 means

-S-、 -S-,

-C(O)O-、 -C(O)O-,

-CONR54-、 -CONR 54 -

-O-CONR54-、 -O-CONR 54 -

-CONR54-(CH2)u5-(Si(R54)2O)m5-Si(R54)2-、 -CONR 54 -(CH 2 ) u5 -(Si(R 54 ) 2 O) m5 -Si(R 54 ) 2 -,

-CONR54-(CH2)u5-N(R54)-、或 -CONR 54 -(CH 2 ) u5 -N(R 54 )-, or

-CONR54-(鄰、間或對伸苯基)-Si(R54)2- -CONR 54 -(o-, m- or p-phenyl)-Si(R 54 ) 2 -

(式中,各記號與上述同義)]。 (In the formula, each symbol has the same meaning as above)].

更佳為、上述XZ分別獨立地為單鍵、 More preferably, the above X and Z are each independently a single key,

C1-20伸烷基、 C 1-20 alkylene,

-(CH2)s5-X53-、 -(CH 2 ) s 5 -X 53 -,

-(CH2)s5-X53-(CH2)t5- -(CH 2 ) s5 -X 53 -(CH 2 ) t5 -

-X54-、或 -X 54 -, or

-X54-(CH2)t5- -X 54 -(CH 2 ) t5 -

[式中,X53、X54、s5及t5與上述同義]。 [wherein, X 53 , X 54 , s5 and t5 have the same meanings as above].

更佳為上述XZ分別獨立地可為單鍵、 More preferably, the above X and Z can be a single key,

C1-20伸烷基、 C 1-20 alkylene,

-(CH2)s5-X53-(CH2)t5-、或 -(CH 2 ) s5 -X 53 -(CH 2 ) t5 -, or

-X54-(CH2)t5- -X 54 -(CH 2 ) t5 -

[式中,各記號與上述同義]。 [In the formula, each symbol has the same meaning as above].

於較佳態樣中,上述XZ分別獨立地可為單鍵 In a preferred embodiment, the above X and Z can be single keys independently.

C1-20伸烷基、 C 1-20 alkylene,

-(CH2)s5-X53-、或 -(CH 2 ) s 5 -X 53 -, or

-(CH2)s5-X53-(CH2)t5- -(CH 2 ) s5 -X 53 -(CH 2 ) t5 -

[式中, [Where,

X53為-O-、-CONR54-、或-O-CONR54-, X 53 is -O-, -CONR 54 -, or -O-CONR 54 -,

R54分別獨立地表示氫原子、苯基或C1-6烷基, R 54 each independently represents a hydrogen atom, a phenyl group or a C 1-6 alkyl group,

s5為1至20之整數, s5 is an integer from 1 to 20,

t5為1至20之整數]。 t5 is an integer between 1 and 20].

於較佳態樣中,上述XZ分別獨立地可為 In a preferred embodiment, the above X and Z can be independently

-(CH2)s5-O-(CH2)t5- -(CH 2 ) s5 -O-(CH 2 ) t5 -

-CONR54-(CH2)t5- -CONR 54 -(CH 2 ) t5 -

[式中, [Where,

R54表示分別獨立地、氫原子、苯基或C1-6烷基, R 54 represents independently, a hydrogen atom, a phenyl group or a C 1-6 alkyl group,

s5為1至20之整數, s5 is an integer from 1 to 20,

t5為1至20之整數]。 t5 is an integer between 1 and 20].

於一態樣中,上述XZ分別獨立地為單鍵、 In one embodiment, the above X and Z are independently single keys,

C1-20伸烷基、 C 1-20 alkylene,

-(CH2)s5-O-(CH2)t5-、 -(CH 2 ) s5 -O-(CH 2 ) t5 -,

-(CH2)s5-(Si(R53)2O)m5-Si(R53)2-(CH2)t5-、 -(CH 2 ) s5 -(Si(R 53 ) 2 O) m5 -Si(R 53 ) 2 -(CH 2 ) t5 -,

-(CH2)s5-O-(CH2)u5-(Si(R53)2O)m5-Si(R53)2-(CH2)t5-、或 -(CH 2 ) s5 -O-(CH 2 ) u5 -(Si(R 53 ) 2 O) m5 -Si(R 53 ) 2 -(CH 2 ) t5 -, or

-(CH2)s5-O-(CH2)t5-Si(R53)2-(CH2)u5-Si(R53)2-(CvH2v)- -(CH 2 ) s5 -O-(CH 2 ) t5 -Si(R 53 ) 2 -(CH 2 ) u5 -Si(R 53 ) 2 -(C v H 2v )-

[式中,R53、m5、s5、t5及u5與上述同義,v5為1至20之整數,較佳為2至6之整數,更佳為2至3之整數]。 [wherein, R 53 , m5, s5, t5 and u5 have the same meanings as above, and v5 is an integer from 1 to 20, preferably an integer from 2 to 6, and more preferably an integer from 2 to 3].

上述式中,-(CvH2v)-可為直鏈或分枝鏈,例如,可為-CH2CH2-、-CH2CH2CH2-、-CH(CH3)-、-CH(CH3)CH2-。 In the above formula, -(C v H 2v )- may be a straight chain or a branched chain, for example, it may be -CH 2 CH 2 -, -CH 2 CH 2 CH 2 -, -CH(CH 3 )-, or -CH(CH 3 )CH 2 -.

上述XZ分別獨立地可被選自氟原子、C1-3烷基及C1-3氟烷基(較佳為、C1-3全氟烷基)之1個或超過1個之取代基取代。於一態樣中,XZ為未取代。 The above XZ may be independently substituted by one or more substituents selected from fluorine atoms, C1-3 alkyl groups and C1-3 fluoroalkyl groups (preferably C1-3 perfluoroalkyl groups). In one embodiment, XZ is unsubstituted.

尚且,上述XZ,各式之左側係鍵結至RF3或RF4,右側係鍵結至RSiMoreover, in each of the above X Z , the left side is bonded to RF3 or RF4 , and the right side is bonded to R Si .

於一態樣中,XZ分別獨立地可為-O-C1-6伸烷基以外。 In one embodiment, X and Z can each independently be other than -OC 1-6 alkylene.

於其他態樣中,作為XZ,係列舉例如下述之基: In other aspects, X Z is a basis such as:

Figure 112112312-A0202-12-0086-25
Figure 112112312-A0202-12-0086-25

Figure 112112312-A0202-12-0087-26
Figure 112112312-A0202-12-0087-26

[式中,R41分別獨立地為氫原子、苯基、碳數1至6之烷基、或C1-6烷氧基,較佳為甲基; [wherein, R 41 is independently a hydrogen atom, a phenyl group, an alkyl group having 1 to 6 carbon atoms, or a C 1-6 alkoxy group, preferably a methyl group;

D為選自下述之基: D is a base selected from the following:

-CH2O(CH2)2-、 -CH 2 O(CH 2 ) 2 -,

-CH2O(CH2)3-、 -CH 2 O(CH 2 ) 3 -,

-CF2O(CH2)3-、 -CF 2 O(CH 2 ) 3 -,

-(CH2)2-、 -(CH 2 ) 2 -,

-(CH2)3-、 -(CH 2 ) 3 -,

-(CH2)4-、 -(CH 2 ) 4 -,

-CONH-(CH2)3-、 -CONH-(CH 2 ) 3 -,

-CON(CH3)-(CH2)3-、 -CON(CH 3 )-(CH 2 ) 3 -,

-CON(Ph)-(CH2)3-(式中,Ph意指苯基)、及 -CON(Ph)-(CH 2 ) 3 - (wherein Ph means phenyl), and

Figure 112112312-A0202-12-0088-27
Figure 112112312-A0202-12-0088-27

(式中,R42分別獨立地表示氫原子、C1-6之烷基或C1-6之烷氧基,較佳為甲基或甲氧基,更佳為甲基) (wherein R 42 independently represents a hydrogen atom, a C 1-6 alkyl group or a C 1-6 alkoxy group, preferably a methyl group or a methoxy group, more preferably a methyl group)

E為-(CH2)n(n為2至6之整數), E is -(CH 2 ) n (n is an integer from 2 to 6),

D鍵結至分子主鏈之RF3或RF4,E鍵結至RSi] D is bonded to RF3 or RF4 of the main chain of the molecule, and E is bonded to R Si ]

作為上述XZ之具體例,係列舉例如: As specific examples of the above X Z , the following are listed:

單鍵、 Single key,

-CH2OCH2- -CH 2 OCH 2 -

-CH2O(CH2)2-、 -CH 2 O(CH 2 ) 2 -,

-CH2O(CH2)3-、 -CH 2 O(CH 2 ) 3 -,

-CH2O(CH2)4-、 -CH 2 O(CH 2 ) 4 -,

-CH2O(CH2)5-、 -CH 2 O(CH 2 ) 5 -,

-CH2O(CH2)6-、 -CH 2 O(CH 2 ) 6 -,

-CH2O(CH2)3Si(CH3)2OSi(CH3)2(CH2)2-、 -CH 2 O(CH 2 ) 3 Si(CH 3 ) 2 OSi(CH 3 ) 2 (CH 2 ) 2 -,

-CH2O(CH2)3Si(CH3)2OSi(CH3)2OSi(CH3)2(CH2)2-、 -CH 2 O(CH 2 ) 3 Si(CH 3 ) 2 OSi(CH 3 ) 2 OSi(CH 3 ) 2 (CH 2 ) 2 -,

-CH2O(CH2)3Si(CH3)2O(Si(CH3)2O)2Si(CH3)2(CH2)2-、 -CH 2 O(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 2 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CH2O(CH2)3Si(CH3)2O(Si(CH3)2O)3Si(CH3)2(CH2)2-、 -CH 2 O(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 3 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CH2O(CH2)3Si(CH3)2O(Si(CH3)2O)10Si(CH3)2(CH2)2-、 -CH 2 O(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 10 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CH2O(CH2)3Si(CH3)2O(Si(CH3)2O)20Si(CH3)2(CH2)2-、 -CH 2 O(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 20 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CH2OCF2CHFOCF2-、 -CH 2 OCF 2 CHFOCF 2 -,

-CH2OCF2CHFOCF2CF2-、 -CH 2 OCF 2 CHFOCF 2 CF 2 -,

-CH2OCF2CHFOCF2CF2CF2-、 -CH 2 OCF 2 CHFOCF 2 CF 2 CF 2 -,

-CH2OCH2CF2CF2OCF2-、 -CH2OCH2CF2CF2OCF2- ,

-CH2OCH2CF2CF2OCF2CF2-、 -CH 2 OCH 2 CF 2 CF 2 OCF 2 CF 2 -,

-CH2OCH2CF2CF2OCF2CF2CF2-、 -CH 2 OCH 2 CF 2 CF 2 OCF 2 CF 2 CF 2 -,

-CH2OCH2CF2CF2OCF(CF3)CF2OCF2-、 -CH2OCH2CF2CF2OCF ( CF3 ) CF2OCF2- ,

-CH2OCH2CF2CF2OCF(CF3)CF2OCF2CF2-、 -CH2OCH2CF2CF2OCF ( CF3 ) CF2OCF2CF2- ,

-CH2OCH2CF2CF2OCF(CF3)CF2OCF2CF2CF2-、 -CH2OCH2CF2CF2OCF ( CF3 ) CF2OCF2CF2CF2- ,

-CH2OCH2CHFCF2OCF2-、 -CH 2 OCH 2 CHFCF 2 OCF 2 -,

-CH2OCH2CHFCF2OCF2CF2-、 -CH 2 OCH 2 CHFCF 2 OCF 2 CF 2 -,

-CH2OCH2CHFCF2OCF2CF2CF2-、 -CH 2 OCH 2 CHFCF 2 OCF 2 CF 2 CF 2 -,

-CH2OCH2CHFCF2OCF(CF3)CF2OCF2-、 -CH2OCH2CHFCF2OCF ( CF3 ) CF2OCF2- ,

-CH2OCH2CHFCF2OCF(CF3)CF2OCF2CF2-、 -CH 2 OCH 2 CHFCF 2 OCF(CF 3 )CF 2 OCF 2 CF 2 -,

-CH2OCH2CHFCF2OCF(CF3)CF2OCF2CF2CF2-、 -CH 2 OCH 2 CHFCF 2 OCF(CF 3 )CF 2 OCF 2 CF 2 CF 2 -,

-CH2OCF2CHFOCF2CF2CF2-C(O)NH-CH2-、 -CH 2 OCF 2 CHFOCF 2 CF 2 CF 2 -C(O)NH-CH 2 -,

-CH2OCH2(CH2)7CH2Si(OCH3)2OSi(OCH3)2(CH2)2Si(OCH3)2OSi(OCH3)2(CH2)2-、 -CH 2 OCH 2 (CH 2 ) 7 CH 2 Si(OCH 3 ) 2 OSi(OCH 3 ) 2 (CH 2 ) 2 Si(OCH 3 ) 2 OSi(OCH 3 ) 2 (CH 2 ) 2 -,

-CH2OCH2CH2CH2Si(OCH3)2OSi(OCH3)2(CH2)3-、 -CH 2 OCH 2 CH 2 CH 2 Si(OCH 3 ) 2 OSi(OCH 3 ) 2 (CH 2 ) 3 -,

-CH2OCH2CH2CH2Si(OCH2CH3)2OSi(OCH2CH3)2(CH2)3-、 -CH 2 OCH 2 CH 2 CH 2 Si(OCH 2 CH 3 ) 2 OSi(OCH 2 CH 3 ) 2 (CH 2 ) 3 -,

-CH2OCH2CH2CH2Si(OCH3)2OSi(OCH3)2(CH2)2-、 -CH 2 OCH 2 CH 2 CH 2 Si(OCH 3 ) 2 OSi(OCH 3 ) 2 (CH 2 ) 2 -,

-CH2OCH2CH2CH2Si(OCH2CH3)2OSi(OCH2CH3)2(CH2)2-、 -CH 2 OCH 2 CH 2 CH 2 Si(OCH 2 CH 3 ) 2 OSi(OCH 2 CH 3 ) 2 (CH 2 ) 2 -,

-(CH2)2-Si(CH3)2-(CH2)2-、 -(CH 2 ) 2 -Si(CH 3 ) 2 -(CH 2 ) 2 -,

-CH2-、 -CH2- ,

-(CH2)2-、 -(CH 2 ) 2 -,

-(CH2)3-、 -(CH 2 ) 3 -,

-(CH2)4-、 -(CH 2 ) 4 -,

-(CH2)5-、 -(CH 2 ) 5 -,

-(CH2)6-、 -(CH 2 ) 6 -,

-CO-、 -CO-,

-CONH-、 -CONH-,

-CONH-CH2-、 -CONH- CH2- ,

-CONH-(CH2)2-、 -CONH-(CH 2 ) 2 -,

-CONH-(CH2)3-、 -CONH-(CH 2 ) 3 -,

-CONH-(CH2)4-、 -CONH-(CH 2 ) 4 -,

-CONH-(CH2)5-、 -CONH-(CH 2 ) 5 -,

-CONH-(CH2)6-、 -CONH-(CH 2 ) 6 -,

-CON(CH3)-CH2-、 -CON(CH 3 )-CH 2 -,

-CON(CH3)-(CH2)2-、 -CON(CH 3 )-(CH 2 ) 2 -,

-CON(CH3)-(CH2)3-、 -CON(CH 3 )-(CH 2 ) 3 -,

-CON(CH3)-(CH2)4-、 -CON(CH 3 )-(CH 2 ) 4 -,

-CON(CH3)-(CH2)5-、 -CON(CH 3 )-(CH 2 ) 5 -,

-CON(CH3)-(CH2)6-、 -CON(CH 3 )-(CH 2 ) 6 -,

-CON(Ph)-CH2-(式中,Ph意指苯基)、 -CON(Ph)-CH 2 - (wherein Ph means phenyl),

-CON(Ph)-(CH2)2-(式中,Ph意指苯基)、 -CON(Ph)-(CH 2 ) 2 - (wherein Ph means phenyl),

-CON(Ph)-(CH2)3-(式中,Ph意指苯基)、 -CON(Ph)-(CH 2 ) 3 - (wherein Ph means phenyl),

-CON(Ph)-(CH2)4-(式中,Ph意指苯基)、 -CON(Ph)-(CH 2 ) 4 - (wherein Ph means phenyl),

-CON(Ph)-(CH2)5-(式中,Ph意指苯基)、 -CON(Ph)-(CH 2 ) 5 - (wherein Ph means phenyl),

-CON(Ph)-(CH2)6-(式中,Ph意指苯基)、 -CON(Ph)-(CH 2 ) 6 - (wherein Ph means phenyl),

-CONH-(CH2)2NH(CH2)3-、 -CONH-(CH 2 ) 2 NH(CH 2 ) 3 -,

-CONH-(CH2)6NH(CH2)3-、 -CONH-(CH 2 ) 6 NH(CH 2 ) 3 -,

-CH2O-CONH-(CH2)3-、 -CH 2 O-CONH-(CH 2 ) 3 -,

-CH2O-CONH-(CH2)6-、 -CH 2 O-CONH-(CH 2 ) 6 -,

-S-(CH2)3-、 -S-(CH 2 ) 3 -,

-(CH2)2S(CH2)3-、 -(CH 2 ) 2 S(CH 2 ) 3 -,

-CONH-(CH2)3Si(CH3)2OSi(CH3)2(CH2)2-、 -CONH-(CH 2 ) 3 Si(CH 3 ) 2 OSi(CH 3 ) 2 (CH 2 ) 2 -,

-CONH-(CH2)3Si(CH3)2OSi(CH3)2OSi(CH3)2(CH2)2-、 -CONH-(CH 2 ) 3 Si(CH 3 ) 2 OSi(CH 3 ) 2 OSi(CH 3 ) 2 (CH 2 ) 2 -,

-CONH-(CH2)3Si(CH3)2O(Si(CH3)2O)2Si(CH3)2(CH2)2-、 -CONH-(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 2 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CONH-(CH2)3Si(CH3)2O(Si(CH3)2O)3Si(CH3)2(CH2)2-、 -CONH-(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 3 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CONH-(CH2)3Si(CH3)2O(Si(CH3)2O)10Si(CH3)2(CH2)2-、 -CONH-(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 10 Si(CH 3 ) 2 (CH 2 ) 2 -,

-CONH-(CH2)3Si(CH3)2O(Si(CH3)2O)20Si(CH3)2(CH2)2-、 -CONH-(CH 2 ) 3 Si(CH 3 ) 2 O(Si(CH 3 ) 2 O) 20 Si(CH 3 ) 2 (CH 2 ) 2 -,

-C(O)O-(CH2)3-、 -C(O)O-(CH 2 ) 3 -,

-C(O)O-(CH2)6-、 -C(O)O-(CH 2 ) 6 -,

-CH2-O-(CH2)3-Si(CH3)2-(CH2)2-Si(CH3)2-(CH2)2-、 -CH2 -O-( CH2 ) 3 -Si( CH3 ) 2- ( CH2 ) 2 -Si( CH3 ) 2- ( CH2 ) 2- ,

-CH2-O-(CH2)3-Si(CH3)2-(CH2)2-Si(CH3)2-CH(CH3)-、 -CH2 -O-( CH2 ) 3 -Si( CH3 ) 2- ( CH2 ) 2 -Si( CH3 ) 2 -CH( CH3 )-,

-CH2-O-(CH2)3-Si(CH3)2-(CH2)2-Si(CH3)2-(CH2)3-、 -CH2 -O-( CH2 ) 3 -Si( CH3 ) 2- ( CH2 ) 2 -Si( CH3 ) 2- ( CH2 ) 3- ,

-CH2-O-(CH2)3-Si(CH3)2-(CH2)2-Si(CH3)2-CH(CH3)-CH2-、 -CH2 -O-( CH2 ) 3 -Si( CH3 ) 2- ( CH2 ) 2 -Si( CH3 ) 2 -CH( CH3 ) -CH2- ,

-OCH2-、 -OCH2- ,

-O(CH2)3-、 -O(CH 2 ) 3 -,

-OCFHCF2-、 -OCFHCF 2 -,

Figure 112112312-A0202-12-0092-30
Figure 112112312-A0202-12-0092-31
等。
Figure 112112312-A0202-12-0092-30
,
Figure 112112312-A0202-12-0092-31
wait.

另一於其他態樣中,XZ分別獨立地為式:-(R16)x1-(CFR17)y1-(CH2)z1-所示之基。式中,x1、y1及z1分別獨立地為0至10之整數,x1、y1及z1之和為1以上,以括弧括起之各重複單元在式中的存在順序為任意。 In another embodiment, X and Z are independently a group represented by the formula: -(R 16 ) x1 -(CFR 17 ) y1 -(CH 2 ) z1 -, wherein x1, y1 and z1 are independently integers from 0 to 10, the sum of x1, y1 and z1 is greater than 1, and the order of the repeating units enclosed in brackets in the formula is arbitrary.

上述式中,R16分別獨立地為氧原子、伸苯基、咔唑啉、-NR18-(式中,R18表示氫原子或有機基)或2價之有機基。較佳為R18為氧原子或2價之極性基。 In the above formula, R 16 is independently an oxygen atom, a phenylene group, a carbazoline group, -NR 18 - (wherein R 18 is a hydrogen atom or an organic group) or a divalent organic group. Preferably, R 18 is an oxygen atom or a divalent polar group.

作為上述「2價之極性基」,並無特別限定,惟係列舉:-C(O)-、-C(=NR19)-、及-C(O)NR19-(此等之式中,R19表示氫原子或低級烷基)。該「低級烷基」,例如,為碳數1至6之烷基,例如甲基、乙基、正丙基,此等之為可被1個或超過1個之氟原子取代。 The above-mentioned "bivalent polar group" is not particularly limited, but examples thereof include: -C(O)-, -C(=NR 19 )-, and -C(O)NR 19 - (in these formulas, R 19 represents a hydrogen atom or a lower alkyl group). The "lower alkyl group" is, for example, an alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, and n-propyl, which may be substituted by 1 or more fluorine atoms.

上述式中,R17分別獨立地為氫原子、氟原子或低級氟烷基,較佳為氟原子。該「低級氟烷基」,例如,為碳數1至6,較佳為碳數1至3之氟烷基,較佳為碳數1至3之全氟烷基,更佳為三氟甲基、五氟乙基,又更佳為三氟甲基。 In the above formula, R 17 is independently a hydrogen atom, a fluorine atom or a lower fluoroalkyl group, preferably a fluorine atom. The "lower fluoroalkyl group" is, for example, a fluoroalkyl group having 1 to 6 carbon atoms, preferably a fluoroalkyl group having 1 to 3 carbon atoms, preferably a perfluoroalkyl group having 1 to 3 carbon atoms, more preferably a trifluoromethyl group, a pentafluoroethyl group, and even more preferably a trifluoromethyl group.

另一於其他態樣中,作為XZ之例,係列舉下述之基: In another aspect, as an example of X Z , the following bases are listed:

Figure 112112312-A0202-12-0093-32
Figure 112112312-A0202-12-0093-32

[式中, [Where,

R41分別獨立地為氫原子、苯基、碳數1至6之烷基、或C1-6烷氧基,較佳為甲基; R 41 is independently a hydrogen atom, a phenyl group, an alkyl group having 1 to 6 carbon atoms, or a C 1-6 alkoxy group, preferably a methyl group;

各XZ基中,T之中任一者為分子主鏈之RF3或鍵結至RF3的下述之基: In each XZ group, any one of T is RF3 of the main chain of the molecule or the following groups bonded to RF3 :

-CH2O(CH2)2-、 -CH 2 O(CH 2 ) 2 -,

-CH2O(CH2)3-、 -CH 2 O(CH 2 ) 3 -,

-CF2O(CH2)3-、 -CF 2 O(CH 2 ) 3 -,

-(CH2)2-、 -(CH 2 ) 2 -,

-(CH2)3-、 -(CH 2 ) 3 -,

-(CH2)4-、 -(CH 2 ) 4 -,

-CONH-(CH2)3-、 -CONH-(CH 2 ) 3 -,

-CON(CH3)-(CH2)3-、 -CON(CH 3 )-(CH 2 ) 3 -,

-CON(Ph)-(CH2)3-(式中,Ph意指苯基)、或 -CON(Ph)-(CH 2 ) 3 - (wherein Ph means phenyl), or

Figure 112112312-A0202-12-0094-33
Figure 112112312-A0202-12-0094-33

[式中,R42分別獨立地表示氫原子、C1-6之烷基或C1-6之烷氧基,較佳為甲基或甲氧基,更佳為甲基], [wherein, R 42 independently represents a hydrogen atom, a C 1-6 alkyl group or a C 1-6 alkoxy group, preferably a methyl group or a methoxy group, more preferably a methyl group],

其他T之任一者鍵結至分子主鏈之RSi而存在之情況下,其餘的T分別獨立地為甲基、苯基、C1-6烷氧基或自由基捕獲基或紫外線吸收基。 When any of the other T groups is bonded to R Si of the main chain of the molecule, the remaining T groups are independently methyl, phenyl, C 1-6 alkoxy, free radical scavenging group or ultraviolet absorbing group.

自由基捕獲基只要係可捕獲藉由光照射而產生的自由基者則無特別限定,惟係列舉例如:二苯基酮類、苯并三唑類、安息香酸酯類、水楊酸苯酯類、巴豆酸類、丙二酸酯類、有機丙烯酸酯類、受阻胺類、受阻酚類、或三

Figure 112112312-A0202-12-0094-50
類之殘基。 The free radical scavenging group is not particularly limited as long as it can capture free radicals generated by light irradiation, but examples thereof include: diphenyl ketones, benzotriazoles, benzoic acid esters, phenyl salicylates, crotonic acids, malonic acid esters, organic acrylates, hindered amines, hindered phenols, or tris(III) esters.
Figure 112112312-A0202-12-0094-50
The residue of the class.

紫外線吸收基只要係可吸收紫外線者則無特別限定,惟係列舉例如:苯并三唑類、羥基二苯基酮類、取代及未取代安息香酸或者水楊氧化合物之酯類、丙烯酸酯或烷氧基肉桂酸酯類、草醯胺類、草醯苯胺類、苯并

Figure 112112312-A0202-12-0094-51
酮類、苯并
Figure 112112312-A0202-12-0094-52
唑類之殘基。 The ultraviolet absorbing group is not particularly limited as long as it can absorb ultraviolet rays, but examples thereof include benzotriazoles, hydroxydiphenyl ketones, esters of substituted and unsubstituted benzoic acid or salicylic acid compounds, acrylates or alkoxycinnamates, oxalamides, oxalanilides, benzotriazoles,
Figure 112112312-A0202-12-0094-51
Ketones, benzo
Figure 112112312-A0202-12-0094-52
The residue of azoles.

於較佳態樣中,作為較佳自由基捕獲基或紫外線吸收基係列舉: In a preferred embodiment, the following are listed as the best free radical scavenging groups or UV absorbing groups:

Figure 112112312-A0202-12-0095-34
Figure 112112312-A0202-12-0095-34

該態樣中,XZ分別獨立地可為3至10價之有機基。 In this aspect, X and Z can each independently be a tri- to decavalent organic group.

另一於其他態樣中,作為XZ之例,係列舉下述之基: In another aspect, as an example of X Z , the following bases are listed:

Figure 112112312-A0202-12-0095-36
Figure 112112312-A0202-12-0095-36

[式中,R25、R26及R27分別獨立地為2至6價之有機基, [wherein, R 25 , R 26 and R 27 are independently di- to hexavalent organic groups,

R25鍵結至至少1個之RF,R26及R27分別鍵結至至少1個之RSi] R25 is bonded to at least one RF , and R26 and R27 are bonded to at least one RSi, respectively.]

於一態樣中,上述R25為單鍵、C1-20伸烷基、C3-20環伸烷基、C5-20亞芳基、-R57-X58-R59-、-X58-R59-、或-R57-X58-。上述R57及R59分別獨立地為單鍵、C1-20伸烷基、C3-20環伸烷基、或C5-20亞芳基。上述X58為-O-、-S-、-CO-、-O-CO-或-COO-。 In one embodiment, R 25 is a single bond, a C 1-20 alkylene group, a C 3-20 cycloalkylene group, a C 5-20 arylene group, -R 57 -X 58 -R 59 -, -X 58 -R 59 -, or -R 57 -X 58 -. R 57 and R 59 are independently a single bond, a C 1-20 alkylene group, a C 3-20 cycloalkylene group, or a C 5-20 arylene group. X 58 is -O-, -S-, -CO-, -O-CO-, or -COO-.

於一態樣中,上述R26及R27分別獨立地為烴,或者在烴之端或主鏈中具有選自N、O及S之至少1個原子的基,較佳為列舉C1-6烷基、-R36-R37-R36-、-R36-CHR38 2-等。於此,R36分別獨立地為單鍵或碳數1至6之烷基,較佳為碳數1至6之烷基。R37為N、O或S,較佳為N或O。R38為-R45-R46-R45-、-R46-R45-或-R45-R46-。於此,R45分別獨立地為碳數1至6之烷基。R46為N、O或S,較佳為O。 In one embodiment, the above R 26 and R 27 are independently a hydrocarbon, or a group having at least one atom selected from N, O and S at the end of the hydrocarbon or in the main chain, preferably a C 1-6 alkyl, -R 36 -R 37 -R 36 -, -R 36 -CHR 38 2 -, etc. Here, R 36 is independently a single bond or an alkyl group having 1 to 6 carbon atoms, preferably an alkyl group having 1 to 6 carbon atoms. R 37 is N, O or S, preferably N or O. R 38 is -R 45 -R 46 -R 45 -, -R 46 -R 45 - or -R 45 -R 46 -. Here, R 45 is independently an alkyl group having 1 to 6 carbon atoms. R46 is N, O or S, preferably O.

該態樣中,XZ分別獨立地可為3至10價之有機基。 In this aspect, X and Z can each independently be a tri- to decavalent organic group.

另一於其他態樣中,作為XZ之例,係列舉下述所示之基: In another aspect, as an example of XZ , the following bases are listed:

Figure 112112312-A0202-12-0096-37
Figure 112112312-A0202-12-0096-37

[式中,Xa為單鍵或2價之有機基] [wherein Xa is a single bond or a divalent organic group]

上述Xa為直接鍵結至異氰尿酸環之單鍵或二價之連接基。作為Xa,較佳為包含選自單鍵、伸烷基、或醚鍵結、酯鍵結、醯胺鍵結及硫鍵結所組成之群組之至少1種鍵結的二價之基,更佳為包含選自單鍵、碳數1至10之伸烷基、或醚鍵結、酯鍵結、醯胺鍵結及硫鍵結所組成之群組之至少1種鍵結的碳數1至10之二價烴基。 The above-mentioned Xa is a single bond or a divalent linking group directly bonded to the isocyanuric acid ring. As Xa , it is preferably a divalent group containing at least one bond selected from the group consisting of a single bond, an alkylene group, or an ether bond, an ester bond, an amide bond, and a sulfide bond, and more preferably a divalent hydrocarbon group containing at least one bond selected from the group consisting of a single bond, an alkylene group having 1 to 10 carbon atoms, or an ether bond, an ester bond, an amide bond, and a sulfide bond.

作為Xa,更佳為下述式所示之基: More preferably, X a is a group represented by the following formula:

-(CX121X122)x1-(Xa1)y1-(CX123X124)z1- -(CX 121 X 122 ) x1 -(X a1 ) y1 -(CX 123 X 124 ) z1 -

(式中,X121至X124分別獨立地為H、F、OH、或-OSi(OR121)3(式中,3個R121分別獨立地為碳數1至4之烷基), (wherein, X 121 to X 124 are independently H, F, OH, or -OSi(OR 121 ) 3 (wherein, three R 121 are independently alkyl groups having 1 to 4 carbon atoms),

上述Xa1為-C(=O)NH-、-NHC(=O)-、-O-、-C(=O)O-、-OC(=O)-、-OC(=O)O-、或-NHC(=O)NH-(各鍵結之左側係鍵結至CX121X122), The above-mentioned X a1 is -C(=O)NH-, -NHC(=O)-, -O-, -C(=O)O-, -OC(=O)-, -OC(=O)O-, or -NHC(=O)NH- (the left side of each bond is bonded to CX 121 X 122 ),

x1為0至10之整數,y1為0或1、z1為1至10之整數)。 x1 is an integer between 0 and 10, y1 is 0 or 1, and z1 is an integer between 1 and 10).

作為上述Xa1,較佳為-O-或-C(=O)O-。 The above-mentioned X a1 is preferably -O- or -C(=O)O-.

作為上述Xa,特佳為下述式: The above-mentioned X a is particularly preferably the following formula:

-(CF2)m11-(CH2)m12-O-(CH2)m13-所示之基 -(CF 2 ) m11 -(CH 2 ) m12 -O-(CH 2 ) m13 - the group represented by

(式中,m11為1至3之整數,m12為1至3之整數,m13為1至3之整數), (In the formula, m11 is an integer from 1 to 3, m12 is an integer from 1 to 3, and m13 is an integer from 1 to 3),

-(CF2)m14-(CH2)m15-O-CH2CH(OH)-(CH2)m16-所示之基 -(CF 2 ) m14 -(CH 2 ) m15 -O-CH 2 CH(OH)-(CH 2 ) m16 - The group represented by

(式中,m14為1至3之整數,m15為1至3之整數,m16為1至3之整數), (In the formula, m14 is an integer from 1 to 3, m15 is an integer from 1 to 3, and m16 is an integer from 1 to 3),

-(CF2)m17-(CH2)m18-所示之基, -(CF 2 ) m17 -(CH 2 ) m18 -,

(式中,m17為1至3之整數,m18為1至3之整數) (In the formula, m17 is an integer from 1 to 3, and m18 is an integer from 1 to 3)

-(CF2)m19-(CH2)m20-O-CH2CH(OSi(OCH3)3)-(CH2)m21-所示之基 -(CF 2 ) m19 -(CH 2 ) m20 -O-CH 2 CH(OSi(OCH 3 ) 3 )-(CH 2 ) m21 - The group represented by

(式中,m19為1至3之整數,m20為1至3之整數,m21為1至3之整數)、或 (where m19 is an integer from 1 to 3, m20 is an integer from 1 to 3, and m21 is an integer from 1 to 3), or

-(CH2)m22-所示之基 -(CH 2 ) m22 - represented by the group

(式中,m22為1至3之整數)。 (In the formula, m22 is an integer from 1 to 3).

作為上述Xa,並無特別限定,惟具體而言,係列舉: The above-mentioned X a is not particularly limited, but specifically, the following are listed:

-CH2-、-C2H4-、-C3H6-、-C4H8-、-C4H8-O-CH2-、-CO-O-CH2-CH(OH)-CH2-、-(CF2)n5-(n5為0至4之整數)、-(CF2)n5-(CH2)m5-(n5及m5分別獨立地為0至4之整數)、-CF2CF2CH2OCH2CH(OH)CH2-、-CF2CF2CH2OCH2CH(OSi(OCH3)3)CH2-等。 -CH2-, -C2H4- , -C3H6- , -C4H8- , -C4H8- O - CH2- , -CO-O - CH2 - CH(OH) -CH2- , -( CF2 ) n5- (n5 is an integer from 0 to 4), -( CF2 ) n5- ( CH2 ) m5- (n5 and m5 are independently an integer from 0 to 4), -CF2CF2CH2OCH2CH ( OH) CH2- , -CF2CF2CH2OCH2CH ( OSi ( OCH3 ) 3 ) CH2- , and the like.

該態樣中,XZ分別獨立地可為2或3價之有機基。 In this aspect, X and Z can each independently be a divalent or trivalent organic group.

上述式(B1)或式(B2)所示之含氟聚醚基之矽烷化合物,並無特別限定,惟就組成物黏度、與各成分之溶解性、及與硬化物之物性間的平衡而言,較佳為具有1,000至32,000,更佳為1,500至8,000之平均分 子量。又,這些「平均分子量」係稱為數目平均分子量,「平均分子量」係藉由19F-NMR所測定之值。 The silane compound containing a fluorine polyether group represented by the above formula (B1) or formula (B2) is not particularly limited, but preferably has an average molecular weight of 1,000 to 32,000, more preferably 1,500 to 8,000, in terms of the viscosity of the composition, the solubility of each component, and the balance between the physical properties of the cured product. In addition, these "average molecular weights" are called number average molecular weights, and the "average molecular weight" is a value measured by 19 F-NMR.

上述式(B1)或式(B2)所示之含氟聚醚基之矽烷化合物,例如,可藉由本身習知方法,例如國際公開第97/07155號、日本特表2008-534696號、特開2014-218639號、特開2017-82194號等記載之方法而得。 The fluorinated polyether group-containing silane compound represented by the above formula (B1) or formula (B2) can be obtained, for example, by methods known per se, such as those described in International Publication No. 97/07155, Japanese Patent Publication No. 2008-534696, Japanese Patent Publication No. 2014-218639, Japanese Patent Publication No. 2017-82194, etc.

於其他較佳態樣中,含氟聚醚基之矽烷化合物為下述式(B3)所示之化合物: In other preferred embodiments, the silane compound containing a fluorinated polyether group is a compound represented by the following formula (B3):

R39 j-R38-NR37CO-(RF4-CONR37-R36-NR37CO)r-RF4-CONR37-R38-R39 j (B3) R39j -R38 - NR37CO- ( RF4 - CONR37 - R36 - NR37CO ) r - RF4 - CONR37 - R38 - R39j (B3 )

[式中: [Where:

RF4為-Rf4 p3-RFB-Oq3-; RF4 is -Rf4p3 - RFB - Oq3- ;

Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基; Rf4 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms;

RFB分別獨立地為2價之氟聚醚基; R and FB are each independently a divalent fluoropolyether group;

p3為0或1; p3 is 0 or 1;

q3為0或1; q3 is 0 or 1;

R36分別獨立地為2價之有機基, R 36 is independently a divalent organic group,

R37分別獨立地為氫原子或碳數1至8之一價之有機基, R 37 is independently a hydrogen atom or a monovalent organic group having 1 to 8 carbon atoms,

R38分別獨立地為(j+1)價之有機基, R 38 is independently a (j+1)-valent organic group,

R39分別獨立地為-SiR25 n1R26 3-n1R 39 is independently -SiR 25 n1 R 26 3-n1 ,

R25分別獨立地為羥基或水解性基; R25 are each independently a hydroxyl group or a hydrolyzable group;

R26分別獨立地為氫原子或1價之有機基; R26 are each independently a hydrogen atom or a monovalent organic group;

n1每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數; n1 Each (SiR 25 n1 R 26 3-n1 ) unit is independently an integer from 0 to 3;

j分別獨立地為1至9之整數, j is an integer from 1 to 9 independently,

r為1以上之整數]。 r is an integer greater than 1].

式(B3)中,RF4、Rf4、RFB、R25、R26、n1、p3、及q3與上述關於式(B1)及(B2)之記載同義,並包含相同態樣。 In formula (B3), R F4 , Rf 4 , R FB , R 25 , R 26 , n1, p3, and q3 have the same meanings as those described above for formulas (B1) and (B2), and include the same aspects.

上述式(B3)中,R38分別獨立地為(j+1)價之有機基。 In the above formula (B3), R 38 is independently a (j+1)-valent organic group.

R38為作用為連接R39與醯胺鍵結(CONR32)之連接體的基。R38於每次出現時獨立表示j+1價之有機基。於此,j之值表示存在於上述含氟聚醚基之矽烷化合物(B3)之末端的含矽原子之基的數,其值為1至9之範圍。藉此,R38於每次出現時獨立表示2至10價之有機基。因此,該R38只要係上述含氟聚醚基之矽烷化合物(B3)可穩定地存在的2至10價之有機基,則可為任何之基。作為R38之具體例,上述式(B1)及(B2)中,與XZ同義,且可包含相同態樣。R38較佳為2至7價,更佳為2至4價,又更佳為2價之有機基。 R 38 is a group that acts as a linker connecting R 39 and the amide bond (CONR 32 ). R 38 represents an organic group with a valence of j+1 independently at each occurrence. Here, the value of j represents the number of silicon-atom-containing groups present at the end of the above-mentioned fluorinated polyether group-containing silane compound (B3), and its value ranges from 1 to 9. Thus, R 38 represents an organic group with a valence of 2 to 10 independently at each occurrence. Therefore, R 38 may be any group as long as it is an organic group with a valence of 2 to 10 that can stably exist in the above-mentioned fluorinated polyether group-containing silane compound (B3). As specific examples of R 38 , in the above-mentioned formulas (B1) and (B2), it is synonymous with X Z and may include the same aspects. R 38 is preferably a divalent to heptavalent organic group, more preferably a divalent to tetravalent organic group, and even more preferably a divalent organic group.

R38較佳為在直接連接R39與醯胺鍵結之分子鏈上不具雜原子或芳香族之結構,更佳為不具芳香族之結構。作為R38,較佳為依據情況可具雜原子之脂肪族烴基,更佳為未取代之脂肪族烴,又更佳為2價之伸烷基。作為R38,更佳為C1-20伸烷基,又更佳為C1-6伸烷基,尤其係具體而言,為亞甲基、伸乙基、伸丙基、甲基伸乙基、伸丁基、六亞甲基等。上述含氟聚醚基之矽烷化合物(B3)中存在的二個R38可相同或相異,惟就易於調配化合物而言,較佳為相同。此外,R38將具有j+1個之鍵結處,惟可以任何鍵結處與-C(=O)NR37-部分鍵結。 R 38 is preferably a structure without heteroatoms or aromatic groups on the molecular chain directly connecting R 39 and the amide bond, and more preferably a structure without aromatic groups. R 38 is preferably an aliphatic hydrocarbon group which may have heteroatoms as the case may be, more preferably an unsubstituted aliphatic hydrocarbon group, and more preferably a divalent alkylene group. R 38 is more preferably a C 1-20 alkylene group, and more preferably a C 1-6 alkylene group, and more specifically, a methylene group, an ethylene group, a propylene group, a methylethylene group, a butylene group, a hexamethylene group, and the like. The two R 38 groups in the above-mentioned fluorinated polyether group-containing silane compound (B3) may be the same or different, but are preferably the same in terms of ease of compound preparation. Furthermore, R 38 will have j+1 bonding sites, but can bond to the -C(=O)NR 37 - moiety at any bonding site.

上述式(B3)中,j分別獨立地為1至9之整數,較佳為1至6之整數,更佳為1至3之整數,再更佳為1。 In the above formula (B3), j is independently an integer from 1 to 9, preferably an integer from 1 to 6, more preferably an integer from 1 to 3, and even more preferably 1.

上述式(B3)中,R36分別獨立地為2價之有機基。 In the above formula (B3), R 36 is independently a divalent organic group.

R36為連接位置於其兩端的-C(=O)NR37-所示之結構彼此的2價之有機基。「2價之有機基」之定義與R38屬於2價之有機基之情況中相同,惟作為R36,較佳為2價之伸烷基,更佳為C1-20伸烷基,又更佳為C1-6伸烷基,尤其係具體而言,為亞甲基、伸乙基、伸丙基、甲基伸乙基、伸丁基、六亞甲基等。此外,R36為連接2個-C(=O)NR37-部分之基,惟只要此可調配成穩定的化合物,則R36具有的2個鍵結處可與其兩側之-C(=O)NR37-部分之任一個鍵結。例如,式(B3)中R36屬於甲基伸乙基(-CH(CH3)CH2-)之情況下,甲基伸乙基之CH2-部分可鍵結至式(B3)中位於右側的-C(=O)NR37-部分,可鍵結至位於左側的-C(=O)NR37-部分。例如,可藉由使二胺及能夠經由醯胺鍵結在RF4之兩末端與R38或R36形成鍵結的具有反應性官能基的化合物而導入R36部分。分子鏈中之R36部分的個數(換言之,r之值)可藉由調整反應物之量關係而操作。 R 36 is a divalent organic group that connects the structures represented by -C(=O)NR 37 - at both ends. The definition of "divalent organic group" is the same as that of the case where R 38 belongs to the divalent organic group, but R 36 is preferably a divalent alkylene group, more preferably a C 1-20 alkylene group, and still more preferably a C 1-6 alkylene group, and specifically, methylene, ethylene, propylene, methylethylene, butylene, hexamethylene, etc. In addition, R 36 is a group that connects two -C(=O)NR 37 - parts, but as long as this can be formulated into a stable compound, the two bonding sites of R 36 may be bonded to any of the -C(=O)NR 37 - parts on both sides thereof. For example, when R 36 in formula (B3) is a methylethylidene group (-CH(CH 3 )CH 2 -), the CH 2 - part of the methylethylidene group may be bonded to the -C(=O)NR 37 - part located on the right side of formula (B3), or may be bonded to the -C(=O)NR 37 - part located on the left side. For example, the R 36 part may be introduced by allowing a diamine and a compound having a reactive functional group capable of forming a bond with R 38 or R 36 to be bonded to both ends of RF4 via an amide. The number of R 36 parts in the molecular chain (in other words, the value of r) may be manipulated by adjusting the amount of reactants.

於較佳態樣中,R38與R36同為2價之伸烷基。 In a preferred embodiment, R 38 and R 36 are both divalent alkylene groups.

上述式(B3)中,R37分別獨立地為氫原子或碳數1至8之一價之有機基。 In the above formula (B3), R 37 is independently a hydrogen atom or a monovalent organic group having 1 to 8 carbon atoms.

R37中之碳數1至8之一價之有機基較佳為C1-8烷基、C3-8環烷基、或C5-8芳基,更佳為C1-6烷基或苯基,又更佳為C1-3烷基,特佳為甲基。 The monovalent organic group having 1 to 8 carbon atoms in R 37 is preferably a C 1-8 alkyl group, a C 3-8 cycloalkyl group, or a C 5-8 aryl group, more preferably a C 1-6 alkyl group or a phenyl group, still more preferably a C 1-3 alkyl group, and particularly preferably a methyl group.

於一態樣中,R37為氫原子。 In one embodiment, R 37 is a hydrogen atom.

於一態樣中,R37為C1-8烷基,較佳為甲基。 In one embodiment, R 37 is C 1-8 alkyl, preferably methyl.

上述式(B3)中,r為1以上之整數。 In the above formula (B3), r is an integer greater than 1.

於一態樣中,r較佳為1至100之整數,更佳為1至10之整數,又更佳為1至5之整數,例如2至10之整數,又更佳為2至5之整數。 In one embodiment, r is preferably an integer from 1 to 100, more preferably an integer from 1 to 10, and even more preferably an integer from 1 to 5, such as an integer from 2 to 10, and even more preferably an integer from 2 to 5.

上述式(B3)所示之含氟聚醚基之矽烷化合物,並無特別限定者,惟可具有5×102至1×105之平均分子量。這些範圍之中,就組成物黏度、與各成分之溶解性、及與硬化物之物性間的平衡而言,較佳為1,000至32,000,更佳為1,500至8,000之平均分子量。又,這些「平均分子量」係指數目平均分子量,「平均分子量」係藉由19F-NMR所測定之值。 The fluorinated polyether group-containing silane compound represented by the above formula (B3) is not particularly limited, but may have an average molecular weight of 5×10 2 to 1×10 5. Within these ranges, the average molecular weight is preferably 1,000 to 32,000, and more preferably 1,500 to 8,000, in terms of the balance between the viscosity of the composition, the solubility of each component, and the physical properties of the cured product. In addition, these "average molecular weights" refer to the number average molecular weight, and the "average molecular weight" is the value measured by 19 F-NMR.

上述式(B3)所示之所示之含氟聚醚基之矽烷化合物,例如,可藉由國際公開第2021/125058號等記載之方法而製造。 The fluorinated polyether group-containing silane compound represented by the above formula (B3) can be produced, for example, by the method described in International Publication No. 2021/125058.

於一態樣中,上述含氟聚醚基之矽烷化合物包含式(B1)或(B2)所示之化合物。例如,上述含氟聚醚基之矽烷化合物為式(B1)或(B2)所示之化合物。 In one embodiment, the silane compound containing a fluorinated polyether group includes a compound represented by formula (B1) or (B2). For example, the silane compound containing a fluorinated polyether group is a compound represented by formula (B1) or (B2).

於一態樣中,上述含氟聚醚基之矽烷化合物包含式(B1)所示之化合物。例如,上述含氟聚醚基之矽烷化合物為式(B1)所示之化合物。 In one embodiment, the silane compound containing a fluorinated polyether group includes a compound represented by formula (B1). For example, the silane compound containing a fluorinated polyether group is a compound represented by formula (B1).

於一態樣中,上述含氟聚醚基之矽烷化合物包含式(B2)所示之化合物。例如,上述含氟聚醚基之矽烷化合物為式(B2)所示之化合物。 In one embodiment, the silane compound containing a fluorinated polyether group includes a compound represented by formula (B2). For example, the silane compound containing a fluorinated polyether group is a compound represented by formula (B2).

於一態樣中,上述含氟聚醚基之矽烷化合物包含式(B3)所示之化合物。例如,上述含氟聚醚基之矽烷化合物為式(B3)所示之化合物。 In one embodiment, the silane compound containing a fluorinated polyether group includes a compound represented by formula (B3). For example, the silane compound containing a fluorinated polyether group is a compound represented by formula (B3).

於較佳態樣中,上述含氟聚醚基之矽烷化合物包含式(B2)所示之化合物及/或式(B3)所示之化合物。例如,上述含氟聚醚基之矽烷化合物為式(B2)所示之化合物及/或式(B3)所示之化合物。 In a preferred embodiment, the silane compound containing a fluorinated polyether group includes a compound represented by formula (B2) and/or a compound represented by formula (B3). For example, the silane compound containing a fluorinated polyether group is a compound represented by formula (B2) and/or a compound represented by formula (B3).

於其他較佳態樣中,上述含氟聚醚基之矽烷化合物包含式(B2)所示之化合物及式(B3)所示之化合物。例如,上述含氟聚醚基之矽烷化合物為式(B2)所示之化合物及式(B3)所示之化合物。 In other preferred embodiments, the silane compound containing a fluorinated polyether group includes a compound represented by formula (B2) and a compound represented by formula (B3). For example, the silane compound containing a fluorinated polyether group is a compound represented by formula (B2) and a compound represented by formula (B3).

在兩末端具有水解性矽基的化合物(例如,式(B2)所示之化合物及式(B3)所示之化合物)、及在單末端具有水解性矽基的化合物(例如,式(B1)所示之化合物)之莫耳比(兩末端化合物/單末端化合物),較佳可為50/50至100/0,更佳為60/40至100/0,又更佳為90/10至100/0。 The molar ratio (compounds at both ends/compounds at one end) of the compound having a hydrolyzable silicon group at both ends (e.g., the compound represented by formula (B2) and the compound represented by formula (B3)) and the compound having a hydrolyzable silicon group at one end (e.g., the compound represented by formula (B1)) is preferably 50/50 to 100/0, more preferably 60/40 to 100/0, and even more preferably 90/10 to 100/0.

本揭示之硬化性組成物中,相對於成分(A)與成分(B)之合計量,成分(A)之含量,較佳可為10至90質量%,更佳為20至80質量%,又更佳為30至70質量%。藉由將上述含氟聚醚基之丙烯酸化合物之含量設為上述範圍,可更提升獲得的硬化物之UV硬化性及柔軟性,此外,可更減少滲出。 In the curable composition disclosed herein, the content of component (A) relative to the total amount of component (A) and component (B) is preferably 10 to 90% by mass, more preferably 20 to 80% by mass, and even more preferably 30 to 70% by mass. By setting the content of the fluorinated polyether-containing acrylic compound to the above range, the UV curability and flexibility of the obtained cured product can be further improved, and the exudation can be further reduced.

成分(C):交聯劑 Ingredient (C): Crosslinking agent

上述交聯劑,並無特別限定,惟例如,可為烷氧基矽烷化合物。 The above crosslinking agent is not particularly limited, but for example, it can be an alkoxysilane compound.

於較佳態樣中,上述交聯劑較佳為式(C1)所示之化合物: In a preferred embodiment, the crosslinking agent is preferably a compound represented by formula (C1):

(Rg1-O)δ-Si-Rg2 4-δ (C1) (R g1 -O) δ -Si-R g2 4-δ (C1)

[式中: [Where:

Rg1於每次出現時分別獨立地為氫原子或1價之有機基; Rg1, at each occurrence, is independently a hydrogen atom or a monovalent organic group;

Rg2分別獨立地為1價之有機基; R g2 are each independently a monovalent organic group;

δ為2至4之整數]。 δ is an integer between 2 and 4].

Rg1分別獨立地較佳可為1價之有機基,更佳為C1-6烷基,又更佳為甲基或乙基。 Rg1 is independently preferably a monovalent organic group, more preferably a C1-6 alkyl group, and even more preferably a methyl group or an ethyl group.

Rg2分別獨立地較佳可為C1-16烷基、C3-16環烷基、C6-16芳基、或C1-16烯基,更佳為C1-16烷基,又更佳為C1-10烷基,再更佳為C1-3烷基。 R g2 is preferably independently C 1-16 alkyl, C 3-16 cycloalkyl, C 6-16 aryl, or C 1-16 alkenyl, more preferably C 1-16 alkyl, still more preferably C 1-10 alkyl, and still more preferably C 1-3 alkyl.

作為Rg2,係列舉例如:甲基、乙基、丙基、異丙基、丁基、異丁基、三級丁基、戊基、新戊基、己基、庚基、辛基、壬基、癸基等之烷基;環戊基、環己基、環庚基等之環烷基;苯基、甲苯基、二甲苯基、萘基等之芳基;苄基、苯基乙基、苯基丙基等之芳烷基;乙烯基、烯丙基、丙烯基、丁烯基等之烯基。 Examples of Rg2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, pentyl, neopentyl, hexyl, heptyl, octyl, nonyl and decyl; cycloalkyl groups such as cyclopentyl, cyclohexyl and cycloheptyl; aryl groups such as phenyl, tolyl, xylyl and naphthyl; aralkyl groups such as benzyl, phenylethyl and phenylpropyl; and alkenyl groups such as vinyl, allyl, propenyl and butenyl.

δ較佳為3或4。於一態樣中,δ為3。於其他態樣中,δ為4。 δ is preferably 3 or 4. In one embodiment, δ is 3. In other embodiments, δ is 4.

上述交聯劑較佳為四乙氧基矽烷、四甲氧基矽烷、甲基三乙氧基矽烷、甲基三甲氧基矽烷、二甲基二甲氧基矽烷、二甲基三甲氧基矽烷、胺基丙基三乙氧基矽烷、胺基丙基三甲氧基矽烷、十三氟正辛基三乙氧基矽烷、或十三氟正辛基三甲氧基矽烷。 The crosslinking agent is preferably tetraethoxysilane, tetramethoxysilane, methyltriethoxysilane, methyltrimethoxysilane, dimethyldimethoxysilane, dimethyltrimethoxysilane, aminopropyltriethoxysilane, aminopropyltrimethoxysilane, tridecafluorooctyltriethoxysilane, or tridecafluorooctyltrimethoxysilane.

相對於上述成分(A)及成分(B)之合計100質量份,成分(C)之含量,較佳為0.1至20質量份,更佳為1至10質量份,又更佳為1至5質量份。 Relative to 100 parts by weight of the above-mentioned components (A) and (B) in total, the content of component (C) is preferably 0.1 to 20 parts by weight, more preferably 1 to 10 parts by weight, and even more preferably 1 to 5 parts by weight.

成分(D):觸媒 Ingredient (D): Catalyst

上述觸媒,並無特別限定,惟例如,可為酸(例如乙酸、三氟乙酸等)、鹼(例如氨、三乙胺、二乙胺等)、過渡金屬(例如Ti、Ni、Sn等)、金屬錯 合物,例如錫系觸媒、鈦系觸媒、氧化鋯系觸媒、鉍系觸媒、有機胺系觸媒等。 The above catalyst is not particularly limited, but for example, it can be an acid (such as acetic acid, trifluoroacetic acid, etc.), a base (such as ammonia, triethylamine, diethylamine, etc.), a transition metal (such as Ti, Ni, Sn, etc.), a metal complex, such as a tin catalyst, a titanium catalyst, a zirconium oxide catalyst, a bismuth catalyst, an organic amine catalyst, etc.

作為上述錫系觸媒,係列舉二月桂酸二正丁基錫(IV)。 As the above-mentioned tin-based catalyst, di-n-butyltin (IV) dilaurate is exemplified.

作為上述鈦系觸媒,係列舉二異丙氧基雙(乙醯乙酸乙酯)鈦、四正丁氧基鈦、四-2-乙基己氧基鈦、四乙醯丙酮鈦。 Examples of the titanium catalysts include diisopropoxybis(ethyl acetate), tetra-n-butoxytitanium, tetra-2-ethylhexyloxytitanium, and tetraacetylacetonate titanium.

作為上述氧化鋯系觸媒,係列舉四乙醯丙酮鋯、四正丁氧基鋯、二丁氧基雙(乙醯乙酸乙酯)鋯。 Examples of the above-mentioned zirconium oxide catalysts include zirconium tetraacetylacetonate, zirconium tetra-n-butoxy, and zirconium dibutoxybis(ethyl acetate).

作為上述鉍系觸媒,係列舉參(2-己酸乙酯)鉍。 As the above-mentioned bismuth catalyst, bismuth (2-ethyl hexanoate) is listed as an example.

作為上述有機胺系觸媒,係列舉二氮雜雙環十一碳烯。 As the above-mentioned organic amine catalyst, diazide bicyclic undecene is listed.

上述觸媒可在即將使用之前添加至硬化性組成物。 The above catalyst may be added to the hardening composition immediately before use.

因應使用方法,上述觸媒可在即將使用之前額外添加至硬化性組成物。 Depending on the method of use, the above catalyst may be additionally added to the curable composition immediately before use.

相對於上述成分(A)及成分(B)之合計100質量份,上述成分(D)之含量,較佳為0.1至20質量份,更佳為0.2至10質量份,又更佳為0.5至5質量份。 Relative to 100 parts by weight of the total of the above-mentioned components (A) and (B), the content of the above-mentioned component (D) is preferably 0.1 to 20 parts by weight, more preferably 0.2 to 10 parts by weight, and even more preferably 0.5 to 5 parts by weight.

成分(E):自由基聚合起始劑 Ingredient (E): Free radical polymerization initiator

上述自由基聚合起始劑可較佳為自由基光聚合起始劑。作為自由基光聚合起始劑,係列舉例如:苄基、二乙醯等之-二酮類、安息香等之醯偶姻類、安息香甲基醚、安息香乙基醚、安息香異丙基醚等之醯偶姻醚類、噻噸酮、2,4-二乙基噻噸酮、噻噸酮-4-磺酸等之噻噸酮類、二苯甲酮、4,4’-雙(二甲基胺基)二苯甲酮、4,4’-雙(二乙基胺基)二苯甲酮等之二苯甲酮類、苯乙酮、2-(4-甲苯磺醯氧基)-2-苯基苯乙酮、對二甲基胺基苯乙酮、2,2’- 二甲氧基-2-苯基苯乙酮、對甲氧基苯乙酮、2-甲基[4-(甲基硫基)苯基]-2-

Figure 112112312-A0202-12-0105-55
啉基-1-丙酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-12-0105-54
啉基苯基)-丁-1-酮等之苯乙酮類、蒽醌、1,4-萘醌等之醌類、2-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸(正丁氧基)乙酯、4-二甲基胺基苯甲酸異戊酯、4-二甲基胺基苯甲酸2-乙基己酯等之胺基苯甲酸類、苯甲醯氯、三鹵甲基苯基碸等之鹵素化合物、醯基氧化膦類、二-三級丁基過氧化物等之過氧化物等。 The free radical polymerization initiator may preferably be a free radical photopolymerization initiator. As the free radical photopolymerization initiator, for example, benzyl, diacetyl and other diketones, benzoin and other acyloin ethers, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether and other acyloin ethers, thiothione, 2,4-diethylthiothione, thiothione-4-sulfonic acid and other thiothiones, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone and other benzophenones, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, p-methoxyacetophenone, 2-methyl[4-(methylthio)phenyl]-2-
Figure 112112312-A0202-12-0105-55
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-12-0105-54
Acetophenones such as (1,4-dimethylaminophenyl)-butan-1-one, quinones such as anthraquinone and 1,4-naphthoquinone, aminobenzoic acids such as ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, (n-butoxy)ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, halogen compounds such as benzoyl chloride and trihalomethylphenyl sulfone, acyl phosphine oxides, peroxides such as di- and tri-butyl peroxides, etc.

於較佳態樣中,上述自由基聚合起始劑為安息香、安息香甲基醚、安息香乙基醚、安息香異丙基醚、噻噸酮、2,4-二乙基噻噸酮、噻噸酮-4-磺酸、二苯甲酮、4,4’-雙(二甲基胺基)二苯甲酮、4,4’-雙(二乙基胺基)二苯甲酮、苯乙酮、2-(4-甲苯磺醯氧基)-2-苯基苯乙酮、對二甲基胺基苯乙酮、2,2’-二甲氧基-2-苯基苯乙酮、對甲氧基苯乙酮、2-甲基[4-(甲基硫基)苯基]-2-

Figure 112112312-A0202-12-0105-56
啉基-1-丙酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-12-0105-57
啉基苯基)-丁-1-酮、蒽醌、1,4-萘醌、2-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸(正丁氧基)乙酯、4-二甲基胺基苯甲酸異戊酯、4-二甲基胺基苯甲酸2-乙基己酯、苯甲醯氯、三鹵甲基苯基碸、醯基氧化膦、或二-三級丁基過氧化物、苯甲醯甲酸甲酯、1-羥基-環己基-苯基-酮、1-[4-(2-羥基乙氧基)-苯基]-2-羥基-2-甲基-1-丙-1-酮、2-羥基-1-{4-[4-(2-羥基-2-甲基-丙醯基)-苄基]苯基}-2-甲基-丙-1-酮、2-甲基-1-(4-甲基硫基苯基)-2-
Figure 112112312-A0202-12-0105-59
啉基丙-1-酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-12-0105-58
啉基苯基)-1-丁酮、2-(二甲基胺基)-2-[(4-甲基苯基)甲基]-1-[4-(4-
Figure 112112312-A0202-12-0105-60
啉基)苯基]-1-丁酮、雙(2,4,6-三甲基苯甲醯基)-苯基氧化膦、雙(η5-2,4-環戊二烯-1-基)-雙(2,6-二氟-3-(1H- 吡咯-1-基)-苯基)鈦、1,2-辛二酮,1-[4-(苯基硫基)-,2-(O-苯甲醯基肟)]、乙酮,1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]-,1-(0-乙醯肟)、2-羥基-2-甲基-1-苯基-丙-1-酮、2,4,6-三甲基苯甲醯基-二苯基-氧化膦、三級丁基氫過氧化物、氫過氧化異丙苯、二異丙苯氫過氧化物、對-薄荷烷氫過氧化物、或三級甲基丁基氫過氧化物。 In a preferred embodiment, the free radical polymerization initiator is benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, thiothione, 2,4-diethylthiothione, thiothione-4-sulfonic acid, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, p-methoxyacetophenone, 2-methyl[4-(methylthio)phenyl]-2-
Figure 112112312-A0202-12-0105-56
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-12-0105-57
1-Butanone, anthraquinone, 1,4-naphthoquinone, ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate (n-butoxy) ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, benzoyl chloride, trihalomethylphenyl sulfone, acylphosphine oxide, or di-tert-butyl peroxide benzoic acid methyl ester, 1-hydroxy-cyclohexyl-phenyl-ketone, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, 2-methyl-1-(4-methylthiophenyl)-2-
Figure 112112312-A0202-12-0105-59
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-12-0105-58
1-Butanone, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-
Figure 112112312-A0202-12-0105-60
1-Butanone, bis(2,4,6-trimethylbenzyl)-phenylphosphine oxide, bis(η5-2,4-cyclopentadien-1-yl)-bis(2,6-difluoro-3-(1H- 1-[(4-(phenylthio)-,2-(O-benzoyl oxime)], ethyl ketone, 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-,1-(0-acetyl oxime), 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2,4,6-trimethylbenzyl-diphenyl-phosphine oxide, tertiary butyl hydroperoxide, isopropylbenzene hydroperoxide, diisopropylbenzene hydroperoxide, p-menthane hydroperoxide, or tertiary methyl butyl hydroperoxide.

作為上述自由基光聚合起始劑之市售品,係例示下述者。 The following are examples of commercially available free radical photopolymerization initiators.

OMNIRAD 651:2,2-二甲氧基-1,2-二苯基乙-1-酮、 OMNIRAD 651: 2,2-dimethoxy-1,2-diphenylethan-1-one,

OMNIRAD 184:1-羥基-環己基-苯基-酮、 OMNIRAD 184: 1-Hydroxy-cyclohexyl-phenyl-ketone,

OMNIRAD 2959:1-[4-(2-羥基乙氧基)-苯基]-2-羥基-2-甲基-1-丙-1-酮、 OMNIRAD 2959: 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one,

OMNIRAD 127:2-羥基-1-{4-[4-(2-羥基-2-甲基-丙醯基)-苄基]苯基}-2-甲基-丙-1-酮、 OMNIRAD 127: 2-Hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one,

OMNIRAD 907:2-甲基-1-(4-甲基硫基苯基)-2-

Figure 112112312-A0202-12-0106-61
啉基丙-1-酮、 OMNIRAD 907: 2-Methyl-1-(4-methylthiophenyl)-2-
Figure 112112312-A0202-12-0106-61
Linopropan-1-one,

OMNIRAD 369:2-苄基-2-二甲基胺基-1-(4-

Figure 112112312-A0202-12-0106-62
啉基苯基)-丁酮-1、 OMNIRAD 369: 2-Benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-12-0106-62
1-Butanone (1-(4-(4-(4-(4-phenyl)-2-oxo-1-yl)-1 ...

OMNIRAD 379:2-(二甲基胺基)-2-[(4-甲基苯基)甲基]-1-[4-(4-

Figure 112112312-A0202-12-0106-63
啉基)苯基]-1-丁酮、 OMNIRAD 379: 2-(Dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-
Figure 112112312-A0202-12-0106-63
[(1-(4 ...

OMNIRAD 819:雙(2,4,6-三甲基苯甲醯基)-苯基氧化膦、 OMNIRAD 819: Bis(2,4,6-trimethylbenzyl)-phenylphosphine oxide,

OMNIRAD 784:雙(η5-2,4-環戊二烯-1-基)-雙(2,6-二氟-3-(1H-吡咯-1-基)-苯基)鈦、 OMNIRAD 784: Bis(η5-2,4-cyclopentadien-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium,

OMNIRAD OXE 01:1,2-辛二酮,1-[4-(苯基硫基)-,2-(O-苯甲醯基肟)]、 OMNIRAD OXE 01: 1,2-octanedione, 1-[4-(phenylthio)-, 2-(O-benzoyl oxime)],

OMNIRAD OXE 02:乙酮,1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]-,1-(0-乙醯肟)、 OMNIRAD OXE 02: Ethyl ketone, 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]-, 1-(0-acetyl oxime),

OMNIRAD261、OMNIRAD369、OMNIRAD500、 OMNIRAD261, OMNIRAD369, OMNIRAD500,

DAROCUR 1173:2-羥基-2-甲基-1-苯基-丙-1-酮、 DAROCUR 1173: 2-Hydroxy-2-methyl-1-phenyl-propan-1-one,

DAROCUR TPO:2,4,6-三甲基苯甲醯基-二苯基-氧化膦、 DAROCUR TPO: 2,4,6-trimethylbenzyl-diphenyl-phosphine oxide,

DAROCUR1116、DAROCUR2959、DAROCUR1664、DAROCUR4043、 DAROCUR1116, DAROCUR2959, DAROCUR1664, DAROCUR4043,

OMNIRAD 754羥苯基乙酸:2-[2-側氧基-2-苯基乙醯氧基乙氧基]乙基酯與羥苯基乙酸、2-(2-羥基乙氧基)乙基酯之混合物、 OMNIRAD 754 Hydroxyphenylacetic acid: a mixture of 2-[2-hydroxy-2-phenylacetyloxyethoxy]ethyl ester, hydroxyphenylacetic acid, and 2-(2-hydroxyethoxy)ethyl ester,

OMNIRAD 500:OMNIRAD 184與二苯甲酮之混合物(1:1)、 OMNIRAD 500: A mixture of OMNIRAD 184 and benzophenone (1:1),

OMNIRAD 1300:OMNIRAD 369與OMNIRAD 651之混合物(3:7)、 OMNIRAD 1300: A mixture of OMNIRAD 369 and OMNIRAD 651 (3:7),

OMNIRAD 1800:CGI403與OMNIRAD 184之混合物(1:3)、 OMNIRAD 1800: a mixture of CGI403 and OMNIRAD 184 (1:3),

OMNIRAD 1870:CGI403與OMNIRAD 184之混合物(7:3)、 OMNIRAD 1870: a mixture of CGI403 and OMNIRAD 184 (7:3),

DAROCUR 4265:DAROCUR TPO與DAROCUR 1173之混合物(1:1)。 DAROCUR 4265: A mixture of DAROCUR TPO and DAROCUR 1173 (1:1).

又,OMNIRAD為BASF公司製,DAROCUR為MERCK Group Japan公司製。 In addition, OMNIRAD is manufactured by BASF, and DAROCUR is manufactured by MERCK Group Japan.

相對於上述成分(A)及成分(B)之合計100質量份,成分(E)之含量,較佳為0.1至20質量份,更佳為1至10質量份,又更佳為1至5質量份。 Relative to 100 parts by weight of the above-mentioned components (A) and (B) in total, the content of component (E) is preferably 0.1 to 20 parts by weight, more preferably 1 to 10 parts by weight, and even more preferably 1 to 5 parts by weight.

成分(F)溶劑 Ingredient (F) Solvent

上述溶劑較佳可為脂肪族烴類、芳香族烴類、酯類、酮類、乙二醇醚類、醇類、乙二醇類、環狀醚類、醯胺類、醚醇類、碳數5至12之全氟脂肪族烴、聚氟芳香族烴、聚氟脂肪族烴、氫氟烴、氫氯氟烴、或氫氟醚。溶劑可為此等之2種以上的混合溶劑。 The above solvents are preferably aliphatic hydrocarbons, aromatic hydrocarbons, esters, ketones, glycol ethers, alcohols, glycols, cyclic ethers, amides, ether alcohols, perfluoroaliphatic hydrocarbons with 5 to 12 carbon atoms, polyfluoroaromatic hydrocarbons, polyfluoroaliphatic hydrocarbons, hydrofluorocarbons, hydrochlorofluorocarbons, or hydrofluoroethers. The solvent may be a mixture of two or more of these solvents.

於較佳態樣中,溶劑為醇類、或氫氟醚,或者此等之2種以上的混合溶劑。 In a preferred embodiment, the solvent is an alcohol, or hydrofluoric acid, or a mixed solvent of two or more thereof.

作為上述脂肪族烴類,係列舉:己烷、環己烷、庚烷、辛烷、壬烷、癸烷、十一烷、十二烷、礦油精等。 Examples of the above-mentioned aliphatic hydrocarbons include hexane, cyclohexane, heptane, octane, nonane, decane, undecane, dodecane, mineral spirits, etc.

作為上述芳香族烴類,係列舉:苯、甲苯、二甲苯、萘、溶劑油(Solvent Naphtha)等。 Examples of the above-mentioned aromatic hydrocarbons include benzene, toluene, xylene, naphthalene, solvent naphtha, etc.

作為上述酯類,係列舉:乙酸甲酯、乙酸乙酯、乙酸丙酯、乙酸正丁酯、乙酸異丙酯、乙酸異丁酯、乙酸賽珞蘇、丙二醇甲醚乙酸、乙酸卡必醇、草酸二乙酯、丙酮酸乙酯、2-羥基丁酸乙酯、乙醯乙酸乙酯、乙酸戊酯、乳酸甲酯、乳酸乙酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、2-羥基異酪酸甲酯、2-羥基異酪酸乙酯等。 As the above-mentioned esters, there are exemplified: methyl acetate, ethyl acetate, propyl acetate, n-butyl acetate, isopropyl acetate, isobutyl acetate, celecoxole acetate, propylene glycol methyl ether acetic acid, carbitol acetate, diethyl oxalate, ethyl pyruvate, ethyl 2-hydroxybutyrate, ethyl acetylacetate, amyl acetate, methyl lactate, ethyl lactate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 2-hydroxyisobutyrate, ethyl 2-hydroxyisobutyrate, etc.

作為上述酮類,係列舉:丙酮、甲基乙基酮、甲基異丁酮、2-己酮、環己酮、甲基胺基酮、2-庚酮等。 Examples of the above-mentioned ketones include acetone, methyl ethyl ketone, methyl isobutyl ketone, 2-hexanone, cyclohexanone, methyl amino ketone, 2-heptanone, etc.

作為上述乙二醇醚類,係列舉:乙基賽珞蘇、甲基賽珞蘇、乙酸甲賽珞蘇、乙酸乙賽珞蘇、丙二醇單甲基醚、丙二醇單乙基醚、丙二醇單丁基醚、丙二醇單甲基醚乙酸、丙二醇單乙基醚乙酸、丙二醇單丁基醚乙酸、二丙二醇二甲基醚、二乙二醇單乙基醚乙酸等。 As the above-mentioned glycol ethers, there are listed: ethyl cellulose, methyl cellulose, methyl cellulose acetate, ethyl cellulose acetate, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monobutyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monobutyl ether acetate, dipropylene glycol dimethyl ether, diethylene glycol monoethyl ether acetate, etc.

作為上述醇類,係列舉:甲醇、乙醇、異丙醇、正丁醇、異丁醇、三級丁醇、二級丁醇、3-戊醇、辛基醇、3-甲基-3-甲氧基丁醇、三級戊醇等。醇類,較佳為甲醇、乙醇、異丙醇。 As the above-mentioned alcohols, there are listed: methanol, ethanol, isopropanol, n-butanol, isobutanol, tertiary butanol, di-butanol, 3-pentanol, octyl alcohol, 3-methyl-3-methoxybutanol, tertiary pentanol, etc. Alcohols are preferably methanol, ethanol, and isopropanol.

作為上述乙二醇類,係列舉:乙二醇、丙二醇等。 Examples of the above-mentioned glycols include ethylene glycol, propylene glycol, etc.

作為上述環狀醚類,係列舉:四氫呋喃、四氫吡喃、二

Figure 112112312-A0202-12-0109-64
烷等。 Examples of the cyclic ethers include tetrahydrofuran, tetrahydropyran, dihydrofuran,
Figure 112112312-A0202-12-0109-64
Alkane, etc.

作為上述醯胺類,係列舉:N,N-二甲基甲醯胺、N,N-二甲基乙醯胺等。 Examples of the above-mentioned amides include: N,N-dimethylformamide, N,N-dimethylacetamide, etc.

作為上述醚醇類,係列舉:甲基賽珞蘇、賽珞蘇、異丙基賽珞蘇、丁基賽珞蘇、二乙二醇單甲基醚等。 As the above-mentioned ether alcohols, there are listed: methyl cellulose sulfide, cellulose sulfide, isopropyl cellulose sulfide, butyl cellulose sulfide, diethylene glycol monomethyl ether, etc.

作為上述碳數5至12之全氟脂肪族烴,係列舉:全氟己烷、全氟甲基環己烷、全氟-1,3-二甲基環己烷等。 Examples of the above-mentioned perfluoroaliphatic hydrocarbons having 5 to 12 carbon atoms include perfluorohexane, perfluoromethylcyclohexane, perfluoro-1,3-dimethylcyclohexane, etc.

作為上述聚氟芳香族烴,係列舉雙(三氟甲基)苯等。 Examples of the above-mentioned polyfluorinated aromatic hydrocarbons include bis(trifluoromethyl)benzene, etc.

作為上述聚氟脂肪族烴,係列舉C6F13CH2CH3(例如,旭硝子股份有限公司製之ASAHIKLIN(註冊商標)AC-6000)、1,1,2,2,3,3,4-七氟環戊烷(例如,日本ZEON股份有限公司製之ZEORORA(註冊商標)H)等。 Examples of the polyfluoroaliphatic hydrocarbons include C 6 F 13 CH 2 CH 3 (for example, ASAHIKLIN (registered trademark) AC-6000 manufactured by Asahi Glass Co., Ltd.), 1,1,2,2,3,3,4-heptafluorocyclopentane (for example, ZEORORA (registered trademark) H manufactured by ZEON Co., Ltd., Japan).

作為氫氟烴(HFC),係列舉1,1,1,3,3-五氟丁烷(HFC-365mfc))等。 As hydrofluorocarbons (HFC), the series includes 1,1,1,3,3-pentafluorobutane (HFC-365mfc) and the like.

作為氫氯氟烴(hydrochlorofluorocarbon,HCFC),係列舉1,1,2-三氯基-1,2,2-三氟乙烷、1,2-二氯基-1,1,2,2-四氟乙烷、1,1-二氯基-1,2,2,3,3-五氟丙烷(HCFC225)(例如,ASAHIKLIN(註冊商標)AK225))等。 Examples of hydrochlorofluorocarbon (HCFC) include 1,1,2-trichloro-1,2,2-trifluoroethane, 1,2-dichloro-1,1,2,2-tetrafluoroethane, and 1,1-dichloro-1,2,2,3,3-pentafluoropropane (HCFC225) (e.g., ASAHIKLIN (registered trademark) AK225).

作為上述氫氟醚(HFE),係列舉全氟丙基甲基醚(C3F7OCH3)(例如,住友3M股份有限公司製之Novec(商標)7000)、全氟丁基甲基醚(C4F9OCH3)(例如,住友3M股份有限公司製之Novec(商標)7100)、全氟丁基乙基醚(C4F9OC2H5)(例如,住友3M股份有限公司製之Novec(商標)7200)、全氟己基甲基醚(C2F5CF(OCH3)C3F7)(例如,住友3M股份有限公司製之Novec(商標)7300)等之烷基全氟烷基醚(全氟烷基及烷基可為直鏈或支狀)、CF3CH2OCF2CHF2(例如,旭硝子股份有限公司製之ASAHIKLIN(註冊商標)AE-3000)等。 Examples of the hydrofluoroether (HFE) include alkyl perfluoroalkyl ethers (perfluoroalkyl and alkyl groups may be linear or branched), such as perfluoropropyl methyl ether (C 3 F 7 OCH 3 ) (e.g., Novec (trademark) 7000 manufactured by Sumitomo 3M Co., Ltd.), perfluorobutyl methyl ether (C 4 F 9 OCH 3 ) (e.g., Novec (trademark) 7100 manufactured by Sumitomo 3M Co., Ltd.), perfluorobutyl ethyl ether (C 4 F 9 OC 2 H 5 ) (e.g., Novec (trademark) 7200 manufactured by Sumitomo 3M Co., Ltd.), perfluorohexyl methyl ether (C 2 F 5 CF(OCH 3 )C 3 F 7 ) (e.g., Novec (trademark) 7300 manufactured by Sumitomo 3M Co., Ltd.), CF 3 CH 2 OCF 2 CHF 2 (For example, ASAHIKLIN (registered trademark) AE-3000 manufactured by Asahi Glass Co., Ltd.)

於較佳態樣中,溶劑為甲醇、乙醇、異丙醇、全氟丙基甲基醚、全氟丁基甲基醚、全氟丁基乙基醚、全氟己基甲基醚、或CF3CH2OCF2CHF2,或者此等之2種以上的混合溶劑。 In a preferred embodiment, the solvent is methanol, ethanol, isopropanol, perfluoropropyl methyl ether, perfluorobutyl methyl ether, perfluorobutyl ethyl ether, perfluorohexyl methyl ether, or CF 3 CH 2 OCF 2 CHF 2 , or a mixed solvent of two or more thereof.

相對於成分(A)至成分(F)之合計量,成分(F)之含量,為20至90質量%,較佳為40至90質量%。 The content of component (F) is 20 to 90% by mass, preferably 40 to 90% by mass, relative to the total amount of components (A) to (F).

本揭示之硬化性組成物可包含:可理解為含氟油的(非反應性)氟聚醚化合物,較佳為全氟(聚)醚化合物(以下統稱為「含氟油」)、可理解為矽油的(非反應性)聚矽氧化合物(以下稱為「矽油」)、醇類、界面活性劑、阻聚劑、敏化劑等。 The curable composition disclosed herein may include: (non-reactive) fluoropolyether compounds which can be understood as fluorine-containing oils, preferably perfluoro(poly)ether compounds (hereinafter collectively referred to as "fluorine-containing oils"), (non-reactive) polysilicone compounds which can be understood as silicone oils (hereinafter referred to as "silicone oils"), alcohols, surfactants, inhibitors, sensitizers, etc.

作為含氟油,並無特別限定,惟係列舉例如;以下通式(3)所示之化合物(全氟(聚)醚化合物)。 There is no particular limitation on the fluorine-containing oil, but examples thereof include compounds represented by the following general formula (3) (perfluoro (poly) ether compounds).

Rf5-(OC4F8)a’-(OC3F6)b’-(OC2F4)c’-(OCF2)d’-Rf6‧‧‧(3) Rf 5 -(OC 4 F 8 ) a' -(OC 3 F 6 ) b' -(OC 2 F 4 ) c' -(OCF 2 ) d' -Rf 6 ‧‧‧(3)

式中,Rf5表示可被1個或超過1個之氟原子取代的碳數1至16烷基(較佳C1-16之全氟烷基),Rf6表示可被1個或超過1個之氟原子取代的碳 數1至16烷基(較佳為C1-16全氟烷基)、氟原子或氫原子,Rf5及Rf6分別獨立地更佳為C1-3全氟烷基。 In the formula, Rf5 represents an alkyl group with 1 to 16 carbon atoms (preferably a C1-16 perfluoroalkyl group) which may be substituted by 1 or more fluorine atoms, and Rf6 represents an alkyl group with 1 to 16 carbon atoms (preferably a C1-16 perfluoroalkyl group) which may be substituted by 1 or more fluorine atoms, a fluorine atom or a hydrogen atom, and Rf5 and Rf6 are each independently more preferably a C1-3 perfluoroalkyl group.

a’、b’、c’及d’分別表示構成聚合物之主骨架的全氟(聚)醚之4種的重複單元數,且彼此獨立地為0以上300以下之整數,a’、b’、c’及d’之和至少為1,較佳為1至300,更佳為20至300。標註a’、b’、c’或d’並以括弧括起之各重複單元在式中的存在順序為任意。此等之重複單元可為直鏈狀或分枝鏈狀,亦可包含環結構。例如,-(OC4F8)-可為-(OCF2CF2CF2CF2)-、-(OCF(CF3)CF2CF2)-、-(OCF2CF(CF3)CF2)-、-(OCF2CF2CF(CF3))-、-(OC(CF3)2CF2)-、-(OCF2C(CF3)2)-、-(OCF(CF3)CF(CF3))-、-(OCF(C2F5)CF2)-及(OCF2CF(C2F5))-之任一者,惟較佳為-(OCF2CF2CF2CF2)-。-(OC3F6)-可為-(OCF2CF2CF2)-、-(OCF(CF3)CF2)-及(OCF2CF(CF3))-之任一者,惟較佳為-(OCF2CF2CF2)-。-(OC2F4)-可為-(OCF2CF2)-及(OCF(CF3))-之任一者,惟較佳為-(OCF2CF2)-。 a', b', c' and d' respectively represent the number of repeating units of the four types of perfluoro(poly)ether constituting the main skeleton of the polymer, and are independently integers of 0 to 300, and the sum of a', b', c' and d' is at least 1, preferably 1 to 300, and more preferably 20 to 300. The order of existence of each repeating unit marked with a', b', c' or d' and enclosed in parentheses in the formula is arbitrary. Such repeating units may be linear or branched chain-shaped, and may also contain a ring structure. For example, -( OC4F8 )- may be any one of -( OCF2CF2CF2CF2CF2 )-, -(OCF ( CF3 ) CF2CF2 ) - , - (OCF2CF( CF3 ) CF2 )-, -(OCF2CF2CF( CF3 ) ) -, -(OC(CF3)2CF2)-, -(OCF2C(CF3)2 ) - , - ( OCF ( CF3 )CF( CF3 ) ) -, -(OCF ( C2F5 ) CF2 )-, and ( OCF2CF ( C2F5 ))-, but - ( OCF2CF2CF2CF2 ) - is preferred. -(OC 3 F 6 )- may be any of -(OCF 2 CF 2 CF 2 )-, -(OCF(CF 3 )CF 2 )-, and (OCF 2 CF(CF 3 ))-, but is preferably -(OCF 2 CF 2 CF 2 )-. -(OC 2 F 4 )- may be any of -(OCF 2 CF 2 )- and (OCF(CF 3 ))-, but is preferably -(OCF 2 CF 2 )-.

上述環結構可為下述三員環、或四員環: The above ring structure can be the following three-membered ring or four-membered ring:

Figure 112112312-A0202-12-0111-38
Figure 112112312-A0202-12-0111-38

[式中,*顯示鍵結位置]。 [Where * indicates the key position].

例如,(OC4F8)可為 For example, (OC 4 F 8 ) can be

Figure 112112312-A0202-12-0111-39
Figure 112112312-A0202-12-0111-39

[式中,*顯示鍵結位置]。 [Where * indicates the key position].

作為上述通式(3)所示之全氟(聚)醚化合物之例,係列舉以下通式(3a)及(3b)之任一者所示之化合物(可為1種或2種以上之混合物)。 As an example of the perfluoro(poly)ether compound represented by the above general formula (3), there are listed compounds represented by any one of the following general formulas (3a) and (3b) (which may be a mixture of one or more).

Rf5-(OCF2CF2CF2)b”-Rf6‧‧‧(3a) Rf 5 -(OCF 2 CF 2 CF 2 ) b” -Rf 6 ‧‧‧(3a)

Rf5-(OCF2CF2CF2CF2)a”-(OCF2CF2CF2)b”-(OCF2CF2)c”-(OCF2)d”-Rf6‧‧‧(3b) Rf 5 -(OCF 2 CF 2 CF 2 CF 2 ) a” -(OCF 2 CF 2 CF 2 ) b” -(OCF 2 CF 2 ) c” -(OCF 2 ) d” -Rf 6 ‧‧‧(3b)

此等之式中,Rf5及Rf6係如上述;式(3a)中,b”為1以上100以下之整數;式(3b)中,a”及b”分別獨立地為0以上30以下之整數,c”及d”分別獨立地為1以上300以下之整數。標註a”、b”、c”、d”並以括弧括起之各重複單元在式中的存在順序為任意。 In these formulae, Rf5 and Rf6 are as described above; in formula (3a), b" is an integer from 1 to 100; in formula (3b), a" and b" are each independently an integer from 0 to 30, and c" and d" are each independently an integer from 1 to 300. The order in which the repetitive units marked a", b", c", and d" are enclosed in parentheses in the formulae is arbitrary.

此外,就其他觀點而言,含氟油可為通式Rf3-F(式中,Rf3為C5-16全氟烷基)所示之化合物。此外,亦可為氯基三氟乙烯寡聚物。 In addition, from another viewpoint, the fluorine-containing oil may be a compound represented by the general formula Rf 3 -F (wherein Rf 3 is a C 5-16 perfluoroalkyl group). In addition, it may be a chlorotrifluoroethylene oligomer.

上述含氟油可具有500至10000之平均分子量。含氟油之分子量可使用GPC測定。 The above-mentioned fluorinated oil may have an average molecular weight of 500 to 10,000. The molecular weight of the fluorinated oil may be measured using GPC.

相對於本揭示之硬化性組成物,含氟油之含量例如:可為0至50質量%,較佳為0至30質量%,更佳為0至5質量%。於一態樣中,本揭示之硬化性組成物實質上不含含氟油。實質上不含含氟油意指完全不含含氟油、或可含極微量之含氟油。 Relative to the curable composition disclosed herein, the content of fluorine-containing oil may be, for example, 0 to 50% by mass, preferably 0 to 30% by mass, and more preferably 0 to 5% by mass. In one embodiment, the curable composition disclosed herein substantially does not contain fluorine-containing oil. Substantially containing no fluorine-containing oil means that it does not contain any fluorine-containing oil at all, or may contain a very small amount of fluorine-containing oil.

作為上述矽油,可使用例如矽氧烷鍵結為2,000以下之直鏈狀或環狀的矽油。直鏈狀之矽油可為所謂的純矽油(straight silicone oil)及改質矽油。作為純矽油,係列舉二甲基矽油、甲基苯基矽油、甲基氫矽油。作為改質矽油,係列舉使用烷基、芳烷基、聚醚、高級脂肪酸酯、氟烷基、 胺基、環氧基、羧基、醇等將純矽油改質者。環狀之矽油,係列舉例如:環狀二甲基矽氧烷油等。 As the above-mentioned silicone oil, for example, a straight chain or cyclic silicone oil with a siloxane bond of less than 2,000 can be used. Straight chain silicone oils can be so-called straight silicone oils and modified silicone oils. As straight silicone oils, dimethyl silicone oil, methylphenyl silicone oil, and methyl hydrogen silicone oil are listed. As modified silicone oils, pure silicone oils modified with alkyl, arylalkyl, polyether, higher fatty acid ester, fluoroalkyl, amino, epoxy, carboxyl, alcohol, etc. are listed. Cyclic silicone oils include, for example, cyclic dimethyl siloxane oil, etc.

本揭示之硬化性組成物中,相對於上述本揭示之含氟聚醚基之丙烯酸化合物及含氟聚醚基之矽烷化合物之合計100質量份(2種以上之情況下,此等之合計以下亦同),這些矽油之含量,例如:可為0至300質量份,較佳為50至200質量份。 In the curable composition disclosed herein, the content of these silicone oils, for example, can be 0 to 300 parts by mass, preferably 50 to 200 parts by mass, relative to the total 100 parts by mass of the fluorinated polyether-containing acrylic compound and the fluorinated polyether-containing silane compound disclosed herein (in the case of more than two types, the total is the same below).

作為上述醇類,係列舉例如:可被1個或超過1個之氟原子取代的碳數1至6之醇、例如,甲醇、乙醇、異丙醇、三級丁醇、CF3CH2OH、CF3CF2CH2OH、(CF3)2CHOH。藉由將此等之醇類添加於硬化性組成物,可使硬化性組成物之穩定性提升,且可改善含全氟聚醚基之丙烯酸化合物及含氟聚醚基之矽烷化合物與溶劑之相溶性。 Examples of the alcohols include alcohols having 1 to 6 carbon atoms which may be substituted with one or more fluorine atoms, such as methanol, ethanol, isopropyl alcohol, tertiary butyl alcohol, CF 3 CH 2 OH, CF 3 CF 2 CH 2 OH, and (CF 3 ) 2 CHOH. By adding these alcohols to the curable composition, the stability of the curable composition can be improved, and the compatibility between the perfluoropolyether-containing acrylic compound and the fluorinated polyether-containing silane compound and the solvent can be improved.

上述醇較佳為甲醇、乙醇、2,2,3,3,3-五氟-1-丙醇或2,2,2-三氟乙醇。 The above alcohol is preferably methanol, ethanol, 2,2,3,3,3-pentafluoro-1-propanol or 2,2,2-trifluoroethanol.

本揭示之硬化性組成物,除了上述成分以外,可包含微量的雜質,作為雜質,係例如:Pt、Rh、RU、1,3-二乙烯基四甲基二矽氧烷、三苯基膦、NaCl、KCl、矽烷之縮合物等。 The curable composition disclosed herein may contain trace amounts of impurities in addition to the above-mentioned components. The impurities include, for example, Pt, Rh, RU, 1,3-divinyltetramethyldisiloxane, triphenylphosphine, NaCl, KCl, condensates of silane, etc.

本揭示之硬化性組成物之黏度,較佳可為3000mPa‧s以下,更佳可為2000mPa‧s以下,又更佳可為1000mPa‧s以下。藉由減少硬化性組成物之黏度,能夠將硬化性組成物塗佈於形狀更微細的部位。此外,本揭示之硬化性組成物之黏度,較佳可為1mPa‧s以上,更佳可為10mPa‧s以上,又更佳可為100mPa‧s以上。藉由增加硬化性組成物之黏度,有利於厚膜的形成、潤濕鋪展的控制。 The viscosity of the curable composition disclosed herein is preferably below 3000mPa‧s, more preferably below 2000mPa‧s, and even more preferably below 1000mPa‧s. By reducing the viscosity of the curable composition, the curable composition can be applied to a finer shape. In addition, the viscosity of the curable composition disclosed herein is preferably above 1mPa‧s, more preferably above 10mPa‧s, and even more preferably above 100mPa‧s. By increasing the viscosity of the curable composition, it is beneficial to the formation of a thick film and the control of wet spreading.

於一態樣中,本揭示之硬化性組成物之黏度,較佳可為1至3000mPa‧s,更佳可為10至2000mPa‧s,又更佳可為100至1000mPa‧S。 In one embodiment, the viscosity of the curable composition disclosed herein is preferably 1 to 3000 mPa‧s, more preferably 10 to 2000 mPa‧s, and even more preferably 100 to 1000 mPa‧s.

(用途) (Purpose)

本揭示之硬化性組成物的硬化物,例如,可使用於灌注材、密封材等。本揭示之硬化性組成物的硬化物,例如,可藉由填充電子部件之空隙(例如,殼體與印刷基板之結合部分、或樹脂模製金屬端子部分與模製樹脂之間隙等),並使其硬化而使用。 The hardened material of the hardening composition disclosed herein can be used, for example, as a potting material, a sealing material, etc. The hardened material of the hardening composition disclosed herein can be used, for example, by filling the gaps of electronic components (for example, the bonding portion between the housing and the printed circuit board, or the gap between the resin molded metal terminal portion and the molded resin, etc.) and hardening it.

為了形成具有更高耐磨耗性的硬化物(例如,灌注材、密封材),在用本揭示之硬化性組成物進行處理之前,為了去除空隙壁面的油份,較佳為以丙酮、氫氟醚等洗滌處理對象物後,進行乾燥。更且,除了上述之洗滌以外,可藉由以UV臭氧、氧電漿等進行前處理,而更提升硬化物的耐磨耗性。 In order to form a hardened material (e.g., potting material, sealing material) with higher wear resistance, before treating with the hardening composition disclosed in the present invention, in order to remove the oil on the wall of the void, it is preferred to wash the object with acetone, hydrofluoric ether, etc. and then dry it. In addition to the above-mentioned washing, the wear resistance of the hardened material can be further improved by pre-treating with UV ozone, oxygen plasma, etc.

在用本揭示之硬化性組成物進行處理之前,因應需要,藉由對於空隙壁面等實施底漆處理,則可提升由硬化性組成物形成的灌注材的接著性,並可更提升耐磨耗性。底漆處理,依據常規方法,可在與使用矽烷耦合劑之情況的底漆處理相同的條件下進行處理。 Before treating with the curable composition disclosed herein, by applying a primer to the void wall surface, etc., as needed, the adhesion of the potting material formed by the curable composition can be improved, and the wear resistance can be further improved. The primer treatment can be carried out under the same conditions as the primer treatment using a silane coupling agent according to conventional methods.

又,在使由本揭示之硬化性組成物獲得的硬化物與各種基材接著之情況下,亦可併用各種底漆。 Furthermore, when the hardened product obtained from the curable composition disclosed herein is bonded to various substrates, various primers may also be used in combination.

於一態樣中,硬化性組成物可在室溫下硬化。如此之硬化性組成物特別有用作為灌注材形成用的組成物。 In one embodiment, the hardening composition can be hardened at room temperature. Such a hardening composition is particularly useful as a composition for forming a potting material.

於一態樣中,當使用本揭示之硬化性組成物時,可因應其用途、目的使用溶劑進一步稀釋該組成物而使用。作為用於稀釋的溶劑,可使用上述所例示的氟型用劑。例如,可溶解於作為溶劑之1,3-雙(三氟甲基)苯、Fluorinert(3M公司製)、全氟丁基甲基醚、全氟丁基乙基醚等至所需的濃度來使用。尤其係,較佳為在薄膜塗佈用途中使用上述溶劑。 In one embodiment, when the curable composition disclosed herein is used, the composition can be further diluted with a solvent according to its use and purpose. As a solvent for dilution, the fluorine-type agent exemplified above can be used. For example, it can be dissolved in 1,3-bis(trifluoromethyl)benzene, Fluorinert (manufactured by 3M Company), perfluorobutyl methyl ether, perfluorobutyl ethyl ether, etc. as a solvent to the desired concentration for use. In particular, it is preferred to use the above solvent in thin film coating applications.

由於本揭示之硬化性組成物可形成對於金屬或塑料基材具有良好接著性的硬化物,因此尤其可有用於作為電氣電子部件周圍和車載用部件周圍用途的接著劑或密封材。尤其由於本揭示之硬化性組成物即使在低溫中亦具有良好的彈性模數,因此可有用地使用在汽車零件(例如,密封材,具體而言為墊圈片)等,尤其係在寒冷地區(例如-50℃以下)中使用的汽車零件中。更且,本揭示之硬化性組成物的硬化物亦可有用作為奈米壓印之樹脂型(複製模具)。 Since the curable composition disclosed herein can form a cured product with good adhesion to metal or plastic substrates, it can be particularly useful as an adhesive or sealant for use around electrical and electronic components and vehicle-mounted components. In particular, since the curable composition disclosed herein has a good elastic modulus even at low temperatures, it can be usefully used in automotive parts (e.g., sealants, specifically gaskets), etc., especially automotive parts used in cold regions (e.g., below -50°C). Furthermore, the cured product of the curable composition disclosed herein can also be used as a resin type (replica mold) for nanoimprinting.

本揭示之硬化性組成物的硬化物具良好的耐藥性、耐酸性、耐鹼性。如此之本揭示之硬化性組成物的硬化物亦可使用在化學工廠、半導體製造裝置等中。 The cured product of the curable composition disclosed herein has good chemical resistance, acid resistance, and alkali resistance. The cured product of the curable composition disclosed herein can also be used in chemical plants, semiconductor manufacturing equipment, etc.

本揭示提供由本揭示之硬化性組成物獲得的硬化物。本揭示之硬化性組成物,由於硬化性及塗佈性優異而言,故可以作為用於各種用途的硬化物。 The present disclosure provides a hardened product obtained from the hardening composition of the present disclosure. The hardening composition of the present disclosure can be used as a hardened product for various purposes due to its excellent hardening and coating properties.

本揭示包含一種物品,係包含基材、與使本揭示之硬化性組成物在該基材上硬化而成的硬化物層。 The present disclosure includes an article comprising a substrate and a hardened layer formed by hardening the hardening composition of the present disclosure on the substrate.

本揭示中能夠使用的基材,可由例如:玻璃、樹脂(天然或合成樹脂,例如,可為一般的塑料材料)、OCA(Optical Clear Adhesive)、偏 光板金屬、陶瓷、半導體(矽、鍺等)、電子產品、纖維(織物、不織布等)、毛皮、皮革、木材、陶磁器、石材等、建築構件等、衛生用品、任意適合的材料所構成。 The substrate that can be used in the present disclosure can be composed of, for example, glass, resin (natural or synthetic resin, for example, general plastic material), OCA (Optical Clear Adhesive), polarizing plate metal, ceramic, semiconductor (silicon, germanium, etc.), electronic products, fiber (woven fabric, non-woven fabric, etc.), fur, leather, wood, ceramics, stone, etc., building components, etc., sanitary products, and any other suitable materials.

於較佳態樣中,上述基材為玻璃、樹脂、偏光板、OCA(光學膠,Optical Clear Adhesive)或金屬,較佳為玻璃、樹脂、偏光板或OCA(Optical Clear Adhesive)。 In a preferred embodiment, the substrate is glass, resin, polarizing plate, OCA (Optical Clear Adhesive) or metal, preferably glass, resin, polarizing plate or OCA (Optical Clear Adhesive).

作為上述玻璃,係以藍寶石玻璃、鈉鈣玻璃(Soda-lime glass)、鹼鋁矽酸鹽玻璃、硼矽酸玻璃、無鹼玻璃、水晶玻璃、石英玻璃為較佳,並以經化學強化的鈉鈣玻璃(Soda-lime glass)、經化學強化的鹼鋁矽酸鹽玻璃、及經化學鍵結的硼矽酸玻璃為特佳。 As the above-mentioned glass, sapphire glass, soda-lime glass, alkali aluminosilicate glass, borosilicate glass, alkali-free glass, crystal glass, and quartz glass are preferred, and chemically strengthened soda-lime glass, chemically strengthened alkali aluminosilicate glass, and chemically bonded borosilicate glass are particularly preferred.

上述基材之形狀並無特別限定,可為例如,板狀、膜、其他形態。此外,應形成硬化物層之基材的表面區域,可為基材表面之至少一部分,可因應要被製造的物品之用途及具體的規格等適宜決定。 The shape of the substrate is not particularly limited, and may be, for example, a plate, a film, or other forms. In addition, the surface area of the substrate on which the hardened layer is to be formed may be at least a portion of the surface of the substrate, and may be appropriately determined according to the purpose and specific specifications of the article to be manufactured.

本揭示之物品可藉由下列方式來製造:在上述基材之表面形成上述本揭示之硬化性組成物的層,並因應需要將此層進行後處理,藉此可藉由從本揭示之硬化性組成物形成層。 The article disclosed herein can be manufactured by forming a layer of the curable composition disclosed herein on the surface of the substrate, and post-treating the layer as needed to form a layer from the curable composition disclosed herein.

本揭示之硬化性組成物的層形成,可藉由相對於基材表面,將上述硬化性組成物以將該表面以覆蓋的方式適用而實施。覆蓋方法並無特別限定。例如,可使用濕潤覆蓋法及乾燥覆蓋法。 The layer formation of the curable composition disclosed herein can be implemented by applying the curable composition to the surface of the substrate in a covering manner. The covering method is not particularly limited. For example, a wet covering method and a dry covering method can be used.

作為濕潤覆蓋法之例,係列舉浸漬塗佈、棒塗佈、旋塗佈、流塗佈、噴塗佈、輥塗佈、凹版塗佈、針頭配給、噴射配給及類似之方法。 濕潤覆蓋法較佳為棒塗佈、旋塗佈、流塗佈、輥塗佈、針頭配給或噴射配給。 As examples of wet coating methods, dip coating, rod coating, spin coating, flow coating, spray coating, roller coating, gravure coating, needle dispensing, jet dispensing and similar methods are listed. The wet coating method is preferably rod coating, spin coating, flow coating, roller coating, needle dispensing or jet dispensing.

於較佳態樣中,本揭示之物品可為電氣電子部件、車用部件、汽車零件(例如,密封材,具體而言為墊圈片)、化學工廠、半導體製造裝置等。 In a preferred embodiment, the articles disclosed herein may be electrical and electronic components, automotive components, automobile parts (e.g., sealing materials, specifically gaskets), chemical plants, semiconductor manufacturing equipment, etc.

此外,本揭示之物品亦可為醫療設備或醫療材料。 In addition, the articles disclosed herein may also be medical equipment or medical materials.

上述層之厚度並無特別限定,惟例如,可為1μm以上、10μm以上、或100μm以上。此外,上述層之厚度並無特別限定,惟可為1000μm以下、500μm以下、或100μm以下。 The thickness of the above-mentioned layer is not particularly limited, but for example, it can be 1 μm or more, 10 μm or more, or 100 μm or more. In addition, the thickness of the above-mentioned layer is not particularly limited, but it can be 1000 μm or less, 500 μm or less, or 100 μm or less.

以上針對本揭示之硬化性組成物、硬化物、及物品等進行詳述。又,本揭示之硬化性組成物、硬化物、及物品等並非限定於上述所例示者。 The above is a detailed description of the curable composition, cured product, and articles disclosed herein. In addition, the curable composition, cured product, and articles disclosed herein are not limited to the examples given above.

[實施例] [Implementation example]

以下針對本揭示之化合物在實施例中進行說明,惟本揭示並非限定於以下實施例者。又,本實施例中,構成氟聚醚之重複單元的存在順序為任意,以下所示之化學式表示平均組成。 The compounds disclosed in the present invention are described below in the examples, but the present invention is not limited to the following examples. In addition, in the present examples, the order of existence of the repeating units constituting the fluoropolyether is arbitrary, and the chemical formula shown below represents the average composition.

成分(A):含氟聚醚基之丙烯酸化合物的合成 Component (A): Synthesis of fluorinated polyether-containing acrylic compounds

合成例1 Synthesis Example 1

在配備回流冷卻器、溫度計及攪拌機之100mL的3頸燒瓶中,饋入平均組成CH3OCOCF2O(CF2O)12(CF2CF2O)12CF2COOCH3所示之全氟聚醚改質酯體10.0g、1,3-雙(三氟甲基)苯5.0g、及二伸乙基三胺0.20g,在25℃攪拌1小時。繼而,加入3-胺基丙基三甲氧基矽烷0.68g後,在氮氣流下, 於25℃攪拌1小時。其後,藉由在減壓下餾去揮發成分,而獲得下述式所示之矽烷化合物(A)。 In a 100 mL 3-neck flask equipped with a reflux cooler, a thermometer and a stirrer, 10.0 g of a perfluoropolyether modified ester represented by an average composition of CH 3 OCOCF 2 O(CF 2 O) 12 (CF 2 CF 2 O) 12 CF 2 COOCH 3 , 5.0 g of 1,3-bis(trifluoromethyl)benzene and 0.20 g of diethylenetriamine were added and stirred at 25° C. for 1 hour. Subsequently, 0.68 g of 3-aminopropyltrimethoxysilane was added and stirred at 25° C. for 1 hour under a nitrogen flow. Thereafter, the volatile components were distilled off under reduced pressure to obtain a silane compound (A) represented by the following formula.

(CH3O)3SiCH2CH2CH2NHCOCF2O(CF2CF2O)12(CF2O)12CF2CONHCH2CH2NHCH2CH2NHCOCF2O(CF2CF2O)12(CF2O)12CF2CONHCH2CH2CH2Si(OCH3)3 (CH 3 O) 3 SiCH 2 CH 2 CH 2 NHCOCF 2 O(CF 2 CF 2 O) 12 (CF 2 O) 12 CF 2 CONHCH 2 CH 2 NHCH 2 CH 2 NHCOCF 2 O(CF 2 CF 2 O) 12 (CF 2 O) 12 CF 2 CONHCH 2 CH 2 CH 2 Si(OCH 3 ) 3

合成例2 Synthesis Example 2

在配備回流冷卻器、溫度計及攪拌機之100mL的3頸燒瓶中,饋入合成例1獲得的矽烷化合物(A)10.0g、及2-異氰酸基丙烯酸乙酯(昭和電工股份有限公司製Karenz(註冊商標)AOI)0.27g,於25℃攪拌1時,而獲得下述式所示之含氟聚醚基之丙烯酸化合物(B)。 In a 100 mL 3-neck flask equipped with a reflux cooler, a thermometer and a stirrer, 10.0 g of the silane compound (A) obtained in Synthesis Example 1 and 0.27 g of ethyl 2-isocyanate acrylate (Karenz (registered trademark) AOI manufactured by Showa Denko Co., Ltd.) were added, and stirred at 25°C for 1 hour to obtain a fluorinated polyether group-containing acrylic compound (B) represented by the following formula.

(CH3O)3SiCH2CH2CH2NHCOCF2O(CF2CF2O)12(CF2O)12CF2CONHCH2CH2N(X)CH2CH2NHCOCF2O(CF2CF2O)12(CF2O)12CF2CONHCH2CH2CH2Si(OCH3)3 (CH 3 O) 3 SiCH 2 CH 2 CH 2 NHCOCF 2 O(CF 2 CF 2 O) 12 (CF 2 O) 12 CF 2 CONHCH 2 CH 2 N(X)CH 2 CH 2 NHCOCF 2 O(CF 2 CF 2 O) 12 (CF 2 O) 12 CF 2 CONHCH 2 CH 2 CH 2 Si(OCH 3 ) 3

成分(B):含氟聚醚基之矽烷化合物的合成 Component (B): Synthesis of silane compounds containing fluorinated polyether groups

合成例3 Synthesis Example 3

在配備回流冷卻器、溫度計及攪拌機之100mL的3頸燒瓶中,饋入平均組成CH3OCOCF2O(CF2O)12(CF2CF2O)12CF2COOCH3所示之全氟聚醚改質酯體10.0g、1,3-雙(三氟甲基)苯5.0g、及乙二胺0.11g,在氮氣流下於25℃攪拌1小時。繼而,加入3-胺基丙基甲基二甲氧基矽烷0.62g後,於25℃攪拌1小時。其後,藉由在減壓下餾去揮發成分,而獲得下述式所示之含氟聚醚基之矽烷化合物(C)。 In a 100 mL 3-neck flask equipped with a reflux cooler, a thermometer and a stirrer, 10.0 g of a perfluoropolyether modified ester represented by an average composition of CH 3 OCOCF 2 O(CF 2 O) 12 (CF 2 CF 2 O) 12 CF 2 COOCH 3 , 5.0 g of 1,3-bis(trifluoromethyl)benzene and 0.11 g of ethylenediamine were added, and stirred at 25° C. for 1 hour under a nitrogen flow. Subsequently, 0.62 g of 3-aminopropylmethyldimethoxysilane was added, and stirred at 25° C. for 1 hour. Thereafter, the volatile components were distilled off under reduced pressure to obtain a fluorinated polyether group-containing silane compound (C) represented by the following formula.

(CH3O)2CH3SiCH2CH2CH2NHCOCF2O(CF2CF2O)12(CF2O)12CF2CONHCH2CH2NHCOCF2O(CF2CF2O)12(CF2O)12CF2CONHCH2CH2CH2SiCH3(OCH3)2 (CH 3 O) 2 CH 3 SiCH 2 CH 2 CH 2 NHCOCF 2 O(CF 2 CF 2 O) 12 (CF 2 O) 12 CF 2 CONHCH 2 CH 2 NHCOCF 2 O(CF 2 CF 2 O) 12 (CF 2 O) 12 CF 2 CONHCH 2 CH 2 CH 2 SiCH 3 (OCH 3 ) 2

成分(C):交聯劑 Ingredient (C): Crosslinking agent

(C-1)甲基三甲氧基矽烷 (C-1) Methyltrimethoxysilane

成分(D):觸媒 Ingredient (D): Catalyst

(D-1)二異丙氧基雙(乙醯乙酸乙酯)鈦(Olgatrix TC750、Matsumoto Fine Chemical公司製) (D-1) Titanium diisopropoxybis(ethyl acetate) (Olgatrix TC750, manufactured by Matsumoto Fine Chemical Co., Ltd.)

成分(E):自由基聚合起始劑 Ingredient (E): Free radical polymerization initiator

(E-1)苯甲醯甲酸甲酯 (E-1) Methyl benzoate

成分(F):溶劑 Ingredient (F): Solvent

(F-1)全氟己基甲基醚(含水量35ppm)(HFE7300)) (F-1) Perfluorohexyl methyl ether (water content 35ppm) (HFE7300))

實施例及比較例 Implementation examples and comparative examples

將成分(A)至(E)以下述表所示比率(重量比)混合,其次以成分(F)稀釋至預定比例而調配硬化性組成物。針對獲得的硬化性組成物實施以下評估。 Components (A) to (E) were mixed in the ratio (weight ratio) shown in the following table, and then component (F) was diluted to a predetermined ratio to prepare a curable composition. The following evaluation was performed on the obtained curable composition.

UV硬化性試驗 UV curing test

使用塗佈器在玻璃板上形成厚度200μm之膜後,在大氣下使用高壓汞燈進行積算光量1000mJ之UV照射。評估其後塗佈膜的硬化狀態。使用塗佈器在玻璃板上形成200μm的膜後,在大氣中用高壓汞燈以1000mJ的積分光強度進行UV照射。 After forming a 200μm film on a glass plate using a coater, UV irradiation with an integrated light intensity of 1000mJ was performed in the atmosphere using a high-pressure mercury lamp. The curing state of the subsequent coating film was evaluated. After forming a 200μm film on a glass plate using a coater, UV irradiation with an integrated light intensity of 1000mJ was performed in the atmosphere using a high-pressure mercury lamp.

◎:表面與內部均硬化,且失去流動性的狀態 ◎: The surface and the inside are hardened and the fluidity is lost

○:表面硬化,但內部為液態,或者雖無流動性,但表面黏結、硬化不充分。 ○: The surface is hardened, but the inside is liquid, or although there is no fluidity, the surface bonding and hardening are insufficient.

×:內部與表面均為硬化不充分且保持液態。 ×: Both the interior and the surface are not fully hardened and remain liquid.

噴霧塗佈試驗 Spray coating test

使用2流體噴嘴噴霧塗佈各塗佈液,在室溫乾燥數次後,使用高壓汞燈以積算光量成為1000mJ/cm2之方式進行UV照射。其次,在室溫下靜置24小時,使其完全硬化後,使用千分尺測定塗佈膜厚。 Each coating liquid was sprayed using a two-fluid nozzle, dried several times at room temperature, and then irradiated with UV using a high-pressure mercury lamp so that the integrated light intensity was 1000mJ/ cm2 . Next, the coating was left at room temperature for 24 hours to completely cure, and the coating film thickness was measured using a micrometer.

分注器塗佈試驗 Dispenser coating test

將各塗佈液放入10ml注射器,使用在注射器前端設置有180μm之針的氣壓型分注器在玻璃上塗佈10cm之線。在室溫乾燥後,使用高壓汞燈以積算光量成為1000mJ/cm2之方式進行UV照射。在室溫靜置24小時,使其完全硬化後,使用千分尺測定3點塗佈膜厚,取3點的平均值作為膜厚。 Each coating liquid was placed in a 10 ml syringe and coated on a 10 cm line on the glass using a pneumatic dispenser with a 180 μm needle at the tip of the syringe. After drying at room temperature, UV irradiation was performed using a high-pressure mercury lamp in such a way that the integrated light intensity became 1000 mJ/ cm2 . After standing at room temperature for 24 hours and completely curing, the coating film thickness was measured at 3 points using a micrometer, and the average value of the 3 points was taken as the film thickness.

耐化學性: Chemical resistance:

使硬化膜在室溫下於甲苯溶液中浸漬3天,並算出重量膨潤率。 The cured film was immersed in a toluene solution at room temperature for 3 days, and the weight swelling rate was calculated.

◎:重量膨潤率未達3% ◎: Weight expansion rate is less than 3%

○:重量膨潤率3%以上且未達10% ○: Weight expansion rate is 3% or more and less than 10%

×:重量膨潤率10%以上 ×: Weight expansion rate is more than 10%

[表1]

Figure 112112312-A0202-12-0121-40
[Table 1]
Figure 112112312-A0202-12-0121-40

從上述結果確認出本揭示之硬化性組成物能夠以噴霧及分注器之塗佈,達成100μm以下的均勻塗佈。此外,確認出藉由包含成分(A)至(E),尤其係成分(A),變得能夠藉由UV照射而立即硬化(固定化),而此乃在以往的濕氣硬化系統中所無法完成者。 The above results confirm that the curable composition disclosed in the present invention can be applied by spraying and dispensing to achieve uniform coating of less than 100 μm. In addition, it is confirmed that by including components (A) to (E), especially component (A), it becomes possible to be cured (fixed) immediately by UV irradiation, which is impossible in the conventional wet air curing system.

[產業利用性] [Industrial Utilization]

本揭示之硬化性組成物可適合用於在各種各樣的基材上形成硬化物層。 The curable composition disclosed herein can be used to form a cured layer on a variety of substrates.

Claims (45)

一種硬化性組成物,係包含: A hardening composition comprising: 成分(A):含有(甲基)丙烯酸基、水解性矽烷基、及氟聚醚基的含氟聚醚基之丙烯酸化合物, Component (A): a fluorinated polyether-containing acrylic compound containing a (meth) acrylic group, a hydrolyzable silyl group, and a fluorinated polyether group, 成分(B):含有氟聚醚基、及水解性矽基的含氟聚醚基之矽烷化合物, Component (B): A silane compound containing a fluorinated polyether group and a hydrolyzable silyl group, 成分(C):交聯劑, Ingredient (C): Crosslinking agent, 成分(D):觸媒, Ingredient (D): Catalyst, 成分(E):自由基聚合起始劑,以及 Component (E): free radical polymerization initiator, and 成分(F):溶劑。 Ingredient (F): Solvent. 如請求項1所述之硬化性組成物,其中,相對於成分(A)至成分(F)之合計量,成分(F)之含量係20至90質量%。 The curable composition as described in claim 1, wherein the content of component (F) is 20 to 90 mass % relative to the total amount of components (A) to (F). 如請求項1或2所述之硬化性組成物,其中,相對於成分(A)至成分(F)之合計量,成分(F)之含量係40至90質量%。 The curable composition as described in claim 1 or 2, wherein the content of component (F) is 40 to 90 mass % relative to the total amount of components (A) to (F). 如請求項1至3中任一項所述之硬化性組成物,其中,前述溶劑為脂肪族烴類、芳香族烴類、酯類、酮類、乙二醇醚類、醇類、乙二醇類、環狀醚類、醯胺類、醚醇類、碳數5至12之全氟脂肪族烴、多氟芳香族烴、多氟脂肪族烴、氫氟烴、氫氯氟烴、或氫氟醚,或者此等之2種以上的混合溶劑。 The curable composition as described in any one of claims 1 to 3, wherein the solvent is aliphatic hydrocarbons, aromatic hydrocarbons, esters, ketones, glycol ethers, alcohols, glycols, cyclic ethers, amides, ether alcohols, perfluoroaliphatic hydrocarbons with 5 to 12 carbon atoms, polyfluoroaromatic hydrocarbons, polyfluoroaliphatic hydrocarbons, hydrofluorocarbons, hydrochlorofluorocarbons, or hydrofluoroethers, or a mixed solvent of two or more of these. 如請求項1至4中任一項所述之硬化性組成物,其中,前述溶劑為醇類、或氫氟醚,或者此等之2種以上的混合溶劑。 The curable composition as described in any one of claims 1 to 4, wherein the solvent is an alcohol, or hydrofluoric ether, or a mixed solvent of two or more thereof. 如請求項1至5中任一項所述之硬化性組成物,其中,前述溶劑為甲醇、乙醇、異丙醇、全氟丙基甲基醚、全氟丁基甲基醚、全氟 丁基乙基醚、全氟己基甲基醚、或CF3CH2OCF2CHF2,或者此等之2種以上的混合溶劑。 The curable composition as claimed in any one of claims 1 to 5, wherein the solvent is methanol, ethanol, isopropyl alcohol, perfluoropropyl methyl ether, perfluorobutyl methyl ether, perfluorobutyl ethyl ether, perfluorohexyl methyl ether, or CF 3 CH 2 OCF 2 CHF 2 , or a mixed solvent of two or more thereof. 如請求項1至6中任一項所述之硬化性組成物,其中,前述含氟聚醚基之丙烯酸化合物包含下述式(A1)、(A2)或(A3)所示之化合物, A curable composition as described in any one of claims 1 to 6, wherein the aforementioned fluorinated polyether group-containing acrylic compound comprises a compound represented by the following formula (A1), (A2) or (A3), RF1-XA-XBRAc m (A1) R F1 -X A -X B R Ac m (A1) RAc mXB-XA-RF2-XA-XBRAc m (A2) R Ac m X B -X A -R F2 -X A -X B R Ac m (A2) RAc mXB-XA-(RF2-Rg-Ra(RAc)m3-Rg)x-RF2-XA-XBRAc m (A3) R Ac m X B -X A -(R F2 -R g -R a (R Ac ) m3 -R g ) x -R F2 -X A -X B R Ac m (A3) 式中: In the formula: RF1為Rf1-RF-Oq-, RF1 is Rf1 - RF - Oq- , RF2分別獨立地為-Rf2 p-RF-Oq-, RF2 is independently -Rf2p - RF - Oq- , Rf1為可被1個或超過1個之氟原子取代的C1-16烷基, Rf1 is a C1-16 alkyl group which may be substituted by 1 or more fluorine atoms, Rf2為可被1個或超過1個之氟原子取代的C1-6伸烷基, Rf2 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms, RF分別獨立地為二價之氟聚醚基, R and F are independently divalent fluoropolyether groups, p為0或1, p is 0 or 1, q分別獨立地為0或1, q is independently 0 or 1, XA分別獨立地為單鍵、或二價之有機基, X and A are independently a single bond or a divalent organic group, XB分別獨立地為(m+1)價之基, X and B are independently (m+1)-valent bases, 惟,各式中,至少1個XB為含有水解性矽基之(m+1)價的基, However, in each formula, at least one XB is a (m+1)-valent group containing a hydrolyzable silicon group. RAc分別獨立地為-XD-XE(-XF-OCO-CR5=CH2)m’R Ac are independently -X D -X E (-X F -OCO-CR 5 =CH 2 ) m' , XD為單鍵、或二價之基, X D is a single bond or a divalent group, XE為單鍵、或(m’+1)價之基, XE is a single bond or a (m'+1) valence base, XF分別獨立地為單鍵、或二價之基, X and F are independently a single bond or a divalent group, R5為氫原子、鹵素原子、或碳數1至8之一價的有機基, R5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms, m’為1至10之整數, m’ is an integer from 1 to 10, m分別獨立地為0至10之整數, m is an integer from 0 to 10 independently. Ra分別獨立地為(m3+2)價之有機基, R a is independently an organic group with a valence of (m3+2), m3為0至4之整數, m3 is an integer from 0 to 4, 惟,m及m3之至少一者為1以上, However, at least one of m and m3 is greater than 1, Rg分別獨立地為-NRcCO-Re-、-NRcCOO-Re-、或-NRcCONRc-Re-,於此,此等基之左側係鍵結至RaR g is independently -NR c CO- Re -, -NR c COO- Re -, or -NR c CONR c -Re -, wherein the left side of these groups is bonded to Ra , Rc分別獨立地為氫原子、C1-6烷基、或C6-16芳基, R c are each independently a hydrogen atom, a C 1-6 alkyl group, or a C 6-16 aryl group, Re分別獨立地為單鍵、或2價之有機基, R e each independently represents a single bond or a divalent organic group, x為1以上之整數。 x is an integer greater than 1. 如請求項7所述之硬化性組成物,其中,RF分別獨立地為下述式所示之基, The curable composition as claimed in claim 7, wherein R and F are independently a group represented by the following formula: -(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3RFa 6)d-(OC2F4)e-(OCF2)f- -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - 式中,RFa分別獨立地為氫原子、氟原子或氯原子, Wherein, R Fa is independently a hydrogen atom, a fluorine atom or a chlorine atom, a、b、c、d、e及f分別獨立地為0至200之整數,a、b、c、d、e及f之和為1以上,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意,惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上。 a, b, c, d, e and f are each independently an integer from 0 to 200, the sum of a, b, c, d, e and f is 1 or more, and the order of presence of the repeating units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary, provided that, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more. 如請求項7或8所述之硬化性組成物,其中,RF分別獨立地為下述式(f1)、(f2)、(f3)、(f4)、(f5)、或(f6)所示之基, The curable composition according to claim 7 or 8, wherein R and F are independently a group represented by the following formula (f1), (f2), (f3), (f4), (f5), or (f6), -(OC3F6)d-(OC2F4)e- (f1) -(OC 3 F 6 ) d -(OC 2 F 4 ) e - (f1) 式中,d為1至200之整數,e為0或1; In the formula, d is an integer from 1 to 200, and e is 0 or 1; -(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f2) -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f2) 式中,c及d分別獨立地為0至30之整數; In the formula, c and d are independently integers between 0 and 30; e及f分別獨立地為1至200之整數; e and f are independently integers between 1 and 200; c、d、e及f之和為10至200之整數; The sum of c, d, e and f is an integer between 10 and 200; 標註c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意; The order of the repeated units marked with c, d, e or f and enclosed in brackets in the formula is arbitrary; -(R6-R7)g- (f3) -(R 6 -R 7 ) g - (f3) 式中,R6為OCF2或OC2F4Wherein, R 6 is OCF 2 or OC 2 F 4 ; R7為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為選自此等基之2或3個基的組合; R7 is a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups selected from these groups ; g為2至100之整數; g is an integer from 2 to 100; -(R6-R7)g-Rr-(R7’-R6’)g’- (f4) -(R 6 -R 7 ) g -R r -(R 7' -R 6' ) g' - (f4) 式中,R6為OCF2或OC2F4Wherein, R 6 is OCF 2 or OC 2 F 4 , R7為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R7 is a group selected from OC2F4 , OC3F6 , OC4F8 , OC5F10 and OC6F12 , or a combination of 2 or 3 groups independently selected from these groups, R6’為OCF2或OC2F4R 6' is OCF 2 or OC 2 F 4 , R7’為選自OC2F4、OC3F6、OC4F8、OC5F10及OC6F12之基,或者,為從此等基中獨立選擇之2或3個基的組合, R 7' is a group selected from OC 2 F 4 , OC 3 F 6 , OC 4 F 8 , OC 5 F 10 and OC 6 F 12 , or a combination of 2 or 3 groups independently selected from these groups, g為2至100之整數, g is an integer from 2 to 100, g’為2至100之整數, g’ is an integer from 2 to 100, RrR r is
Figure 112112312-A0202-13-0005-41
Figure 112112312-A0202-13-0005-41
式中,*顯示鍵結位置; In the formula, * shows the bond position; -(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f5) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f5) 式中,e為1以上200以下之整數,a、b、c、d及f分別獨立地為0以上200以下之整數,a、b、c、d、e及f之和至少為1,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意; In the formula, e is an integer greater than 1 and less than 200, a, b, c, d and f are each independently an integer greater than 0 and less than 200, and the sum of a, b, c, d, e and f is at least 1. In addition, the order of the repeated units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary; -(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3F6)d-(OC2F4)e-(OCF2)f- (f6) -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f6) 式中,f為1以上200以下之整數,a、b、c、d及e分別獨立地為0以上200以下之整數,a、b、c、d、e及f之和至少為1,此外,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意。 In the formula, f is an integer between 1 and 200, a, b, c, d, and e are each independently an integer between 0 and 200, and the sum of a, b, c, d, e, and f is at least 1. In addition, the order of the repeated units marked with a, b, c, d, e, or f and enclosed in parentheses in the formula is arbitrary.
如請求項7至9中任一項所述之硬化性組成物,其中,XE為單鍵。 The hardenable composition as described in any one of claims 7 to 9, wherein XE is a single bond. 如請求項7至10中任一項所述之硬化性組成物,其中,XE為-XG-XHThe hardenable composition according to any one of claims 7 to 10, wherein XE is -XG - XH ; XG為單鍵、 X G is a single key, C1-6伸烷基、 C 1-6 alkylene, -(CH2)z9-O-(CH2)z10-(式中,z9為0至6之整數,z10為0至6之整數)、或 -(CH 2 ) z9 -O-(CH 2 ) z10 -(wherein z9 is an integer from 0 to 6, and z10 is an integer from 0 to 6), or -(CH2)z11-伸苯基-(CH2)z12-(式中,z11為0至6之整數,z12為0至6之整數); -(CH 2 ) z11 -phenylene-(CH 2 ) z12 - (wherein z11 is an integer from 0 to 6, and z12 is an integer from 0 to 6); XH為如下者, X H is as follows,
Figure 112112312-A0202-13-0006-42
Figure 112112312-A0202-13-0006-42
R8為氫原子、或C1-6烷基。 R8 is a hydrogen atom or a C1-6 alkyl group.
如請求項7至11中任一項所述之硬化性組成物,其中,XD為-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-、-OCONH-、-NHCOO-、-NH-CO-NH-、-CH2CH(OH)CH2-、-CH(CH2OH)CH2-、-(OSiR14 2)d5-、 The curable composition as described in any one of claims 7 to 11, wherein XD is -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-, -OCONH-, -NHCOO-, -NH-CO-NH-, -CH2CH (OH) CH2-, -CH ( CH2OH ) CH2- , -( OSiR142 ) d5- ,
Figure 112112312-A0202-13-0006-43
Figure 112112312-A0202-13-0006-43
式中,*及**顯示鍵結位置,*鍵結至XB,**鍵結至XEWherein, * and ** indicate the bond positions, * is bonded to X B , ** is bonded to X E ; R14為C1-6烷基、或C6-16芳基; R 14 is C 1-6 alkyl or C 6-16 aryl; d5為1至10之整數。 d5 is an integer from 1 to 10.
如請求項7至12中任一項所述之硬化性組成物,其中,XF為單鍵、 The hardenable composition as claimed in any one of claims 7 to 12, wherein X F is a single bond, C1-6伸烷基、 C 1-6 alkylene, -(CH2)z5-O-(CH2)z6-(式中,z5為0至6之整數,z6為0至6之整數)、或 -(CH 2 ) z5 -O-(CH 2 ) z6 -(wherein z5 is an integer from 0 to 6, and z6 is an integer from 0 to 6), or -(CH2)z7-伸苯基-(CH2)z8-(式中,z7為0至6之整數,z8為0至6之整數)。 -(CH 2 ) z7 -phenylene-(CH 2 ) z8 - (wherein z7 is an integer from 0 to 6, and z8 is an integer from 0 to 6). 如請求項7至13中任一項所述之硬化性組成物,其中,R5為氫原子、或甲基。 The curable composition as described in any one of claims 7 to 13, wherein R 5 is a hydrogen atom or a methyl group. 如請求項7至14中任一項所述之硬化性組成物,其中,XA分別獨立地為單鍵、或下述式所示之基; The curable composition as described in any one of claims 7 to 14, wherein X and A are independently a single bond or a group represented by the following formula: -(C α R11 2α )s1-R12 t1- -(C α R 11 2 α ) s1 -R 12 t1 - 式中: In the formula: R11分別獨立地為氫原子或氟原子, R 11 is independently a hydrogen atom or a fluorine atom, α分別獨立地為1至10之整數, α is an integer from 1 to 10 independently. R12分別獨立地為-O-、-CO-、-NR10-、-CONR10-、-NR10CO-、-COO-、-OCO-、或-OCONH-, R 12 are independently -O-, -CO-, -NR 10 -, -CONR 10 -, -NR 10 CO-, -COO-, -OCO-, or -OCONH-, R10為氫原子或C1-6烷基, R10 is a hydrogen atom or a C1-6 alkyl group, s1為0至3之整數, s1 is an integer from 0 to 3, t1為0至3之整數, t1 is an integer between 0 and 3, s1與t1之合計為1以上, The sum of s1 and t1 is greater than 1, 標註s1或t1並以括弧括起之各重複單元在式中的存在順序為任意。 The order of the repeated units marked with s1 or t1 and enclosed in parentheses in the formula is arbitrary. 如請求項7至15中任一項所述之硬化性組成物,其中,XA為-CONR10-Cα1H2α1-、-(Cα2H2α2)-OCONR10-、-(Cα3H2α3)-、或-(Cα4H2α4)-O-(Cα5H2α5), The hardenable composition according to any one of claims 7 to 15, wherein XA is -CONR10 -Cα1H2α1- , - ( Cα2H2α2 ) -OCONR10- , - ( Cα3H2α3 ) -, or -( Cα4H2α4 )-O-( Cα5H2α5 ), R10為氫原子或C1-6烷基, R10 is a hydrogen atom or a C1-6 alkyl group, α1為1至10之整數, α1 is an integer from 1 to 10, α2為1至10之整數, α2 is an integer from 1 to 10, α3為1至10之整數, α3 is an integer from 1 to 10, α4為0至6之整數, α4 is an integer from 0 to 6, α5為0至6之整數。 α5 is an integer between 0 and 6. 如請求項7至16中任一項所述之硬化性組成物,其中,XB分別獨立地為包含下述式所示之基的基; The curable composition as described in any one of claims 7 to 16, wherein X B each independently represents a group comprising a group represented by the following formula: SiR1 nbRsb 4-nb SiR 1 nb R sb 4-nb 式中: In the formula: R1為羥基或水解性基, R1 is a hydroxyl group or a hydrolyzable group, Rsb為單鍵, R sb is a single bond. nb為1或2。 nb is 1 or 2. 如請求項7至16中任一項所述之硬化性組成物,其中,XB分別獨立地為XBa(RSi)na所示之基; The hardenable composition as described in any one of claims 7 to 16, wherein X B is independently a group represented by X Ba (R Si ) na ; 式中: In the formula: XBa分別獨立地為(m+na+1)價之基, X Ba are independently (m+na+1)-valence bases, RSi分別獨立地為-XC-SiR1 n’R2 3-n’R Si are independently -X C -SiR 1 n' R 2 3-n' , XC為碳數1至10之二價的有機基, X C is a divalent organic group having 1 to 10 carbon atoms, R1分別獨立地為羥基或水解性基, R1 is independently a hydroxyl group or a hydrolyzable group, R2分別獨立地為氫原子或1價之有機基, R2 is independently a hydrogen atom or a monovalent organic group, n’為1至3之整數, n’ is an integer from 1 to 3, na為1至10之整數。 na is an integer from 1 to 10. 如請求項18所述之硬化性組成物,其中,XC為C1-6伸烷基、 The curable composition as claimed in claim 18, wherein X C is a C 1-6 alkylene group, -(CH2)a1-O-(CH2)z2-(式中,z1為0至6之整數,z2為0至6之整數)、或 -(CH 2 ) a1 -O-(CH 2 ) z2 - (wherein z1 is an integer from 0 to 6, and z2 is an integer from 0 to 6), or -(CH2)z3-伸苯基-(CH2)z4-(式中,z3為0至6之整數,z4為0至6之整數)。 -(CH 2 ) z3 -phenylene-(CH 2 ) z4 - (wherein z3 is an integer from 0 to 6, and z4 is an integer from 0 to 6). 如請求項18或19所述之硬化性組成物,其中,n’為3。 A hardening composition as described in claim 18 or 19, wherein n' is 3. 如請求項18至20中任一項所述之硬化性組成物,其中,XBa為3價之基,n為1,m為1。 The hardenable composition as described in any one of claims 18 to 20, wherein X Ba is a trivalent group, n is 1, and m is 1. 如請求項18至21中任一項所述之硬化性組成物,其中,XBa為N、或-C(-O-)-,n為1,m為1。 The hardenable composition as described in any one of claims 18 to 21, wherein X Ba is N or -C(-O-)-, n is 1, and m is 1. 如請求項7至20中任一項所述之硬化性組成物,其中,式(A3)為 A hardening composition as described in any one of claims 7 to 20, wherein formula (A3) is Rb 2N-Rd-CO-(RF2-CO-NRc-Ra(RAc)m3-NRc-CO)x-RF2-CO-Rd-NRb 2 (A3-b) R b 2 NR d -CO-(R F 2 -CO-NR c -R a (R Ac ) m3 -NR c -CO) x -R F 2 -CO-R d -NR b 2 (A3-b) 式中, In the formula, Rb分別獨立地為RSi、RAc、或RcR b is independently R Si , R Ac , or R c , 惟,Rb之至少1個為RSiHowever, at least one of R b is R Si , RSi分別獨立地為-XC-SiR1 n’R2 3-n’R Si are independently -X C -SiR 1 n' R 2 3-n' , XC為碳數1至10之二價的有機基, X C is a divalent organic group having 1 to 10 carbon atoms, R1分別獨立地為羥基或水解性基, R1 is independently a hydroxyl group or a hydrolyzable group, R2分別獨立地為氫原子或1價之有機基, R2 is independently a hydrogen atom or a monovalent organic group, n’為1至3之整數, n’ is an integer from 1 to 3, Rd分別獨立地為單鍵、或二價之有機基, R d are each independently a single bond or a divalent organic group, RF2、Ra、Rc、RAc、m3、及x與請求項4之記載同義。 RF2 , Ra , Rc , RAc , m3, and x have the same meanings as those described in claim 4. 如請求項23所述之硬化性組成物,其中,與式(A3)中之位於各末端的N原子鍵結的Rb之1個為RSi,其他為Rc或RAcThe curable composition as described in claim 23, wherein one of the R b bonded to the N atom at each terminal in formula (A3) is R Si , and the other is R c or R Ac . 如請求項23或24所述之硬化性組成物,其中,Rd分別獨立地為單鍵、或-(CH2)z17-NR10-(CH2)z18-(式中,R10為氫原子或C1-6烷基,z17為0至6之整數,z18為0至6之整數)。 The curable composition as described in claim 23 or 24, wherein R d is independently a single bond, or -(CH 2 ) z17 -NR 10 -(CH 2 ) z18 - (wherein R 10 is a hydrogen atom or a C 1-6 alkyl group, z17 is an integer from 0 to 6, and z18 is an integer from 0 to 6). 如請求項7至25中任一項所述之硬化性組成物,其中,Ra分別獨立地為下述式所示之基, The curable composition as described in any one of claims 7 to 25, wherein Ra is independently a group represented by the following formula: -R9-(Ra’-R9)k- -R 9 -(R a' -R 9 ) k - 式中: In the formula: R9分別獨立地為C1-6伸烷基, R 9 are each independently C 1-6 alkylene, Ra’分別獨立地為3價之基, R a' is independently a trivalent group, k為1至4之整數。 k is an integer from 1 to 4. 如請求項26所述之硬化性組成物,其中,Ra’分別獨立地為在N、-C(-O-)-、碳-碳原子間可包含胺鍵結、醯胺鍵結、胺甲酸乙酯鍵結、脲鍵結、醚鍵結、或酯鍵結之3價之基。 The curable composition as described in claim 26, wherein Ra ' is independently a trivalent group that may include an amine bond, an amide bond, a urethane bond, a urea bond, an ether bond, or an ester bond between N, -C(-O-)-, and a carbon-carbon atom. 如請求項26或27所述之硬化性組成物,其中,k為1或2。 A hardening composition as described in claim 26 or 27, wherein k is 1 or 2. 如請求項7至28中任一項所述之硬化性組成物,其中,Rc分別獨立地為氫原子或C1-6烷基。 The curable composition as described in any one of claims 7 to 28, wherein R c is independently a hydrogen atom or a C 1-6 alkyl group. 如請求項7至29中任一項所述之硬化性組成物,其中,x為1以上5以下之整數。 A hardening composition as described in any one of claims 7 to 29, wherein x is an integer greater than 1 and less than 5. 如請求項7至30中任一項所述之硬化性組成物,其中,前述含氟聚醚基之丙烯酸化合物包含式(A1)或(A2)所示之化合物。 The curable composition as described in any one of claims 7 to 30, wherein the aforementioned fluorinated polyether group-containing acrylic compound comprises a compound represented by formula (A1) or (A2). 如請求項7至30中任一項所述之硬化性組成物,其中,前述含氟聚醚基之丙烯酸化合物包含式(A3)所示之化合物。 A curable composition as described in any one of claims 7 to 30, wherein the aforementioned fluorinated polyether group-containing acrylic compound comprises a compound represented by formula (A3). 如請求項1至32中任一項所述之硬化性組成物,其中,前述含氟聚醚基之矽烷化合物為下述式(B1)或(B2)所示之含氟聚醚基之矽烷化合物, A curable composition as described in any one of claims 1 to 32, wherein the aforementioned fluorinated polyether group-containing silane compound is a fluorinated polyether group-containing silane compound represented by the following formula (B1) or (B2), RF3 α-XZ-RSi β (B1) RF3α - XZ - RSiβ ( B1 ) RSi γ-XZ-RF4-XZ-RSi γ (B2) R Si γ -X Z -R F4 -X Z -R Si γ (B2) 式中: In the formula: RF3分別獨立地為Rf3-RFB-Oq3-; R F3 is independently Rf 3 -R FB -O q3 -; RF4為-Rf4 p3-RFB-Oq3-; RF4 is -Rf4p3 - RFB - Oq3- ; Rf3分別獨立地為可被1個或超過1個之氟原子取代的C1-16烷基; Rf 3 are each independently a C 1-16 alkyl group which may be substituted with 1 or more 1 fluorine atoms; Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基; Rf4 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms; RFB分別獨立地為2價之氟聚醚基; R and FB are each independently a divalent fluoropolyether group; p3為0或1; p3 is 0 or 1; q3分別獨立地為0或1; q 3 are independently 0 or 1; RSi分別獨立地為包含與羥基、水解性基、氫原子或1價之有機基鍵結的Si原子之1價之基; R Si are each independently a monovalent group comprising a Si atom bonded to a hydroxyl group, a hydrolyzable group, a hydrogen atom or a monovalent organic group; 至少1個之RSi為包含與羥基或水解性基鍵結的Si原子之1價之基; At least one R Si is a monovalent group including a Si atom bonded to a hydroxyl group or a hydrolyzable group; XZ分別獨立地為單鍵或2至10價之有機基; X and Z are each independently a single bond or a 2- to 10-valent organic group; α為1至9之整數; α is an integer from 1 to 9; β為1至9之整數; β is an integer from 1 to 9; γ分別獨立地為1至9之整數。 γ is an integer from 1 to 9 independently. 如請求項33所述之硬化性組成物,其中,RSi為下述式(S1)、(S2)、(S3)、(S4)或(S5)所示之基, The curable composition as claimed in claim 33, wherein R Si is a group represented by the following formula (S1), (S2), (S3), (S4) or (S5),
Figure 112112312-A0202-13-0012-44
Figure 112112312-A0202-13-0012-44
- SiR25 n1R26 3-n1 (S2) -SiR 25 n1 R 26 3-n1 (S2) - SiRa1 k1Rb1 l1Rc1 m1 (S3) -SiR a1 k1 R b1 l1 R c1 m1 (S3) - CRd1 k2Re1 l2Rf1 m2 (S4) - CR d1 k2 R e1 l2 R f1 m2 (S4) - NRg1Rh1 (S5) -NR g1 R h1 (S5) 式中: In the formula: R25分別獨立地為羥基或水解性基; R25 are each independently a hydroxyl group or a hydrolyzable group; R26分別獨立地為氫原子或1價之有機基; R26 are each independently a hydrogen atom or a monovalent organic group; n1在每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數; n1 is an integer from 0 to 3 independently in each (SiR 25 n1 R 26 3-n1 ) unit; X11分別獨立地為單鍵或2價之有機基; X11 is independently a single bond or a divalent organic group; R27分別獨立地為氫原子或1價之有機基; R27 are each independently a hydrogen atom or a monovalent organic group; t分別獨立地為2以上之整數; t are each independently an integer greater than 2; R28分別獨立地為氫原子、鹵素原子或-X11-SiR25 n1R26 3-n1R 28 are each independently a hydrogen atom, a halogen atom or -X 11 -SiR 25 n1 R 26 3-n1 ; R29分別獨立地為單鍵、氧原子、碳數1至6之伸烷基或碳數1至6之伸烷氧基; R29 is independently a single bond, an oxygen atom, an alkylene group having 1 to 6 carbon atoms, or an alkoxyene group having 1 to 6 carbon atoms; Ra1分別獨立地為-Z1-SiR21 p1R22 q1R23 r1R a1 is independently -Z 1 -SiR 21 p1 R 22 q1 R 23 r1 ; Z1分別獨立地為氧原子或2價之有機基; Z 1 each independently represents an oxygen atom or a divalent organic group; R21分別獨立地為-Z1’-SiR21’ p1’R22’ q1’R23’ r1’R 21 is independently -Z 1' -SiR 21' p1' R 22' q1' R 23' r1' ; R22分別獨立地為羥基或水解性基; R22 are each independently a hydroxyl group or a hydrolyzable group; R23分別獨立地為氫原子或1價之有機基; R23 are each independently a hydrogen atom or a monovalent organic group; p1分別獨立地為0至3之整數; p1 is an integer from 0 to 3 independently; q1分別獨立地為0至3之整數; q1 is an integer from 0 to 3 independently; r1分別獨立地為0至3之整數; r1 is an integer from 0 to 3 independently; Z1’分別獨立地為氧原子或2價之有機基; Z 1' is independently an oxygen atom or a divalent organic group; R21’分別獨立地為-Z1”-SiR22” q1”R23” r1”R 21′ is independently -Z 1″ -SiR 22″ q1″ R 23″ r1″ ; R22’分別獨立地為羥基或水解性基; R 22' is independently a hydroxyl group or a hydrolyzable group; R23’分別獨立地為氫原子或1價之有機基; R 23' is independently a hydrogen atom or a monovalent organic group; p1’分別獨立地為0至3之整數; p1’ is an integer from 0 to 3 independently; q1’分別獨立地為0至3之整數; q1’ is an integer from 0 to 3 independently; r1’分別獨立地為0至3之整數; r1’ is an integer from 0 to 3 independently; Z1”分別獨立地為氧原子或2價之有機基; Z 1" are each independently an oxygen atom or a divalent organic group; R22”分別獨立地為羥基或水解性基; R 22" are each independently a hydroxyl group or a hydrolyzable group; R23”分別獨立地為氫原子或1價之有機基; R 23" are each independently a hydrogen atom or a monovalent organic group; q1”分別獨立地為0至3之整數; q1" are independently integers from 0 to 3; r1”分別獨立地為0至3之整數; r1" are independently integers from 0 to 3; Rb1分別獨立地為羥基或水解性基; R b1 are each independently a hydroxyl group or a hydrolyzable group; Rc1分別獨立地為氫原子或1價之有機基; R c1 each independently represents a hydrogen atom or a monovalent organic group; k1分別獨立地為0至3之整數; k1 is an integer from 0 to 3 independently; l1分別獨立地為0至3之整數; l1 are independently integers from 0 to 3; m1分別獨立地為0至3之整數; m1 is an integer from 0 to 3 independently; Rd1分別獨立地為-Z2-CR31 p2R32 q2R33 r2R d1 is independently -Z 2 -CR 31 p2 R 32 q2 R 33 r2 ; Z2分別獨立地為單鍵、氧原子或2價之有機基; Z2 are each independently a single bond, an oxygen atom or a divalent organic group; R31分別獨立地為-Z2’-CR32’ q2’R33’ r2’R 31 is independently -Z 2' -CR 32' q2' R 33' r2' ; R32分別獨立地為-Z3-SiR34 n2R35 3-n2R 32 is independently -Z 3 -SiR 34 n2 R 35 3-n2 ; R33分別獨立地為氫原子、羥基或1價之有機基; R 33 each independently represents a hydrogen atom, a hydroxyl group or a monovalent organic group; p2分別獨立地為0至3之整數; p2 is an integer from 0 to 3 independently; q2分別獨立地為0至3之整數; q2 is an integer from 0 to 3 independently; r2分別獨立地為0至3之整數; r2 is an integer from 0 to 3 independently; Z2’分別獨立地為單鍵、氧原子或2價之有機基; Z 2' is independently a single bond, an oxygen atom or a divalent organic group; R32’分別獨立地為-Z3-SiR34 n2R35 3-n2R 32′ is independently -Z 3 -SiR 34 n2 R 35 3-n2 ; R33’分別獨立地為氫原子、羥基或1價之有機基; R 33' is independently a hydrogen atom, a hydroxyl group or a monovalent organic group; q2’分別獨立地為0至3之整數; q2’ is an integer from 0 to 3 independently; r2’分別獨立地為0至3之整數; r2’ is an integer from 0 to 3 independently; Z3分別獨立地為單鍵、氧原子或2價之有機基; Z 3 are each independently a single bond, an oxygen atom or a divalent organic group; R34分別獨立地為羥基或水解性基; R 34 are each independently a hydroxyl group or a hydrolyzable group; R35分別獨立地為氫原子或1價之有機基; R 35 is independently a hydrogen atom or a monovalent organic group; n2分別獨立地為0至3之整數; n2 is an integer from 0 to 3 independently; Re1分別獨立地為-Z3-SiR34 n2R35 3-n2R e1 is independently -Z 3 -SiR 34 n2 R 35 3-n2 ; Rf1分別獨立地為氫原子、羥基或1價之有機基; R f1 are each independently a hydrogen atom, a hydroxyl group or a monovalent organic group; k2分別獨立地為0至3之整數; k2 is an integer from 0 to 3 independently; l2分別獨立地為0至3之整數; l2 are independently integers from 0 to 3; m2分別獨立地為0至3之整數; m2 is an integer from 0 to 3 independently; Rg1及Rh1分別獨立地為-Z4-SiR25 n1R26 3-n1、-Z4-SiRa1 k1Rb1 l1Rc1 m1、-Z4-CRd1 k2Re1 l2Rf1 m2R g1 and R h1 are independently -Z 4 -SiR 25 n1 R 26 3-n1 , -Z 4 -SiR a1 k1 R b1 l1 R c1 m1 , -Z 4 -CR d1 k2 R e1 l2 R f1 m2 ; Z4分別獨立地為單鍵、氧原子或2價之有機基; Z 4 are each independently a single bond, an oxygen atom or a divalent organic group; 惟,式(S1)、(S2)、(S3)、(S4)及(S5)中,存在至少1個與羥基或水解性基鍵結的Si原子。 However, in formulas (S1), (S2), (S3), (S4) and (S5), there is at least one Si atom bonded to a hydroxyl group or a hydrolyzable group.
如請求項1至32中任一項所述之硬化性組成物,其中,前述含氟聚醚基之矽烷化合物為下述式(B3)所示之含氟聚醚基之矽烷化合物, A curable composition as described in any one of claims 1 to 32, wherein the aforementioned fluorinated polyether group-containing silane compound is a fluorinated polyether group-containing silane compound represented by the following formula (B3), R39 j-R38-NR37CO-(RF4-CONR37-R36-NR37CO)r-RF4-CONR37-R38-R39 j (B3) R39j -R38 - NR37CO- ( RF4 - CONR37 - R36 - NR37CO ) r - RF4 - CONR37 - R38 - R39j (B3 ) 式中: In the formula: RF4為-Rf4 p3-RFB-Oq3-; RF4 is -Rf4p3 - RFB - Oq3- ; Rf4為可被1個或超過1個之氟原子取代的C1-6伸烷基; Rf4 is a C1-6 alkylene group which may be substituted by 1 or more fluorine atoms; RFB分別獨立地為2價之氟聚醚基; R and FB are each independently a divalent fluoropolyether group; p3為0或1; p3 is 0 or 1; q3為0或1; q3 is 0 or 1; R36分別獨立地為2價之有機基, R 36 is independently a divalent organic group, R37分別獨立地為氫原子或碳數1至8之一價之有機基, R 37 is independently a hydrogen atom or a monovalent organic group having 1 to 8 carbon atoms, R38分別獨立地為(j+1)價之有機基, R 38 is independently a (j+1)-valent organic group, R39分別獨立地為-SiR25 n1R26 3-n1R 39 is independently -SiR 25 n1 R 26 3-n1 , R25分別獨立地為羥基或水解性基; R25 are each independently a hydroxyl group or a hydrolyzable group; R26分別獨立地為氫原子或1價之有機基; R26 are each independently a hydrogen atom or a monovalent organic group; n1在每個(SiR25 n1R26 3-n1)單元分別獨立地為0至3之整數; n1 is an integer from 0 to 3 independently in each (SiR 25 n1 R 26 3-n1 ) unit; j分別獨立地為1至9之整數, j is an integer from 1 to 9 independently, r為1以上之整數。 r is an integer greater than 1. 如請求項33至35中任一項所述之硬化性組成物,其中,RFB分別獨立地為下述式所示之基, The curable composition as described in any one of claims 33 to 35, wherein R FB are independently a group represented by the following formula: -(OC6F12)a-(OC5F10)b-(OC4F8)c-(OC3RFa 6)d-(OC2F4)e-(OCF2)f- -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - 式中,RFa分別獨立地為氫原子、氟原子或氯原子, Wherein, R Fa is independently a hydrogen atom, a fluorine atom or a chlorine atom, a、b、c、d、e及f分別獨立地為0至200之整數,a、b、c、d、e及f之和為1以上,標註a、b、c、d、e或f並以括弧括起之各重複單元在式中的存在順序為任意,惟,在所有之RFa為氫原子或氯原子之情況下,a、b、c、e及f之至少1個為1以上。 a, b, c, d, e and f are each independently an integer from 0 to 200, the sum of a, b, c, d, e and f is 1 or more, and the order of presence of the repeating units marked with a, b, c, d, e or f and enclosed in parentheses in the formula is arbitrary, provided that, when all R Fa are hydrogen atoms or chlorine atoms, at least one of a, b, c, e and f is 1 or more. 如請求項1至36中任一項所述之硬化性組成物,其中,前述交聯劑為式(C1)所示之化合物, A curable composition as described in any one of claims 1 to 36, wherein the crosslinking agent is a compound represented by formula (C1), (Rg1-O)δ-Si-Rg2 4-δ (C1) (R g1 -O) δ -Si-R g2 4-δ (C1) 式中; In the formula; Rg1於每次出現時分別獨立地為氫原子或1價之有機基; Rg1, at each occurrence, is independently a hydrogen atom or a monovalent organic group; Rg2分別獨立地為1價之有機基; R g2 are each independently a monovalent organic group; δ為2至4之整數。 δ is an integer between 2 and 4. 如請求項1至37中任一項所述之硬化性組成物,其中,前述交聯劑為四乙氧基矽烷、四甲氧基矽烷、甲基三乙氧基矽烷、甲基三甲氧基矽烷、二甲基二甲氧基矽烷、二甲基三甲氧基矽烷、胺基丙基三乙氧基矽烷、胺基丙基三甲氧基矽烷、十三氟正辛基三乙氧基矽烷、或十三氟正辛基三甲氧基矽烷。 The curable composition as described in any one of claims 1 to 37, wherein the crosslinking agent is tetraethoxysilane, tetramethoxysilane, methyltriethoxysilane, methyltrimethoxysilane, dimethyldimethoxysilane, dimethyltrimethoxysilane, aminopropyltriethoxysilane, aminopropyltrimethoxysilane, tridecafluorooctyltriethoxysilane, or tridecafluorooctyltrimethoxysilane. 如請求項1至38中任一項所述之硬化性組成物,其中,前述觸媒為酸、鹼、過渡金屬、或者選自錫系觸媒、鈦系觸媒、氧化鋯系觸媒、鉍系觸媒、及有機胺系觸媒的金屬錯合物。 A hardening composition as described in any one of claims 1 to 38, wherein the catalyst is an acid, an alkali, a transition metal, or a metal complex selected from tin-based catalysts, titanium-based catalysts, zirconium oxide-based catalysts, bismuth-based catalysts, and organic amine-based catalysts. 如請求項1至39中任一項所述之硬化性組成物,其中,前述觸媒為乙酸、三氟乙酸、氨、三乙胺、二乙胺、Ti、Ni、Sn、二月桂酸二正丁基錫(IV)、二異丙氧基雙(乙醯乙酸乙酯)鈦、四正丁氧基鈦、四-2-乙基己氧基鈦、四乙醯丙酮鈦、四乙醯丙酮鋯、四正丁氧基鋯、二丁氧基雙(乙醯乙酸乙酯)鋯、或參(2-己酸乙酯)鉍。 A curable composition as described in any one of claims 1 to 39, wherein the catalyst is acetic acid, trifluoroacetic acid, ammonia, triethylamine, diethylamine, Ti, Ni, Sn, di-n-butyltin(IV) dilaurate, titanium diisopropoxybis(ethyl acetate), titanium tetra-n-butoxy, titanium tetra-2-ethylhexyloxy, titanium tetraacetylacetonate, zirconium tetraacetylacetonate, zirconium tetra-n-butoxy, zirconium dibutoxybis(ethyl acetate), or bismuth (2-ethyl hexanoate). 如請求項1至40中任一項所述之硬化性組成物,其中,前述自由基聚合起始劑為二酮類、醯偶姻類、醯偶姻醚類、噻噸酮類、二苯甲酮類、苯乙酮類、醌類、胺基苯甲酸類、鹵素化合物、醯基氧化膦類、或過氧化物。 A curable composition as described in any one of claims 1 to 40, wherein the free radical polymerization initiator is a diketone, an acyloin, an acyloin ether, a thioxanthine, a benzophenone, an acetophenone, a quinone, an aminobenzoic acid, a halogen compound, an acylphosphine oxide, or a peroxide. 如請求項1至41中任一項所述之硬化性組成物,其中,前述自由基聚合起始劑為安息香、安息香甲基醚、安息香乙基醚、安息香異丙基醚、噻噸酮、2,4-二乙基噻噸酮、噻噸酮-4-磺酸、二苯甲酮、4,4’-雙(二甲基胺基)二苯甲酮、4,4’-雙(二乙基胺基)二苯甲酮、苯乙酮、2-(4-甲苯磺醯氧基)-2-苯基苯乙酮、對二甲基胺基苯乙酮、2,2’-二甲氧基-2-苯基苯乙酮、對甲氧基苯乙酮、2-甲基[4-(甲基硫基)苯基]-2-
Figure 112112312-A0202-13-0018-65
啉基-1-丙酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-13-0018-66
啉基苯基)-丁-1-酮、蒽醌、1,4-萘醌、2-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸乙酯、4-二甲基胺基苯甲酸(正丁氧基)乙酯、4-二甲基胺基苯甲酸異戊酯、4-二甲基胺基苯甲酸2-乙基己酯、苯甲醯氯、三鹵甲基苯基碸、醯基氧化膦、或二-三級丁基過氧化物、苯甲醯甲酸甲酯、1-羥基-環己基-苯基-酮、1-[4-(2-羥基乙氧基)-苯基]-2-羥基-2-甲基-1-丙-1-酮、2-羥基-1-{4-[4-(2-羥基-2-甲基-丙醯基)-苄基]苯基}-2-甲基-丙-1-酮、2-甲基-1-(4-甲基硫基苯基)-2-
Figure 112112312-A0202-13-0018-68
啉基丙-1-酮、2-苄基-2-二甲基胺基-1-(4-
Figure 112112312-A0202-13-0018-69
啉基苯基)-1-丁酮、2-(二甲基胺基)-2-[(4-甲基苯基)甲基]-1-[4-(4-
Figure 112112312-A0202-13-0018-70
啉基)苯基]-1-丁酮、雙(2,4,6-三甲基苯甲醯基)-苯基氧化膦、雙(η5-2,4-環戊二烯-1-基)-雙(2,6-二氟-3-(1H-吡咯-1-基)-苯基)鈦、1,2-辛二酮,1-[4-(苯基硫基)-,2-(O-苯甲醯基肟)]、乙酮,1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]-,1-(0-乙醯肟)、2-羥基-2-甲基-1-苯基-丙-1-酮、2,4,6-三甲基苯甲醯基-二苯基-氧化膦、三級丁基氫過氧化物、氫過氧化異丙苯、二異丙苯氫過氧化物、對薄荷烷氫過氧化物、或三級甲基丁基氫過氧化物。
The curable composition as described in any one of claims 1 to 41, wherein the radical polymerization initiator is benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, thiothionone, 2,4-diethylthiothionone, thiothionone-4-sulfonic acid, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, p-methoxyacetophenone, 2-methyl[4-(methylthio)phenyl]-2-
Figure 112112312-A0202-13-0018-65
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-13-0018-66
1-Butanone, anthraquinone, 1,4-naphthoquinone, ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate (n-butoxy) ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, benzoyl chloride, trihalomethylphenyl sulfone, acylphosphine oxide, or di-tert-butyl peroxide benzoic acid methyl ester, 1-hydroxy-cyclohexyl-phenyl-ketone, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, 2-methyl-1-(4-methylthiophenyl)-2-
Figure 112112312-A0202-13-0018-68
1-Phenylpropanone, 2-benzyl-2-dimethylamino-1-(4-
Figure 112112312-A0202-13-0018-69
1-Butanone, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-
Figure 112112312-A0202-13-0018-70
1-Butanone, bis(2,4,6-trimethylbenzyl)phenylphosphine oxide, bis( η 5-2,4-cyclopentadien-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium, 1,2-octanedione, 1-[4-(phenylthio)-,2-(O-benzoyl oxime)], ethyl ketone, 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-,1-(0-acetyl oxime), 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2,4,6-trimethylbenzyl-diphenyl-phosphine oxide, tertiary butyl hydroperoxide, isopropylbenzene hydroperoxide, diisopropylbenzene hydroperoxide, p-menthane hydroperoxide, or tertiary methylbutyl hydroperoxide.
如請求項1至42中任一項所述之硬化性組成物,其更含有溶劑。 The hardening composition as described in any one of claims 1 to 42 further contains a solvent. 一種硬化物,係由請求項1至43中任一項所述之硬化性組成物獲得者。 A hardened product obtained from the hardening composition described in any one of claims 1 to 43. 一種物品,係包含基材、以及由請求項1至43中任一項所述之硬化性組成物形成在該基材之表面的層。 An article comprising a substrate and a layer formed on the surface of the substrate by a curable composition as described in any one of claims 1 to 43.
TW112112312A 2022-03-31 2023-03-30 Curable composition TW202411300A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022-060061 2022-03-31

Publications (1)

Publication Number Publication Date
TW202411300A true TW202411300A (en) 2024-03-16

Family

ID=

Similar Documents

Publication Publication Date Title
CN105602226B (en) Water/oil repellent treatment agent having heat resistance, method for producing the same, and treated article
EP3569673B1 (en) Surface treatment agent containing perfluoro(poly)ether group-containing compound
EP2725078A1 (en) Coating composition, surface treating material containing said composition, and article whose surface is treated with said surface treating material
KR20200055784A (en) Curable composition
JP7007599B2 (en) Curable composition
KR20200055785A (en) Curable composition
WO2018216404A1 (en) Fluorine-containing coating agent composition, surface treatment agent containing said composition, and article
CN111278918A (en) Curable composition
KR102355679B1 (en) curable composition
TW202411300A (en) Curable composition
JP6962491B1 (en) Curable composition
TW202405052A (en) Curable composition
TW202405053A (en) Curable composition
WO2023190725A1 (en) Curable composition
WO2023190723A1 (en) Curable composition
TWI837488B (en) Curable composition
EP3705532A1 (en) Curable composition
WO2023210653A1 (en) Surface treatment agent
EP4047035A1 (en) Surface treatment agent
TW202402880A (en) Fluoropolyether group-containing oxyalkyleneamide compound
TW202328278A (en) Surface treatment agent
CN116640498A (en) Surface treating agent
JP2023163157A (en) surface treatment agent